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Abstract
The initial aim of this study was to investigate the potential of oxygen 
releasing compounds as an antimicrobial treatment to reduce the transmission of C. 
jejuni. C. jejuni was highly sensitive to MgO], CaO] and 2Na2C03 .3H202 when 
exposed to these compounds in Maximum Recovery Diluent (MRD), Ultra Heat 
Treated (UHT) skimmed milk and soil microcosms. In MRD, initial counts of 1 x 10^  
colony forming units per ml fell to undetectable levels in 32, 8 and 4 hours in the 
presence of 0.26, 2.6 and 5.2 mM Mg02 respectively. The same reduction in viability 
of C. jejuni was seen within 10 minutes and 30 minutes in the presence of 5.2 mM,
2.6 mM and Ca02 respectively. When C: jejuni cqWs were exposed to 2.6 mM and 5.2 
mM 2Na2C0 s.3H202, viable counts fell by 7-logs in 15 minutes. The survival of C. 
jejuni when exposed to H2O2 was similar to that seen with Mg02 but when catalase 
was added, Mg02 had little impact on C. jejuni killing, suggesting that H2O2 
formation via this metal peroxide is important in the killing process. Electron 
microscope observations revealed an irregular cell morphology and loss of cell wall 
integrity as well as loss of polar flagella.
CorA (Cj0726C), the main magnesium transporter of C. jejuni, was 
inactivated by allelic exchange to determine whether magnesium transport was 
necessary for the oxidative killing seen with magnesium peroxide. The corA mutant 
did not grow without Mg^ "^  supplementation (20 mM), indicating that Mg^^ 
acquisition by corA is essential for C. jejuni growth in vitro that might be important in 
adaptation to low-Mg^^ conditions. However, CorA was not essential in magnesium 
peroxide killing. Whilst a corA mutant showed a reduced ability to kill the larvae of 
Galleria mellonella, CorA did not appear to be required for chicken colonisation by 
oral gavage or for intracellular survival within Caeo-2 cells.
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CHAPTER ONE
INTRODUCTION
Chapter 1: Introduction
1.1 History
The history of Campylobacter started over a century ago, when a German 
bacteriologist, Theodor Escherich, in 1886 observed a spiral organism, which could 
have been Campylobacter, in stool samples of children with diarrhoea (Butzler, 2004; 
Vandamme et a l, 2010). In 1913, McFaydean & Stockman described a 'vibrio', 
which is now known as Campylobacter fetus from foetal tissue from an aborted sheep, 
and Smith in 1918 reported a similar finding in aborted cattle. Later in 1919, these 
organisms were named Vibrio fetus by Smith and Taylor. In 1931, vibrios associated 
with enteritis in cattle were named Vibrio jejuni by Jones et al., 1931, and similar 
organisms associated with diarrhoea in pigs were named Vibrio coli by Doyle in 1944. 
This historical naming and identification of Campylobacters has been extensively 
described in several reviews (Butzler, 2004; Engberg, 2006; Skirrow, 2006; 
Vandamme et al., 2010). However, during those times, little attention was given to 
Campylobacters in the context of human infection and they were only considered 
important primarily in veterinary practice, despite two reports by Levy in 1946, who 
associated V. jejuni with a large milk-borne outbreak of acute diarrhoea affecting 
prison inmates, and by Vinzent et al., in 1947 who associated V. fetus with abortion in 
women (Engberg, 2006).
In the 1950s, Elizabeth King was working on human Campylobacter isolates 
and distinguished two groups of microaerophilic vibrios, one corresponding to the 
original V. fetus description by Smith and Taylor (1919), and the other was referred to
as “related vibrios” (King, 1957). The latter were taken from the bloodstream of 
patients with a preceding diarrhoeal illness. She noted that the vibrio-related strains 
were able to grow at 42°C as opposed to the Vibrio fetus group. King then studied 
several of the Vibrio isolates and systematically discriminated between V. fetus and 
the thermophilic V. jejuni and V. coli (King, 1962). Not long after that, Sebald and 
Véron proposed the name “Campylobacter” in 1963 to describe microaerophilic 
vibrios that differ from the classical cholera species on the basis of the composition of 
its nucleotide sequence as well as the difference in fermentation, oxidation processes 
and its microaerophilic nature (Sebald & Véron, 1963). The word “Campylobacter” 
comes from a Greek word for curved rod, because of the spiral or S-shaped 
morphology of the bacterial cells (Sebald & Véron, 1963).
Not only because of its fastidious growth, but also due to the presence of 
abundant coliforms in the faeces, it took almost 9 years following the work by Sebald 
and Véron before the isolation of Campylobacter from the human faecal samples 
happened for the first time. In 1972, Butzler’s group in Belgium used a veterinary 
filtration method using filters with a pore size that was big enough for motile 
Campylobacters to pass through the 0.65 pM filter and small enough to trap other 
organisms (Butzler et a l, 1973). The membrane filters were then inoculated onto agar 
media. It was only after the development of this isolation procedure that the isolation 
of Campylobacter from human infections became possible (Dekeyser et a l, 1972; 
Slee, 1972; Butzler e?«/., 1973).
In 1977, Martin Skirrow from the Worchester Public Health Laboratory 
developed a blood based selective medium, and using this he isolated Campylobacters
from the faeces, of 7% of patients with diarrhoea. With this development of an 
effective selective medium and a direct culturing technique for faecal samples, the 
examination and culturing of large numbers of Campylobacter samples became 
possible (Skirrow, 1977). Skirrow’s medium was based upon blood agar and 
contained a series of antibiotics, namely vancomycin, polymyxin and trimethoprim 
(Skirrow, 1977). The inoculated plates were then incubated in microaerophilic 
conditions containing 5% (v/v) O2, 10% (v/v) CO2 and 85% (v/v) N2 at 43°C. This 
improved isolation procedure led to Campylobacter being quickly established as an 
important causative agent of human gastroenteritis worldwide.
1.2 Character and Morphology
Campylobacter is a Gram negative non-spore forming, rod shaped bacterium 
(0.5 to 5 pm long and 0.2 to 0.5 pm wide), spirally curved, and slender with 
corkscrew-like darting motility (Fig 1.1) (Snelling et a l, 2005). However, some 
species have been reported to be non-motile {C.gracilis) (Tanner et a l, 1981) and 
some have been shown to have multiple flagella (C. showae) (Etoh et a l, 1993).
Campylobacter often shows morphological changes with time. When exposed 
to stress, Campylobacter can change to the coccoid form (Tangwatcharin et a l, 2006). 
Environmental stress such as lack of nutrients, low temperatures, high pressure, sharp 
changes in pH or osmolarity, and other environmental factors can initiate a complex 
series, or a cascade, that will lead to the aforementioned (coccoid form) changes in 
cellular morphology of Campylobacter (Ng et a l, 1985; Alonso et a l, 2002; 
Tangwatcharin et a l, 2006). Typical short spiral morphology is usually seen in the
m s m s
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Figure 1.1: Scanning electron microscopy diagram showing the corckscrew-like 
appearance of Campylobacter jejuni and bipolar flagella at both ends (Altekruse et al., 
1999).
exponential phase of its growth, but the length of cells becomes two times longer 
when it reaches the mid-stationary phase (Griffiths, 1993). Campylobacters have also 
been reported to undergo elongation before becoming coccoid during the stationary 
growth phase and eventually form membrane blebs in the death phase (Thomas et a l, 
2002).
Not only can they show morphological changes when exposed to 
environmental stresses, but Campylobacter have also been reported to enter a viable 
but nonculturable state (VBNC) (Cools et a l, 2005). Bacteria are said to be in a 
VBNC state when they are unable to grow in a standard culture medium. This usually 
occurs when the bacteria are exposed to an unfavourable environment, such as 
nutrient limitation, temperature outside the normal growth range, elevated osmotic 
concentrations and oxygen concentrations (Gauthier, 2000). However, a number of 
cellular functions such as respiration (Oliver & Bockian, 1995), transcription (Lleo et 
al, 2000) and protein synthesis (Rahman et a l, 1994) are still maintained within the 
bacterial cells.
The term VBNC was first proposed by Xu et a l (1982) in a study that 
described the dormant state of Vibrio cholerae and Escherichia coli (Xu et a l, 1982). 
Since then, many reports have been published describing this phenomenon (Gauthier, 
2000; Keer & Birch, 2003; Oliver, 2005; Oliver et a l, 2005). Even though bacteria in 
this state are unable to grow and form a colony on conventional bacteriological media, 
they are said to be alive and are able to renew the metabolic activity when returned to 
a favourable environment (Oliver, 2005). Some studies have demonstrated that cells 
that enter the VBNC state could resuscitate and thus, are able to cause infection which
could lead to a potential public health hazard, especially for the food-borne pathogens 
(Lleo et a l, 2001; Gupte et al, 2003; Senoh et a l, 2010; Pinto et a l, 2011).
Campylobacter require growth conditions that differ from other food-borne 
bacterial pathogens. They are microaerophilic in nature, and require 5% oxygen, 10% 
carbon dioxide and 85% nitrogen for growth (Garenaux e/ al, 2008) and are unable to 
grow in the presence of air. In addition, Campylobacter also have a restricted
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temperature growth range. The optimum growth temperature is 42 C and they do not 
grow at temperatures below 30 C (Doyle & Roman, 1981), which is believed to be 
due to the absence of cold shock proteins, based on the content of the genome. In 
other bacteria that are able to grow at low temperatures, cold shock proteins are 
important for adaptation to low-temperature conditions (Levin, 2007). The pH growth 
range for Campylobacter is between pH 6.5-7.5 and the organism will not survive 
below a pH of 4.9 and above pH 9.0 (Hazeleger et a l, 1995).
The selective media used for the isolation of Campylobacters, generally 
contain blood or charcoal, both of which act as oxygen scavenging agents and aid the 
growth of Campylobacter which is microaerophilic, and as a consequence, has 
increased sensitivity to oxygen and oxidizing radicals. Campylobacter can be isolated 
on selective media that contain antibiotics that will suppress the growth of other 
normal flora, including Skirrow’s selective medium containing cefoperazone, 
vancomycin and amphotericin B (CVA) and modified chareoal cefoperazone 
deoxycholate agar (mCCDA) (Corry et a l, 1995).
Following isolation on selective media, Campylobacter can be identified using 
the direct microscopic examination either with Gram staining or phase-contrast 
optical systems. The primary diagnostic criteria used to detect Campylobacter are 
colony morphology, corkscrew-like motility and oxidase test. Most clinical 
laboratories use the hippurate test to differentiate C. jejuni from other Campylobacter 
species. This test detects glycine, an end-product of hippurate hydrolysis, which is 
hydrolysed by most C. jejuni strains, as opposed to other Campylobacter species that 
lack this trait and this serves as a useful differentiation charaeteristic (Totten et a l, 
1987).
The last decade has seen the development of many rapid methods which aim 
to make the detection of C. jejuni and C. coli faster than traditional culture techniques. 
Many of these methods use molecular techniques such as the Multiplex-PCR 
technique (Persson & Olsen, 2005), commercial diagnostic PGR (Englen & Fedorka- 
Cray, 2002), real-time PGR using hipO and glyA gene targets (LaGier et a l, 2004) 
and PGR/Elisa (Al Rashid et a l, 2000). Although the PGR methods are faster, species 
specific, and the result can be achieved on the same day, the methods are expensive, 
and labour-intensive (Butzler, 2004).
1.3 Taxonomy
The taxonomy of Campylobacter has changed quite dramatically since the 
name was first proposed by Sebald and Véron in 1963. Not only are there additions of 
new species of Campylobacter in the taxonomy, but some of the taxa which had been 
described as Campylobacter species have also been reclassified into other genera with
the help of technical advances in microbiological methods, and DNA sequencing. 
From just two taxa (C. fetus and C. bulbulus) at the beginning, to four distinct species 
namely C. fetus, C. coli, C. jejuni and C. sputorum in 1973 (Véron & Châtelain, 
1973), the taxonomy now according to On, contains 16 formally named species, six 
recognised subspecies and several biovars (On, 2001). However, Debruyne et al., in 
2005 reported 14 validly named Campylobacter species and more recently, Fernandez 
et al., described 20 species in the genus Campylobacter (Debruyne et a l, 2005; 
Fernandez et a l, 2008).
Strains belonging to C. sputorum are divided into three biovars, sputorum, 
faecalis and paraureolyticus, on the basis of their ability to produce catalase or urease 
(Vandamme & On, 2001). The overview by On in 2001 also reported that 
Campylobacter jejuni subsp. jejuni, C. jejuni subsp. doyley, Campylobacter coli, 
Campylobacter lari, Campylobacter upsaliensis and Campylobacter helveticus form a 
genetically close group of species that {Cjejuni subsp. doyley aside) contains the 
strains most commonly isolated from human and animal diarrhoea (On, 2001). Table 
1.1 presents the members of the family Campylobacteraceae and related organisms, 
and also outlines the disease association for each of the species. On the other hand. 
Table 1.2 shows the various biochemical and phenotypic tests that can be used to 
differentiate Campylobacter species.
Phenotypic methods for taxonomic classification and identification of 
Campylobacter species are often diffieult to practice and time-consuming because of 
its fastidious growth, low biochemical activity and the variability of results (Moore & 
Madden, 2003). However, several genotypic methods are available for the
Taxon Human Disease Association
A. C. jejuni svibs^. jejuni 
C. jejuni subsp. doyleyi 
C. coli 
C. lari
C. upsaliensis 
C. insulaenigrae 
C. helveticus
Enteritis, systemic illness, GBS 
Enteritis, systemic illness, GBS 
Enteritis 
Enteritis
Rare bacteraemia, enteritis 
Enteritis, septicaemia 
Not known
B. C. concisus 
C. curvus 
C. rectus 
C. showae 
C. gracilis 
C. hominis
Ç  sputorum by. sputorum 
C. sputorum bv. faecalis 
C. sputorum hv. paraureolyticus 
[Bacteroides] ureolyticus
Peridontal disease, rare enteritis 
Peridontal disease, enteritis 
Peridontal disease 
Peridontal disease 
Peridontal disease 
Not known 
Peridontal disease 
Peridontal disease 
Peridontal disease 
Bacteraemia
C. C. fetus subsp. fetus 
C. fetus subsp. venerealis 
C. hyointestinalis subsp. hyointestinalis 
C. hyointestinalis subsp. lawsonii 
C. mucosalis 
C. lanienae
Systemic illness, bacteraemia 
Systemic illness, bacteraemia 
Rare, enteritis 
Rare, enteritis 
Rare, enteritis 
Not known
D. A. cryaerophilus 
A. butzleri 
A. skirowii 
A. nitrofigilis 
A. cibarius 
Sulfurospirillum spp.
Bacteraemia 
Bacteraemia, enteritis 
Not known 
Not known 
Not known 
Not known
Table 1.1: The present members of the family Campylobacteraceae (Taken from 
Engberg, 2006).
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identification and taxonomie investigations within the Campylobacter genus (On, 
1996). Vandamme et al., in 1991 carried out a large DNA-rRNA hybridization study 
on the Campylobacter complex which provided the basis for the revision of its 
taxonomy (Vandamme et a l, 1991). In addition. Amplified Fragment Length 
Polymorphism (AFLP) profiles have also been used for the investigation of the 
genetic relationships within the genus (On & Harrington, 2000). Several other studies 
which use sequence-based phytogenies within the genus have been carried out using 
the 16S rRNA and 23S rRNA genes (Van Camp et a l, 1993; Harrington & On, 1999; 
Gorkiewicz et a l, 2003).
The taxonomy and identification of many groups of bacteria has been 
extensively modified with the use of analysis of the sequences of rRNA genes. 
Campylobacter is included in the rRNA superfamily VI, which consists of the family 
Campylobacteraceae. This group is separated from other members of the family 
Vibrionaceae by differences in nucleotide base composition (mol% G+C) and its 
inability to utilise sugars, either oxidatively or fermentatively. Due to the considerable 
length (-1500 bp) of the 16S rRNA, this gene has been utilized extensively for rapid 
detection and identification of Campylobacter species. In addition, the 16S rRNA 
gene is ubiquitous not only in the members of the Campylobacter genus, but also in 
almost all bacteria. It is also a usefiil molecular marker for the study of phylogenetic 
relationships due to the highly conserved nature of the gene in certain regions of the 
16S rRNA. However, the similarity of the 16S rRNA gene between members of the 
Campylobacter genus makes it difficult to differentiate between species and for 
example, it cannot be reliably used to differentiate between C. jejuni and C. coli 
(Harrington & On, 1999; On, 2001). However, the genetic relatedness of this genus
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can now be analysed by using modern, fast, and universal sequencing approaches. For 
example, an approach that uses rpoB, a gene that encodes the beta-subunit of RNA 
polymerase, has been used for the identification and the elaboration of genetic 
relationships in several groups of bacteria (Mollet et al., 1997; Kim et al., 1999; 
Korczak et al:, 2004) and in Campylobacter (Korczak et a l, 2006).
Another example is the Multilocus System Typing (MLST) method, that has 
been used extensively since its development by Maiden et al. 1998 for Neisseria 
meningitidis and which was applied for the first time to C. jejuni by Dingle et al. in 
2001 (Maiden et al., 1998; Dingle et al., 2001). It is a molecular biological approach 
for typing which uses the sequences of multiple loci of a gene or other DNA 
sequences to compare genetic relationships between bacteria. It can be used to 
characterize approximately 450 to 500 base pairs of the DNA sequence of multiple 
unique housekeeping genes using automated DNA sequencers. The difference 
between these sequences defines the sequence type of a particular bacterial species 
(Maiden et al., 1998). MLST has been shown to discriminate C. jejuni isolates 
effectively and can also be applied for the study of population structures and 
evolutionary relationships in Campylobacter (Dingle et al., 2001, Sheppard et al., 
2013). In addition to being expensive to run, the other limitation of MLST is that it 
sometimes fails to discriminate between bacterial strains particularly in 
epidemiological investigations. However, to overcome this problem, a method called 
a multi-virulence-locus sequence type (MVLST) which targets virulence genes 
instead of the housekeeping genes has been developed. This has been shown to be 
effective for Listeria monocytogenes (Zhang et al., 2004; Knabel et al., 2012) but has 
not yet been applied to Campylobacter.
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1.4 The Genome Projects
In recent years, the genomes of a number of different C. jejuni strains and 
Campylobacter species have been fully sequenced. The first genome to be sequenced 
was that of strain NCTC 11168 which is derived from a case of human enteritis 
(Parkhill et a l, 2000). This was followed by RM1221, an isolate from retail chicken 
meat (Fonts et a l, 2005); 81-176, a highly virulent human enteritis isolate (Hofreuter 
et a l, 2006); S3 strain, a poultry isolate (Cooper et a l, 2011) and 81116 (NCTC 
11828), a chicken isolate (Pearson et a l, 2007). Considerable genetic variation has 
been identified across different species of Campylobacter (Gilbert et a l, 2002; 
Pearson et a l, 2003; Poly et a l, 2004; 2005; Taboada et a l, 2004; Fonts et a l, 2005; 
Rivoal et a l, 2005; Parker et a l, 2006; 2007; Gundogdu et a l, 2007). A summary of 
some of the genomic data is presented in Table 1.3.
Antigenic and phase variation occurs frequently in C. jejuni because of slipped 
strand miss pairing due to the presence of hyper variable regions in its genome 
sequence (Pearson et a l, 2003). Particular genes will be switched on or off by these 
antigenic and/or phase variation mechanisms (Moxon et a l, 1994). This process is 
important for the adaptation and survival of C. jejuni in the environment where the 
conditions are not favourable for its growth, and in particular it helps the bacterium to 
avoid and survive the action of the host immune system (Parkhill et al , 2000; Pearson 
et a l, 2003; Wren et a l, 2001). The number of homopolymeric tracts present in 
Campylobacters differs not only between C  jejuni strains, but also across 
Campylobacter species (Pearson et a l, 2003). For example, the genomes of C. jejuni 
strains NCTC 11168 and RM 1221 contain 21 and 8 variable homopolymeric tracts
14
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respectively (Fouts et ah, 2005; Parkhill et al., 2000). In light of the fact that C. jejuni 
lacks some DNA repair functions that are present in other bacteria with larger 
chromosomes such as E. coli, these sequences can be vitally important for the 
bacterium during infection.
The variation described above has been shown to operate within genes for 
lipooligosaccharide (LOS) and capsular polysaccharide (CPS) biosynthesis, flagella 
genes, and genes involved in respiratory metabolism (Poly et a l, 2004; 2005; Parker 
et a l, 2006). The structure and molecules of the LOS and CPS are variable and this 
depends upon genomic phase variation (Aspinall et al., 1992a; Aspinal et al., 1992b; 
Gilbert et al., 2002; Fouts et al., 2005; Karlyshev et al., 2005a). In addition, the 
presence of a plasmid can also play a role in this variation, for example via the 
presence of pVir and pTet plasmids in the 81-176 strain that are absent from other 
strains of C. jejuni (Poly et a l, 2005; Parker et a l, 2006). Strain RM1221 contains 
four genomic islands known as C. jejuni integrated elements (CJIEl-4), which are 
absent in the genomes of other sequenced strains of C. jejuni (Parker et a l, 2006).
The CJIEl element is believed to have a role in encoding a Mu-like phage, 
whereas CJIE2 and CJIE4 are thought to encode phage related endonucleases, 
methylases or repressors. On the other hand, CJIE3 is thought to encode an integrated 
plasmid (Morgan et a l, 2002; Fouts et a l, 2005; Parker et a l, 2006). Whilst these 
elements are not found in other genome sequenced strains of C. jejuni, these CJIEs 
have been shown to be present in other C. jejuni and C. coli strains (Parker et a l, 
2006).
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Amongst all of the C. jejuni strains, the genomes of which have been 
completely sequenced, C. jejuni strain 81-176 is known to be more highly pathogenic 
than the rest of the strains. In this respect, it contains 37 genes that are absent in the 
genomes of the NCTC 11168 and RM1221 (Hofreuter et a l, 2006). These genes 
include those involved in respiration, energy metabolism and electron transport. In 
detail, the genes present only in 81-176 include those encoding a dimethyl sulfoxide 
(DMSO) reductase system, cytochrome C, and a system involved in the efflux of 
succinate (Janausch et a l, 2002; Hofreuter et a l, 2006). These may be responsible for 
the elevated pathogenicity and virulence of this strain (Hofreuter et a/., 2006). Other 
genes which may contribute to 81-176 virulence include genes thought to encode a 
potassium uptake system {kdpA, kdpB and kdpC) (Altendorf et al., 1992), a y- 
glutamyltranspeptidase (Barnes et al., 2007), restriction-modification systems (Miller 
et a l, 2005; Hofreuter et al., 2006) and a serine protease autotransporter (Hofreuter et 
al, 2006).
1.5 Prevalence and Transmission
Campylobacter has been reported as the leading cause of gastroenteritis illness 
in many parts of the world. It is also the leading form of acute bacterial diarrhoea in 
industrialized countries affecting particularly children and young adults (Louis et a l, 
2005; Ethelberg et a l, 2006). In the UK, 55,484 laboratory-confirmed cases were 
reported in 2008, but the true number of cases is estimated to be eight times higher 
than the reported cases because of under-reporting (Health Proteetion Agency, 2009). 
A year later, the European Food Safety Authority (EFSA) reported 
campylobacteriosis as the leading cause of zoonotic disease, with 190,566 reported
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cases in humans in the European Union (EFSA, 2010). In the USA, The Foodbome 
Disease Active Surveillance Network (Foodnet) of the Centres for Disease Control 
and Prevention (CDC) estimated that in 2009, the number of reported Campylobacter 
infections was 6,033 per 100,000 of the population (Anonymous, 2010). It is also 
estimated that Campylobacter causes two million cases of gastroenteritis, resulting in 
13,000 hospitalized patients and more than 100 deaths, in the USA each year 
(Anonymous, 2007).
On the other hand, in developing countries, Campylobacter infection is highest 
in children less than a year old and much less common in adults (Sahin et a l, 2002) 
which might be due to the fact that first exposure to the bacteria occurs at an early age 
because of the general lack of hygiene measures such as close human contact with 
animals, as well as inadequate water treatment (Tauxe, 2001; Gasana et a l, 2002). 
Such early exposure is thought to result in immunity to infection in adulthood (Calva 
et a l, 1988; Taylor et al., 1988). Based on studies in Thailand, Mexico and Peru, the 
ineidence rate for children under the age of 5 was estimated to be 40,000 to 60,000 
cases per 100,000 population (Calva et a l, 1988; Taylor et a l, 1988; Oberhelman & 
Taylor, 2000). In Southeast Asia, Campylobacter infection comprises 2.9% to 15% of 
bacterial enteritis in children less than 5 years (Padungton & Kaneene, 2003).
In temperate countries, the infection is reported to be strongly seasonal, with 
an increase in infection occurring during summer months. In particular, the rate of 
infection appears to correlate with increased outside temperature and sunlight, and 
consequently, it may be linked to the increased use of barbeques, more prevalent 
farming activity, or the presence of more flies (Tauxe, 2001; Louis et a l, 2005). Louis
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et al. in 2005 described that the seasonal rise for Campylobacter infection started at 
the beginning of May with the peak generally occurring between mid-June and mid- 
July in England and Wales (Louis et a l, 2005).
Two species of Campylobacter, C. jejuni and C. coli, are responsible for the 
majority of infections. C. jejuni is responsible for 80-85% of all campylobacteriosis 
whereas C. coli is responsible for 10-15% infections (Moore et a l, 2005). Other 
species such as C. lari, C. upsaliensis and C. fetus may be of importance but the lack 
of specific diagnostic capacities for these may have prevented this being made 
apparent (Lastovica, 2006). Several species other than C. jejuni and C. coli have been 
extensively studied and reported to cause human gastroenteritis, including C. 
consisus, C. hyointestinalis, C. upsaliensis, C. gracilis and C. curvus (Lindblom et al, 
1995; Lastovica & le Roux, 2001; Labarca et a l, 2002; Maher et a l, 2003; Boyanova 
et a l, 2004). Several studies have also linked Campylobacter species to other non- 
gastrointestinal illnesses such as joint and organ infection, cardiac problems (Ahmar 
et a l, 2008; Hull & Varma, 2011) and meningitis (Herve et a l, 2004).
Poultry, particularly chickens, are the major reservoir of Campylobacter and 
are the major recognised source of human infection (Pearson et a l, 1993; Bemdtson 
et a l, 1996). Other important sources of Campylobacter infection in humans also 
include the consumption of raw milk and untreated water (Peterson, 2003; Jakopanec 
et a l, 2008; Karagiannis et a l, 2010), and red meat products (Blaser, 1997; Black et 
al, 2006; Inns et a l, 2010). Campylobacter colonize the caecum of poultry and their 
presence here is generally asymptomatic at levels of at least 10 °^ CPU per gram of 
caecal contents (Shreeve et a l, 2000). It has been reported that one Campylobacter-
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contaminated bird present in a Campylobacter-free flock can result in contamination 
of all the birds in the flock within 3 days (Shanker et a l, 1990). In addition, when an 
uncolonized flock of birds was given C. jejuni eontaminated water, most of the chicks 
were colonized with C. jejuni within 7 days (Shanker et a l, 1990). Both of these 
studies demonstrate that C. jejuni has evolved to be able to colonize rapidly what is 
thought to be its natural hosts, i.e. birds and poultry.
Ingestion of contaminated foods of animal origin is considered to be the 
primary cause of Campylobacter infections in humans. Poultry products in the 
supermarket may be contaminated with Campylobacter at levels up to 10  ^organisms 
with the average level of contamination on poultry products as high as 10  ^per carcass 
(Jacobs-Reitsma, 1997). A population of 10 viable Campylobacter per gram of faeces 
may be present in the gastrointestinal tract of an individual chicken and it is easy to 
see how contamination of poultry products can arise. The farm crates used to transport 
live poultry have also been reported as potential vectors for transmission between 
flocks (Newell et a l, 2001; Stem et a l, 2001; Slader et a l, 2002). It has been reported 
by Hastings et ah that Campylobacter can survive on crates at least 3 hours after 
sanitization (Hastings et a l,2Q \\).
Perinatal transmission in humans is rare but possible during passage through 
the birth canal (Farrell & Harris, 1992), and direct transmission can also occur but 
usually only following high levels of occupational exposure, particularly amongst 
farmers, butchers, and poultry processors (Bemdtson et a l, 1996; Alios, 2001). In 
addition, poultry abattoir workers have also been shown to develop antibody 
responses during their employment in the poultry abattoir. New workers may develop
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clinical signs of typical campylobacteriosis whereas long term workers may shed C. 
jejuni asymptomatically (Cawthraw et a l, 2000). Foreign travel to developing 
countries with inadequate water treatment has also to be taken into account and can 
represent 3-50% of all cases (Butzler, 2004).
1.6 Disease and Symptoms
The most common symptoms and signs for campylobacteriosis are profuse or 
watery diarrhoea, fever with a body temperature of 40°C, abdominal cramps, malaise 
and myalgia, but the infection is usually self-limiting and clears within a week (Alios, 
2001). Fever, headache, asthenia and anorexia may also present preceding diarrhoea. 
The incubation period for Campylobacter is generally 2-5 days, however, it can be up 
to 10 days (Humphrey et a l, 2007). The symptoms of campylobacteriosis are often 
less acute compared to Salmonella or Shigella infections. However, recurrence is 
higher if no treatment is given. Patient’s stools will remain positive for several weeks 
and in some cases, blood may present by the third day of infection (Butzler, 2004). 
Sometimes, it is difficult to differentiate the symptoms from appendicitis if abdominal 
pain is the major feature of the infection (Sherman et al., 2010). Erythromycin, 
amoxicillin, fluoroquinolone and tetracycline are amongst the recommended drugs for 
the treatment of Campylobacter infection if it is deemed necessary.
As mentioned in seetion 1.5 above, the pattern of C. jejuni infeetion differs in 
the developing countries compared to developed areas of the world. In developing 
countries, infants usually suffer with enteritis when infected with C. jejuni whereas 
the disease in adults is often asymptomatic. Pazzaglia et al. have also reported
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asymptomatic shedding of C. jejuni in this group (Pazzaglia et a l, 1991). In addition, 
C. jejuni infection is more prevalent in ehildren less than 2 years of age but in these 
individuals there is significant morbidity and mortality. However, the disease is far 
less common in older children and adults compared to developed countries.
Serious complications may occur following the initial gastrointestinal 
infection including Guillain-Barre Syndrome (GBS) (Parkin et a l, 2000; Godschalk et 
al, 2006; Tam et a l, 2006), Miller-Fisher Syndrome (Salloway et a l, 1996), 
meningitis (Herve et a l, 2004), abortions (Steinkraus & Wright, 1994), cholecystitis 
(Landau et a l, 1995), transient bacteraemia (Akiba et a l, 2002) and urinary tract 
infections (Parkin et a l, 2000). In addition, irritable bowel syndrome (IBS) has been 
increasingly reported to be associated with C. jejuni infection (Schwille-Kiuntke et 
al, 2011; Spiller, 2007). The most serious complication following Campylobacter 
infection reported to date is Guillan-Barre Syndrome, with 30-40% of the GBS cases 
(McCarthy & Giesecke, 2001) being predominantly caused by a prior C. jejuni 
infection (Godschalk et a l, 2006; Parkin et a l, 2000; Tam et a l, 2006).
Typically, GBS starts 1 to 3 weeks after a Campylobacter infection (Alios, 
1997; Hadden & Gregson, 2001). GBS is an autoimmune disease associated with the 
peripheral nervous system, which is usually triggered following acute infection. 
Campylobacter is thought to trigger the production of cross-reactive antibodies to 
gangliosides and these lead to peripheral nerve tissue damage. The symptoms include 
paralysis noted by weakness in the legs, and this can migrate to the upper limbs and to 
the face, eventually leading to complete loss of tendon reflexes (Parkin et a l, 2000). 
In addition, Ang et ah in 2007 have shown that Campylobacter serology is highly
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sensitive and specific in GBS patients (Ang et a l, 2007). It is clear that the host 
immune system plays a major role in the pathogenesis of C. jejuni infection. The host 
immunity is important in limiting C. jejuni infection but also contributes to GBS since 
this sequelae is characterized by the development of autoantibodies.
The first isolation of C. jejuni from stools of a GBS patient was in 1982, by 
Rhodes and Tatersfield and this study provided the basis for further research into C. 
yq/MMz-related GBS (Rhodes & Tattersfield, 1982). Not long after the first isolation of 
C. jejuni from stool samples from a GBS patient in 1982, several studies confirmed 
the association between Campylobacter infections and GBS with 20 to 50% of cases 
in Europe, North and South America, Japan, and Australia having a history of prior 
Campylobacter infection (McGrogan et al., 2009; Poropatich et al., 2010). This 
association has been shown to be even higher in studies carried out in northern China 
and Bangladesh (Ho et a l, 1995; Islam et a l, 2009).
Campylobacter is the most common cause of bacterial gastroenteritis 
particularly in the industrialized world with the financial burden estimated to be £500 
million in the United Kingdom (Humphrey et a l, 2007) and $8 billion in the United 
States (Buzby et al., 1997). The greatest burden resulting from campylobacteriosis 
may derive from its complications, in particular Guillain-Barre Syndrome. The burden 
of campylobacteriosis is reported to be similar to other important bacterial infections 
for example meningitis, sexually transmitted infections and tuberculosis (Batz et al., 
2011, Havelaar et a l, 2012).
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1.7 Pathogenesis
Campylobacter enters the host intestine through oral ingestion from 
contaminated foods. It travels through the stomach acid barrier and colonizes the 
distal ileum and cecum of the host’s intestine. During this process, Campylobacter is 
exposed to multiple stresses particularly from the innate host immune system such as 
the antimicrobial bile salts and peptides inside the stomach, the intestine, and the 
intestinal mucous membrane lining the intestinal wall. Other stresses include 
starvation due to nutrient limitation, competition with other resident flora and 
oxidative stress. In order to survive and to be able to colonize the host, 
Campylobacters need to counteract these harsh conditions. Campylobacter resistance 
and its stress responses to host immunity are vital for its survival and pathogenesis.
A number of virulence factors and stress responses have been characterized in 
Campylobacter, including the polar unsheathed flagellum (Guerry et a l, 1997), 
cytolethal distending toxin (CDT) (Hassane et al., 2003), major antigenic protein 1 
(PEBl) (Pei & Blaser, 1993), Campylobacter invasion antigen (Cia) (Konkel et al., 
1999a), Campylobacter adhesion to Fibronectin protein (CadF) (Konkel et al., 1997) 
C. jejuni lipoprotein A (JlpA) (Jin et a l, 2001), the pVir plasmid (Bacon et a l, 2000), 
phase variable lipooligosaccharide (LOS) (Guerry et a l, 2002) and the capsule 
(Bacon et al., 2001 ; Guerry et al., 2012). Despite this, Campylobacter virulence is far 
less well understood than it is for other important food-borne pathogens.
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1.7.1 Flagella
Motility is one of the most important eharaeteristies of Campylobacter whieh 
assists during intestinal eolonisation in the highly viseous environment of the gut 
(Wassenaar et a l, 1993). In this eontext, the best charaeterized virulenee factor, and 
external structure of C. jejuni is the polar unsheathed flagellum (Fla) which is 
involved in colonization, invasion, and also contributes to the characteristic darting 
motility (Guerry, 1997). Using the flagella, Campylobacter can move up to 75 pm/s in 
highly viscous conditions (such as the mucous) (Szymanski et a l, 1995; Guerry et al, 
2000).
The structure of the flagella consists of a basal motor whieh is anchored in the 
cytoplasmic membrane, the rod which is perpendicular to the cell membrane, the hook 
and the filament (Penn, 2001). The filament is composed of two main protein 
components, FlaA and FlaB. FlaA and FlaB are approximately 60 kDA in size and are 
translationally modified by 0-linked glycosylation whieh is responsible for antigenic 
variation (Constantinidou et a l, 1996; Szymanski et a l, 1999). The genes that encode 
the flagella components are regulated by two different promoters which are under the 
control of and respectively (Penn, 2001). The activity of the dependent 
promoter is growth phase dependent and subject to environmental regulation, whieh 
also suggests the expression of flagellin in C. jejuni can be altered in response to 
environmental conditions (Aim et a l, 1993). Beyond its role in motility, the flaA gene 
product promotes eolonisation and invasion in the intestine. Mutants deficient in flaA 
alone produced truncated filaments with reduced ability to colonize the chicken gut 
whereas the flaB  mutants produced full length filaments (Guerry et a l, 1991).
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Flagella are also thought to be involved in adherence and invasion to the host 
cell (Newell et al., 1985; Guerry et al., 2000), the secretion of virulenee proteins, 
agglutination, mieroeolony formation and avoidance of innate immune response 
(Guerry et a l, 1991). The flagella are also strongly immunogenic and when the sera 
of Campylobacter enteritis patients were investigated, the presence of antibodies 
raised to flagella was detected (Winsor et al., 1986). As a consequence of this, the 
flagellar hook protein, FlgE (Luneberg et al., 1998) and other components of the 
flagellum are subject to phase and antigenie variation (Caldwell et a l, 1985; Harris et 
al, 1987). In light of the fact that the non-motile (aflagellate) Campylobacter are not 
able to colonise in vivo (Caldwell et a l, 1985; Morooka et a l, 1985), it is also 
believed that Campylobacter flagella are important in host eolonisation and, in 
addition, because mutants deficient in flagella also show reduced ability to invade in 
vitro (Wassenaar et a l, 1994), it is believed that flagella also play a role in virulence 
beyond just motility.
C. jejuni secretes a set of proteins called the Cia proteins {Campylobacter 
invasion antigens) as part of its virulenee mechanisms. CiaB is a 73kDa protein and 
has been shown to be translocated into the host cell cytoplasm during in vitro studies 
on cultured epithelial cells. A ciaB mutant is unable to secrete any Cia protein, and 
demonstrates decreased invasion into epithelial cells by a factor of 50-fold (Rivera- 
Amill & Konkel, 1999). C. jejuni lacks a type III secretion system, and it has been 
shown that the flagellar export apparatus also acts as a secretion mechanism for non- 
flagella proteins, including Cia (Konkel et a l, 2004). The secretory role of this system 
has been further studied by Song et a l, in 2004 who showed that C. jejuni flagella 
export apparatus also secretes FlaC, whieh is also thought to be important in invasion
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(Song et a l, 2004). Other flagella proteins are also involved in Cia secretion as 
mutation of flgB,jlgC  or flgE  whieh encode components of the basal body and hook, 
also results in the loss of Cia secretion (Konkel et a l, 2004). Mutation of the export 
system (JlhB, flgB, flgC and JlgE2), filament structure (JliD, flaA, flaB) and filament 
synthesis ifliA) genes also causes decreased invasion, thus further confirming the role 
of the flagella system in Cia protein secretion and also virulence (Konkel et a l, 2004).
A sigma (a) factor is a protein subunit that will bind to the RNA polymerase 
core enzyme (E) to form the holoenzyme Ea and controls the binding specificity of 
RNA polymerase for specific promoter sequences to allow transcription to be initiated 
(Helmann, 2002). The genome sequence of C. jejuni NCTC 11168 is predicted to 
contain 3 sigma factors in its genome, namely and which are encoded by
fliA, rpoN and r/7oZ) respectively (Jagannathan et a l, 2001). As mentioned above 
(1.7.1), and are involved in the regulation of flagellar genes of C. jejuni 
(Jagannathan et a l, 2001). In detail, is involved in the regulation of flaB, flgE  
(hook protein gene), the flagella secretory apparatus and also genes involved in 
nitrogen metabolism (Park, 2000; Hehdrixson & DiRita, 2003). Regulation via is 
dependent on environmental stimuli such as temperature, pH change, and the presence 
of essential inorganic salts and divalent cations (Aim et a l , 1993). On the other hand, 
plays an important role in the regulation of flaA expression and the upregulation 
of this, whieh is dependent on ehemotactic stimuli such as the pH, bovine bile and 
deoxyeholate, and which are thought to be present in the intestine. On the contrary, 
the downregulation of flaA via is thought to be dependent on viscosity (Allen & 
Griffiths, 2001).
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1.7.2 Chemotaxis
Chemotaxis is a response by whieh the bacteria move towards or away from 
chemical attraetants or repellents. Through this response, bacteria are able to detect 
and eventually respond to any chemical gradients present in their surrounding 
environment via a complex signal transduction pathway (Eisenbaeh, 1996). In 
addition, this response allows the flagellated bacteria to rotate, allowing the cell to 
move towards or away from the chemical attraetants or repellents (Eisenbaeh, 1996). 
As Campylobacter has to colonise the mucus layer of the gut, as a prelude to 
infection, this characteristic, that is its ability to identify this environment and move 
towards it, is vital for its pathogenesis.
Several studies on chemotaxis have shown the importance of this trait as a key 
virulenee factor. A study by Takata et al. in 1992 demonstrated that mutants with no 
ehemotactic response failed to colonise the intestines of a mouse model (Takata et a l, 
1992). cheY, encodes a chemotaxis regulatory protein that exists in most bacteria. A 
cheY mutant of C. jejuni is unable to colonise or cause disease in a ferret model (Yao 
et a l, 1997). In addition, CheY has been demonstrated to play a role in C. jejuni 
flagellar motor switching (Marchant et a l, 2002).
Methyl-aeeepting chemotaxis proteins (MCPs) are ehemoreceptors that sense 
extracellular signals and convey this information to the chemotaxis regulatory 
systems. In C. jejuni, docB acts as an MCP and mutants deficient in the corresponding 
protein are decreased in the ability to colonise chicks (Hendrixson & DiRita, 2004). 
The phosphorylation signal transduction cascade controlling chemotaxis recognizes 
the chemical stimulus via the transmembrane MCP or chemoreeeptor. In particular,
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the response regulator (CheY) will be phosphorylated as a result of the ehemoreceptor 
stimulus, and then CheY interacts with the flagellar motor to change its direction 
(Armitage, 1999; Baker et a l, 2006). In many other bacteria, where this pathway 
needs to be downregulated, a phosphatase, designated as CheZ will specifically 
dephosphorylate CheY (Marchant et a l, 2002). However, CheZ or a CheZ homologue 
does not appear to be present in C. jejuni strains NCTC 11168, RM1221 and 81-176 
(Parkhill et a l, 2000; Touts et a l, 2005; Hofreuter et a l, 2006). Another level of 
repressing the CheY response is via CheR, a methyltransferase that will reset the 
MCP ehemoreceptors to their non-signalling state (Baker et a l, 2006). Kanungpean et 
al. (2011) have reported on the involvement of CheR in the chemosensory response of 
C. jejuni where it has been shown to regulate chemotaxis in this manner (Kanungpean 
e ta l.,2 ^ \\) .
1.7.3 Adhesion and invasion
C. jejuni has been shown to be able to adhere to and invade human and animal 
model intestinal epithelial cells in vivo as well as in vitro. However, the molecular 
mechanisms involved in this process have not yet been well understood (Biswas et a l, 
2000; Kopeeko et a l, 2001; Hu et a l, 2006; Zheng et al., 2006). To colonise host 
cells, C. jejuni first needs to adhere to a target cell (Wassenaar & Blaser, 1999).
Attachment of bacteria to the receptors of the host cells is facilitated by 
adhesin molecules. The outer membrane proteins of C. jejuni namely PEBl, CadF and 
JlpA are all believed to assist in the binding of C. jejuni to the host cells. PEBl 
protein is also an amino acid transport system and is also responsible for the
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utilization of aspartate and glutamate as carbon sources (Leon-Kempis et a l, 2006). 
On the other hand, CadF is a surface-exposed outer membrane protein that binds to 
fibroneetin, a glycoprotein that promotes adherence in mammalian cells (Konkel et 
al, 1997). The JlpA protein contains a signal peptide and lipoprotein processing site 
at the N-terminus and also facilitates the adherence of Campylobacters to epithelial 
cells (Jin et a l, 2001). Whilst a parental strain of C. jejuni is able to readily colonize 
the caecum of newly hatched chicks, a cadF mutant was not recovered from any of 60 
chicks challenged, demonstrating that the CadF protein is required for the 
colonization of newly hatched leghorn chickens (Ziprin et a l, 1999). Factors whieh 
also aid adhesion and thereby invasion, include motility, and other Campylobacter 
surface structures such as LOS, CPS, flagella, and glycoproteins (Hu & Kopeeko, 
2000; Bacon et a l, 2001; Karlyshev et a l, 2004).
The pathogenesis of C. jejuni is also thought to involve transloeation across 
intestinal cells. The ability of C. jejuni to penetrate and pass through the intestinal 
epithelial barrier by the transeellular process has been studied by Hu et al., 2008. 
During transeytosis, C. jejuni may be able to alter the Campylobacter-QYi&osomQ 
membrane and fuse with host plasma membrane and eventually trigger basolateral 
exocytosis (Hu et a l, 2008). Another study showed that 86% of Campylobacter 
isolates from individuals with colitis and 48% isolates from individuals with 
noninflammatory disease were able to translocate across polarized Caeo-2 cells 
(Everest et a l, 1992) suggesting that transloeation may be a strain dependent 
property. When this happens, C. jejuni can migrate to the lymphatic system and other 
areas of the body whieh will lead to diseases such as meningitis, mesenteric adenitis 
or baeteraemia (Hu & Kopeeko, 2000). C. jejuni has also been shown to be able to
30
translocate across monolayers of intestinal cells in vitro (Bras & Ketley, 1999; Everest 
et a l, 1992; Konkel et a l, 1992). Polymerisation of the host’s eytoskeleton, for 
instance the microfilaments and mierotubules, is also important for the internalisation 
of Campylobacter and these pathogens are believed to be able to manipulate host cell 
signal transduction pathways (Biswas et a l, 2000 ; Biswas et a l, 2003).
After oral ingestion, Campylobacter invades the cells of the intestinal 
epithelium, which is important for the ability of this pathogen to cause disease. Upon 
entry into epithelial cells, C. jejuni use specific adaptation mechanisms that enable 
itself to survive within the epithelial cells by avoiding delivery to lysosomes, and 
exposure to acidic enzymes that will break down bacterial cell wall (Watson & Galan, 
2008). The internalization into intestinal epithelial cells in C. jejuni is mierotubule- 
dependent (Oelsehlaeger et a l, 1993) and caveolin-1 dependent (Watson & Galan, 
2008) mechanisms. aspA, aspB and sodB are reported to have a role in the efficient 
entry into epithelial cells, however, the exact mechanisms of entry remain unknown 
(Novik et a l, 2010).
When C. jejuni enters the host epithelium, it causes damage to this intestinal 
layer by disrupting the normal absorptive function of the intestine (Wooldridge & 
Ketley, 1997). This disruption is thought to contribute to the typical gastroenteritis 
syndromes (Hu & Kopeeko, 2000). Direct adherence of Campylobacter to host 
intestinal cells combined with the production of eytotoxins (please see section 1.7.6) 
may also be responsible for the production of a watery but non-inflammatory 
diarrhoea (Hu & Kopeeko, 2000; Wooldridge & Ketley, 1997). In addition, the 
invasion and proliferation of Campylobacter within the mucus of the intestine also
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results in an inflammatory response sueh as infiltration by leukocytes and this too is 
likely to produce diarrhoea (Wooldridge & Ketley, 1997; Hu & Kopeeko, 2000).
1.7.4 Lipopolysaccharide and lipooligosaccharide
C. jejuni is able to produce a variety of glycoeonjugants, including 
glycoproteins and glycolipids (also referred to as lipopolysaecharides-LPSs) whieh 
are located at the cell surface. The lipopolysaecharides (LPS) have been shown to be 
virulenee factors for many Gram-negative pathogenic bacteria (Ketley, 1997; 
Rietsehel et a l, 1994). Two types of complex carbohydrates that are produced by C. 
jejuni are the lipo-oligosaeeharide (LOS) and capsular polysaccharide (CPS).
The CPS of C. jejuni is one of the most important virulence features of C. 
jejuni but also plays an additional key role in its survival in the environment. CPS 
consists of an oligosaccharide repeating unit that is polymerised into a long chain 
(Karlyshev et a l, 2005b) and comprises galactose, ribose and glucose residues 
(Szymanski et a l, 2003). As a non-eapsulated mutant of 81-176 shows increased 
serum sensitivity, it is likely that CPS plays an important role as an immune response 
avoiding virulenee factor (Bacon et a l, 2001). It is also important for resistance to 
desiccation, and biofllm formation (Roberson & Firestone, 1992). In addition, CPS 
provides the basis of the Penner serotyping method (Karlyshev et a l, 2000).
C. jejuni expresses both LOS and the high molecular weight LPS. LOS 
possess 3-10 sugar residues within its carbohydrate chain, and lacks the 0-Ag repeats 
found in a typical high molecular weight LPS (Karlyshev et a l, 2000; Karlyshev et
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al, 2001; Szymanski et a l, 2003). An endotoxic lipid A moiety is present in the LPS 
and LOS, and is anchored into the outer membrane of C. jejuni. LPS and LOS are 
involved in serum resistance, resistance to phagocytic killing, endotoxieity and also 
adhesion (MeSweegan & Walker, 1986; van Vliet & Ketley, 2001). The sialic acid 
residues whieh are present in some surface PSs in C. jejuni have also been 
demonstrated to enhance serum resistance in C. jejuni (Guerry et a l, 2000). In 
addition, these sialic acid residues can also disrupt the host’s complement system by 
interfering with the enzyme C3. The biochemistry of C. jejuni surface polysaccharides 
(PSs) is also thought to relate to C. jfyw«/-assoeiated GBS through molecular mimicry 
of host structures (Aspinall et a l, 1994; Kuroki et al., 1993) particularly since sialic 
acid is also present on human gangliosides (Yuki & Odaka, 2005).
Because C. jejuni lacks the extensive (9-side chain of the LPS, this pathogen 
will show reduced non-specific binding to the mucin glycoproteins, and thus may 
avoid the innate immune response of the host’s epithelial cells (MeSweegan & 
Walker, 1986; Young et al., 2007). In addition to other contributions of LOS, Loewen 
et a l, 2008 showed that sialylation of the LOS contributes significantly to epithelial 
invasion (Louwen et a l, 2008).
1.7.5 Bile resistance
Bile is a powerful and natural bactericidal detergent that is present in the 
intestinal tracts of animals, and humans, and it is vital for many enteric pathogens that 
they have systems which are able to provide resistance to this detergent and whieh 
enable them to survive in the host’s intestinal tract. In the absence of any sueh system,
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cells will be killed by the action of bile salts on the lipid bilayer of the bacterial 
membrane (Gunn, 2000). CmeABC, is an efflux pump whieh has been reported to 
play a key role in the resistance of C. jejuni to bile (Lin et a l, 2003). Loss of 
CmeABC function dramatically decreases the resistance of Campylobacter to bile 
salts. Whilst the wild type strain is able to grow in the presence of 2 mM eholate, a 
CmeABC mutant could not (Lin et a l, 2005). Furthermore, in the chicken 
eolonisation study, the wild type strain colonized the birds after 2 days of inoculation 
and reached a cell density of 10^  efu/g faeces whilst a cmgv4.BC mutant failed to 
colonize the chickens throughout the study suggesting that resistance to bile is a key 
virulenee factor for C.yfywm (Lin 2003).
1.7.6 Toxins
In the early stages of Campylobacter research, C. jejuni was reported to 
produce a variety of toxins including enterotoxins, and eytotoxins (Pickett, 1992; 
Paneorbo et a l, 2001). However, only one of these proposed toxins, the cytolethal 
distending toxins (CDT) (Johnson & Lior, 1988; Pickett & Whitehouse, 1999) has 
been confirmed by whole genome sequencing (Parkhill et a l, 2000). As a 
consequence of this, the cytolethal distending toxin (CDT) is the best characterised 
cytotoxin in C. jejuni to date and the only confirmed C. jejuni toxin (AbuOun et a l,
2005). CDT is a heat-labile toxin that causes cells to arrest in the G2/M transition 
phase of the cell cycle (Hickey et a l, 2000; Lara-Tejero & Galan, 2001). The CDT 
protein is encoded by three conserved genes, namely cdtA, cdtB and cdtC (AbuOun et 
al, 2005). cdtB encodes the toxic component whereas cdtA and cdtC are both thought 
to be involved in binding and internalisation of the toxin (Lara-Tejero & Galan,
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2001). CdtB functions as a nuclease that damages the DNA and causes cell cycle 
arrest (Lara-Tejero & Galan, 2000).
Whilst the mode of CDT action and its structure have been well characterized, 
its role in virulence remains uncertain because not all C. jejuni strains possess CDT. 
Naturally occurring CDT negative strains, which have been found to have a deletion 
in both the cdtA and cdtB genes have been isolated from eases of human illness 
(AbuOun et a l, 2005). Other Campylobacter species as well as Gram-negative 
bacteria sueh as E. coli (Johnson & Lior, 1988) and Shigella (Johnson & Lior, 
1987) have also been found to produce CDT.
1.7.7 The TCR systems
TCR (two-eomponent regulatory) systems are important in the regulation of 
virulenee and stress adaptation in many bacteria (Stock et a l, 1989). These systems 
comprise a histidine kinase and response regulator to regulate the expression of 
particular target genes. Studies by Palyada et a l, 2004 revealed 10 putative response 
regulators and 7 histidine kinases in C. jejuni NCTC 11168 and RM1221 (Palyada et 
al, 2004). A number of these systems have at least been partially characterised. The 
RacR/S system has been shown to be important for temperature-dependent growth 
and colonization and regulates the expression of a number of heat shock proteins 
(Bras et a l, 1999), while dccR-dccS (Diminished Capacity to Colonize) was reported 
to be important for in vivo colonisation in chickens (MaeKiehan et a l, 2004). In 
addition, FlgR/S are involved in the activation of RpoN-dependent genes whieh are 
essential for the formation of the hook-basal complex, and essential for the passage
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within the gastrointestinal traet but not for Campylobacter persistence in the eaeea 
(Wosten et al., 2004). The TCR PhoR/S is activated by phosphate limitation and 
important for optimal growth of Campylobacter under this condition (Wosten et a l,
2006). Likewise, Campylobacter planktonic growth regulator R/S (CprR/S) is 
involved in biofilm formation and ehiek eolonisation as well as in the oxidative stress 
response (Svensson et a l, 2009), and the Campylobacter bile resistance regulator 
(CbrR) is involved in chicken colonisation and resistance to bile salts (Raphael et a l,
2005).
1.7.8 Iron acquisition systems
Iron is an essential nutrient for growth, and plays an important role in the 
metabolism of almost all organisms. Iron is a cofaetor of many enzymes whieh 
catalyse basic cell metabolism functions such as electron transport, energy 
metabolism and DNA synthesis (Andrews et a l, 2003). It is a divalent cation that 
exists in the ferrous (Fe^^) and ferric (Fe^^) states. Because of its nearly ubiquitous 
essentiality, nearly all bacteria possess iron acquisition systems. Furthermore, 
effective iron acquisition systems are vital for the eolonisation of the host by 
enteropathogenie bacteria where free iron availability is severely limited. The 
concentration of readily available iron in the mammalian host under aerobic 
conditions at neutral pH has been documented to be in the range of 10'^  ^M to lO’^ "^ M 
(Braun & Hantke, 2011), a concentration that is far too low to support the growth of 
bacteria whieh generally require at least 10'  ^ M of iron (Braun & Hantke, 2011). In 
addition, many pathogenic infecting bacteria including Campylobacter have to 
compete with the resident normal flora for iron in order to successfully colonise the
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host intestine. As a consequence of this, many pathogenic bacteria possess highly 
effective iron acquisition systems whieh enable these bacteria to compete for minute 
amounts of this element and which may even allow them to strip it from host iron 
binding proteins (Miller et al., 2009; Weinberg, 2009; Braun & Hantke, 2011; Franza 
& Expert, 2013). In this eontext many pathogenic bacteria produce compounds called 
siderophores, which have an exceedingly high affinity for, and are able to speeifieally 
chelate, iron (Kakhlon et al., 2010; Saha et al., 2013), and also cognate transporters 
for these molecules.
Iron uptake systems in C. jejuni have been studied since the 1980s (Field et 
al, 1986), but it was not until the completion of the first genome sequence of C. jejuni 
NCTC 11168 (Parkhill et a l, 2000) that the full extent of the iron acquisition 
mechanisms became apparent (Stintzi et a l, 2008).
Strains of C. jejuni are unable to synthesize their own siderophores (Field et 
al, 1986; Pickett et a l, 1992) and no genes encoding for the biosynthesis of 
siderophores have been identified in Campylobacter genome sequences (Parkhill et 
al, 2000; Hofreuter et a l, 2006). They are however able to utilise siderophores 
produced by other bacteria, including those produced by the mierofiora of the host 
gastrointestinal traet (Field et a l, 1986). C. jejuni has been shown to utilize the 
siderophores ferriehrome and enterochelin, and other sources of iron, namely, haemin, 
haemoglobin, haemin-haemopexin and haemoglobin-haptoglobin (Pickett et a l, 
1992).
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Campylobacters can utilize the host compound haemin as a source of iron 
(Pickett et a l, 1992). Mutations in an iron-regulated gene named chuA, resulted in the 
failure of cells to grow when supplied with haemin or haem-eontaining compounds as 
sole iron sources (van Vliet et al., 2002). This finding led to the discovery that chuA 
is an iron binding receptor that is part of an operon, chuABCD which encodes genes 
for haemin uptake (Parkhill et al., 2000; Ridley et a l, 2006). C. jejuni NCTC 11168 
has also been shown to utilize iron bound to the host iron-transport proteins 
transferrin, and laetoferrin for growth (Miller et al., 2008).
C. jejuni is also able to acquire iron from the enterochelin siderophore. Genes 
encoding parts of the enterochelin transport system were first identified in 
Campylobacter coli (Richardson & Park, 1995) and later an operon that encoded an 
uptake system for this siderophore was characterized. This operon, ceuBCDE, is very 
similar in C. jejuni with ceuBC encoding the inner-membrane permease proteins, 
ceuD an ATPase and ceuE, the periplasmie binding lipoprotein (Parkhill et a l, 2000; 
Palyada et a l, 2004). The outer membrane receptor for this system, CfrA, is found 
elsewhere on the genome (Palyada et ah, 2004). Both cfrA and ceuE mutants 
demonstrate impaired colonization of the avian gastrointestinal traet (Palyada et a l,
2004) suggesting that this system and enterochelin uptake are important in this 
process. A strain of C. jejuni, M l29, has been shown to possess a cJhuABD operon 
whieh encodes proteins homologous with the ferriehrome-uptake system in E. coli 
and Pseudomonas aeruginosa (Galindo et al., 2001). This operon has not been found 
in any of the other sequenced strains of C. jejuni (Parkhill et a l, 2000; Fonts et a l, 
2005; Hofreuter et a l, 2006; Pearson et a l, 2007) and confirmation of its roles in the 
uptake of ferriehrome is still required. Finally, the Cjl658-Cjl663 locus of C. jejuni
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NCTC 11168 may be involved in the uptake of iron from the hydroxamate 
siderophore ferri-rhodotorulie aeid (Stintzi et al., 2008).
In an anaerobic environment, iron can exist in the ferrous state. Uptake of this 
state of iron has been well charaeterized in E.coli and occurs via the FeoAB system 
(Kammler et al., 1993). Based upon homology to this iron uptake mechanism, C. 
jejuni has been shown to possess an FeoAB-type iron transporter (Naikare et a l,
2006) which is energised via ATP or GTP hydrolysis (van Vliet et a l, 2002). A C. 
jejuni mutant deficient in FeoB accumulates only 50% of the iron that the parental 
strain is able to and displays reduced ability to colonise and survive within the rabbit 
ileal loop (Naikare et a l, 2006).
The outer membrane receptors for the iron transport systems are located at the 
extremities of the cell, and are therefore distant to the main site of energy production 
in the bacterial cell. As a consequence of this in many bacteria, TonB, a cytoplasmic 
membrane protein, functions to transduce the proton motive force of the cytoplasmic 
membrane to the outer membrane active transporters and thereby provide an energy 
source for the import of iron-siderophore complexes. TonB itself is part of an energy 
transduction complex which also includes ExbB and ExbD (Braun & Hantke, 2011; 
Koebnik, 2005; Sehauer et al., 2008). The genome of NCTC 11168 encodes three 
ExbBD-TonB systems. It is not known however, whether these function with specific 
uptake systems, or whether the different TonB proteins function with any of the iron 
uptake systems (Parkhill et al., 2000; van Vliet et al., 2002).
39
As described above, C. jejuni is able to efficiently acquire iron from a variety 
of sources during eolonisation and infection. A bacterial cell however, has to maintain 
iron homeostasis because high levels of iron can result in the generation of reactive 
oxygen species (ROS) as a consequence of the Fenton Reaction (Cabiscol et al., 
2000). ROS are highly reactive and toxic to cells, and consequently, it is vital for the 
cells to keep cellular iron concentration at a level that both prevents iron limitation, 
but at the same time prevents iron overload, whieh can both delay growth and 
eventually cause cell death. Because of this, many living organisms have evolved 
balanced systems for iron acquisition and iron storage, and using these, iron 
homeostasis is achieved by balancing iron metabolism, transport and storage 
(Wooldridge & Williams, 1993; Sehaible & Kaufinann, 2004).
In many bacteria, the intracellular concentration of iron is monitored by a 
protein called Fur (Ferrous Uptake Regulator) and when the intracellular 
concentration of iron exceeds a certain level, it is able to bind this element. When it 
does so, it is activated to become a repressor which downregulates the transcription of 
genes encoding the iron uptake systems (Escolar et a l, 1999). C. jejuni contains two 
Fur homologues, which are Fur (Wooldridge et a l, 1994) and the peroxide stress 
regulator (PerR) which regulate iron uptake genes and the peroxide stress response, 
respectively (van Vliet et a l, 1999; Van Vliet et a l, 1998).
In bacteria, two types of protein are involved in iron storage, namely ferritin, 
whieh does not contain haem, and the bacterioferritins that do contain haem 
(Andrews, 1998). Both proteins have been identified in C. jejuni NCTC 11168 
(Andrews, 1998; Wai et a l, 1996). A oft mutant of C. jejuni, deficient in ferritin.
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displays reduced growth under iron limited conditions and is more sensitive to 
oxidative stress (Wai et a l, 1996).
1.8 Oxidative and Nitrosative Stress
In the presence of oxygen, deleterious Reactive Oxygen Species (ROS) will be 
produced. ROS will cause damage to DNA, RNA, proteins and lipids of bacterial cells 
and rapidly cause cell death (Cabiscol et a l, 2000). However, bacteria have evolved a 
variety of oxidative stress responses in order to survive the damaging effects of ROS. 
The bacterial response to oxidative stress was first characterised in E. coli whieh was 
found to possess two key mechanisms. The OxyR regulon whieh detects and responds 
to peroxide stress and the SoxRS regulon which forms a coordinated response to 
superoxide stress. Key members of the OxyR and SoxRS regulon include 
respectively, eatalase which detoxifies hydrogen peroxide, and superoxide dismutase 
that converts superoxide radicals into oxygen and hydrogen peroxide (Farr & 
Kogoma, 1991). In addition to this, E. coli is also able to manufacture a potent 
antioxidant called glutathione (GSH; 1-y-glutamyl-l-eysteinylglyeine). GSH is usually 
the most abundant intracellular low-moleeular-weight thiol in E. coli and forms a 
major protective mechanism against oxidants (Masip et al., 2006; Veeravalli et a l, 
2011).
Being microaerophilie in nature, C. jejuni is very susceptible to oxidative 
stress, but it nevertheless possesses a number of mechanisms that provide protection 
against oxidative stress products, that have been characterized. These include the 
superoxide dismutase, SodB (Pesei et a l, 1994; Purdy et a l, 1999; Stead & Park,
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2000), the eatalase KatA (Day et a l, 2000; Grant & Park, 1995; Stead & Park, 2000), 
an iron-regulated alkyl hydroxyperoxide reductase AhpC (Bâillon et a l, 1999), the 
DNA-binding protein DPS (Ishikawa et a l, 2003), the peroxide stress regulator, PerR 
(van Vliet et a l, 1999), the serine protease, HtrA (Brondsted et a l, 2005), the putative 
heat shoek protein, HspR (Andersen et a l, 2005), spoT whieh encodes an alarmone, 
(Gaynor et a l, 2005), and the ferredoxin protein FdxA (Van Vliet et a l, 2001).
Superoxides dismutases (SODs) play a major role in the defence against and 
the removal of superoxide. These enzymes convert superoxides into hydrogen 
peroxide and oxygen (Mruk et al., 2002). As one of the products of this enzymatic 
reaction is hydrogen peroxide, an agent of oxidative stress itself, cells usually possess 
a eatalase or peroxidase which will remove this.
In contrast to E. coli which possesses three SODs (Cabiscol et a l, 2000), C. 
jejuni and C. coli only contain one SOD encoded by the sodB gene (Pesei et a l, 1994; 
Purdy & Park, 1994). SodB is an iron-eofaetored SOD and sodB mutants display 
reduced intracellular survival in epithelial cells but do not show reduced growth under 
microaerophilie conditions (Pesei et al., 1994). In addition, Campylobacter sodB 
mutants exhibit reduced survival following exposure to air, and are less able to 
colonise chickens (Purdy et a l, 1999). Compared to the parental strain, a C. coli sodB 
mutant was also far more susceptible to repeated freeze-thaw stress suggesting that 
oxidative stress is generated by this process (Stead & Park, 2000).
Campylobacters also possess a single eatalase, KatA, whieh in contrast to 
SodB is not required for survival in epithelial cells but is important for intracellular
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growth and survival inside macrophages (Day et a l, 2000). As would be expected, 
Campylobacter katA mutants are hypersensitive to hydrogen peroxide but there is 
conflicting information on the role of KatA during eolonisation depending on whether 
the mutation is in C. coli or C. jejuni. In chicken eolonisation experiments, the role of 
eatalase was different between C. coli and C. jejuni. In C. coli, eatalase does not 
appear to be important for efficient eolonisation of chickens or survival in model 
foods (Purdy et a l, 1999). Recently, CosR (Campylobacter oxidative stress regulator) 
has been reported to regulate the transcription of katA in C. jejuni (Hwang et a l, 
2012) in addition to perR (van Vliet et al., 1999). Hwang et al. (2012) also reported 
that katA does not contribute to survival within human epithelial cells in vitro but does 
contribute to intramaerophage survival (Hwang et al., 2012).
The alkyl hydroperoxide reductase (AhpC) is another peroxidase that has been 
characterized in Campylobacters and its function is to convert reactive alkyl 
hydroperoxides to the corresponding alcohols and thereby detoxify them (Bâillon et 
al, 1999). Only the reduced form of the AhpC subunit reduces alkyl hydroperoxides 
to alcohols and in this process it becomes oxidized. As a consequence of this, in many 
other bacteria, AhpC functions together with an AhpF subunit whieh transfers 
electrons from NAD(P)H to oxidized AhpC and thus re-reducing it (Chae et al., 1994; 
Poole & Ellis 1996; Poole, 1996). In C. jejuni however, there does not appear to a 
cognate AhpF (Bâillon et a l, 1999). An ahpC mutant of C. jejuni displays an 
increased sensitivity to eumene hydroperoxide but not hydrogen peroxide confirming 
its role as an alkylperoxidase (Bâillon et a l, 1999). In addition, the mutant shows an 
increased sensitivity to exposure to atmospheric oxygen suggesting a role for AhpC in 
the more general response to oxidative stress. Upstream of ahpC is a gene encoding
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the FdxA ferredoxin and this has also been reported to be important in the response to 
aerobie stress (Van Vliet et al., 2001).
Two other peroxidases are widespread in bacteria, the thiol peroxidase (Tpx) 
and the baeterioferritin eomigratory protein (Bep), both of which appear to be able to 
use a wide variety of peroxides as substrates (Zeller & Klug, 2006; Ataek et al., 
2008). C. jejuni possesses both of these proteins and whilst single knockout mutations 
in either tpx or bep resulted in normal microaerobie growth, but poorer growth than 
that of the wild type under high-aeration conditions, a tpx/bcp double mutant had a 
severe growth defect in its microaerobie growth (Ataek et al., 2008). Tpx and Bep are 
thus thought to have an indirect role in the response to oxidative stress, where the Tpx 
acts as hydrogen peroxide detoxifying enzyme and Bep acts as a peroxide reductase 
(Ataek a/., 2008).
In E. coli, the expression of ahpC and katA is regulated by the OxyR in direct 
response to peroxide stress (Cabiscol et a l, 2000). In contrast, expression of SodA is 
dependent upon the SoxRS regulatory system whieh speeifieally recognises 
superoxide stress (Cabiscol et al., 2000). Neither OxyR nor SoxRS are present in 
Campylobacters (Parkhill et al., 2000). In C. jejuni, PerR regulates the cellular 
response to peroxide stress including the expression of katA and ahpC (van Vliet et 
al, 1999). This is unusual because PerR and PerR-like proteins are normally found in 
Gram-positive bacteria (Bsat et a l, 1998). Since PerR is a repressor of gene 
expression, a perR mutation results in cells of C. jejuni that are hyper-resistant to 
hydrogen peroxide (van Vliet et a l, 1999). PerR expression has more recently been 
shown to be upregulated by acid shoek (Reid et a l, 2008), and a perR mutation
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significantly impairs chicken eolonisation (Palyada et al., 2009), suggesting that PerR 
plays an important role in various aspects of Campylobacter pathophysiology. More 
recently, CosR (Campylobacter oxidative stress regulator) has also been reported to 
regulate the transcription of katA in C. jejuni (Hwang et al., 2012).
Other components of the Campylobacter defence against oxidative stress 
include dps, whieh encodes a DNA-binding protein that provides protection against 
hydrogen peroxide when cells are grown in the presence of iron (Ishikawa et a l, 
2003). A dps mutant was reported to be more sensitive to hydrogen peroxide killing 
than the wild type, and it is suggested that this iron-binding protein prevented the 
generation of hydroxyl radicals via the Fenton reaction by sequestering intracellular 
free iron (Ishikawa et al., 2003).
Finally, an htrB homologue in C. jejuni whieh is located in the LOS synthesis 
gene cluster (Parkhill et al., 2000) has been reported to be upregulated during aeid, 
heat and oxidative stresses (Phongsisay et a l, 2007). In addition, the heat shoek 
protease HtrA and the regulator HspR were reported to have roles in aerobie survival, 
host adherence and invasion (Anderson et al., 2005; Brondsted et al., 2005).
In the past 20 years the status of nitric oxide has been transformed from a 
pollutant gas to a vital signalling molecule in biological systems (Poole & Hughes, 
2000). In addition, it is produced by the immune system via inducible nitric oxide 
synthase (iNOS), where, as a potent bactericidal compound, it serves as an important 
agent in the host cell defence against microbial infection, including in the intestine 
(Whitthoft et a l, 1998). In order to avoid the nitrosative stress, C. jejuni is able to
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activate the expression of a regulon via the NO-sensitive regulator, NssR, whieh 
consists of the haemoglobin, Cgb and Ctb, a truncated haemoglobin (Elvers et a l,
2005). Cgb-deficient mutants showed increased sensitivity to spermine NONOate, an 
NO-releasing compound, and to other nitrosating agents sueh as S-nitrosoglutathione 
(GSNO) and sodium nitroprusside (SNP), demonstrating the key role of this protein in 
nitrosative stress resistance (Elvers et a l, 2004).
1.9 Oxygen releasing compounds
Being microaerophilie in nature and due to its inherent sensitivity to oxidative 
stress, agents that generate oxidative stress or agents that release oxygen might 
potentially become effective treatments against Campylobacter and might be used to 
control its persistence in the food chain, and eventually may be used to reduce human 
infections. In this eontext, sodium perearbonate, magnesium peroxide and calcium 
peroxide have all been shown to liberate oxygen (Jones, 1999). Magnesium peroxide 
and calcium peroxide, however are far less water soluble than sodium perearbonate, 
which suggests that the metal peroxides might provide a longer period of oxygen 
release compared to sodium perearbonate. In the presence of water, magnesium and 
calcium peroxide produce hydrogen peroxide through the following reactions:
MgO] + 2H2O > Mg(0H)2 + V2 O2 + H2O 
Ca02 + 2H2O > Ca (0H)2 + % O2 +H2O
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Mg02 releases oxygen for up to 300 days, whereas Ca02 and H2O2 will 
release this gas up to 100 and 10 days respectively (Borden et al., 1997). Mg02 can be 
easily prepared commercially at a mass purity of 15-25%, whereas Ca02 can be 
prepared at 60-80% (White et al., 1998). As a consequence of this commercially 
generated Ca02 , it can deliver three to four times higher molecular oxygen than 
commercial preparations of Mg02. In addition, Ca02 is less expensive than Mg02 and 
can be produced very easily in the field by heating lime with hydrogen peroxide 
(Cassidy and Irvine 1999). Mg02 has also been used as an oxygen generating agent 
for example, to reduce the presence of anaerobic sulphate-reducing bacteria that 
would otherwise cause material corrosion under anoxic conditions (Chang et a l, 
2008). It has also been impregnated into filters in order to reduce the number of 
bacteria present and to prevent bacterial growth (Asghari & Farrah, 1993). In addition, 
it has also been used as a peroxide donor for the therapeutic treatment of Helicobacter 
pylori. Since Mg02 is an earth alkali peroxidase and can act as a solid peroxide donor, 
this treatment involved the development of an antibacterial system comprising 
laetoperoxidase and a peroxide donor for prophylactic or therapeutic treatment of 
disease caused by H. pylori (Claesson & Lindewald, 2000. Patent No.US6149908A).
Calcium peroxide has been used as an oxygen liberating agent in a variety of 
remediation studies. For example. Park et al. (2006) reported the use of this chemical 
to enhance the ability of Shepherd’s Purse roots to remediate soil contaminated with 
2,4-dichlorophenol, whilst Hanh et al. (2005) reported its use in the bioremediation of 
polluted sediments in shrimp farms containing high carbon, nitrogen, and phosphorus 
(Hanh et a l, 2005).
47
Given the good availability of oxygen releasing compounds and the inherent 
sensitivity of Campylobacters to this gas, one of the key aims of this study was to 
investigate, for the first time, the impact of these agents (sodium perearbonate, 
magnesium and calcium peroxides) on the survival of eampylobaeters in vitro, in 
foods and in model environments.
1.10 Magnesium Transport Systems
During this current study, Mg02 proved to be a particularly effective agent for 
killing of Campylobacter and consequently a fiirther aim of this study was to 
determine whether magnesium transport would influence survival during exposure to 
this compound. Accordingly, this study also sought to generate a mutant defective in 
transport of this metal and to partially characterize this.
In general, prokaryotes carry three classes of Mg^ "*" transport systems, namely 
CorA, MgtA/B and MgtE with CorA having been the most extensively studied 
(Monerief & Maguire, 1999; Kehres & Maguire, 2002; Knoop et al, 2005, Maguire,
2006). Pfeiffer and colleagues (2002) have shown that in Helicobacter pylori, 
magnesium uptake by CorA is vital for the viability of the organism as a corA mutant 
did not grow in a medium supplemented with less than 20 mM Mg^^. In addition to 
this, CorA of H  pylori was also shown to transport nickel and cobalt as corA mutants 
exhibited resistance to these metals at what would be normally toxic concentrations 
(Pfeiffer et a l, 2002). Interestingly, in E. coli and S. Typhimurium, not only does 
CorA serve as a Mg^ "^  transporter, but a corA mutant has also been shown to be 
hypersensitive to the laetoperoxidase system (Sermon et a l, 2005). The genome
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sequence of C. jejuni predicts a homologue of corA (Cj0726C) and one of the aims of 
this project was to inactivate this gene and determine the role of its product in 
magnesium transport, and also sensitivity to magnesium peroxide.
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1.11 Aims
The specific aims of this project are outlined below:
1. Given its microaerophilic nature and apparent sensitivity to oxygen this 
study sought to investigate whether oxygen releasing agents, such as 
magnesium peroxide and calcium peroxide, were specifically antimicrobial 
towards various strains of Campylobacter, in comparison to other bacterial 
food-borne pathogens.
2. To determine whether magnesium peroxide, which is sold as a human
dietary supplement, had antimicrobial activity against Campylobacters when 
present in model systems (skimmed milk and soil) in order to determine 
whether it has application as a treatment for foods or in the farm 
environment.
3. To determine the particular chemical entities, released by the decay of the
metal peroxides, which are responsible for any antimicrobial activity by the 
use of catalase.
4. To generate a mutant deficient in the major magnesium transporter of C.
jejuni (CorA) and to determine the phenotype of this mutant and to 
establish whether magnesium transport is necessary for the bactericidal 
activity of MgO].
5. To determine the virulence of cor A mutant strain compared to that of the
wild type by using animal models and cell culture. Such studies will 
provide information of the possible role of CorA in virulence and might 
also lead to the development of attenuated vaccine strains of C. jejuni.
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CHAPTER TWO
ETHODOLOGY
Chapter 2: Materials and Methods
Please refer to Appendices for details on all media, buffers and solutions used in this 
study.
2.1 Bacterial strains
All strains of Campylobacter spp. and other organisms and the media 
requirements in this study are listed in Table 2.1. Campylobacter jejuni refers to the 
genome strain NCTC 11168 unless stated otherwise.
2.2 Media and media supplements
Media and media supplements were obtained from Oxoid (Basingstoke, UK) 
unless stated otherwise. Media were prepared with reverse osmosis water and 
sterilised by autoclaving at 121 °C, 151b in"^  for 15 minutes. When required, 
defibrinated sheep blood (TCS Biosciences, UK) and antibiotic supplements were 
aseptically added to warm sterile media at the following concentrations; ampicillin 
100 pg ml'  ^ and kanamycin 50 pg m l'\ All antibiotics were supplied by Sigma- 
Aldrich® (UK). The prepared media were stored at 4°C for a maximum of 2 weeks 
until required.
2.3 Bacterial culture preparation
All strains were stored in Microbank™ (Pro-Lab Diagnostics, UK) vials at 
-80°C until required. Campylobacters were grown routinely either onto Mueller-
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Hinton agar (MHA) or MHA supplemented with 5% defibrinated sheep blood 
(BMHA) in mieroaerobic atmospheres generated using the Campygen (Oxoid) gas 
generating paek (5% O2, 10% CO2 and 85% N2) at 37°C for 48 hours. Unless stated 
otherwise, other bacteria were grown on Nutrient agar (NA) aerobically for 24 hours 
at 37°C. Bacterial cultures were then harvested from plates and grown in Mueller- 
Hinton Broth (MHB) in 250 ml Erlenmeyer flask at 37°C for 18-24 hours and shaking 
at 150 revolutions per minute (rpm) using microaerophilic conditions for 
Campylobacters, and aerobic conditions for other bacterial species. Modified,charcoal 
cefoperazone deoxycholate agar (mCGDA) was also used as a selective medium for 
some Campylobacter survival assays in which competing bacteria were present.
2.4 Bacterial plate counting for the growth and survival curve
For each experiment where bacterial counting was needed, the Miles and 
Misra technique was performed (Miles & Misra, 1938). The bacterial suspension in 
the growth or survival assay was serially diluted using maximum recovery diluent 
(MRD) to enumerate the live bacterial cells in the culture. Five drops of 20 pi of the 
suspension from the dilutions were deposited onto a suitable growth medium. Where a 
spread plate method was required, 0.1 ml of the bacterial suspension was spread on 
the surface of the media with a sterile plastic spreader. C. jejuni inoculated plates 
were then incubated at 37°C in microaerophilic conditions for 48 hours. On the other 
hand, plates inoculated with the other aerobic species were incubated aerobically for 
24 hours. The level of detection of the assay was less than 10 cfu/ml. Where statistical 
analysis was required, two-tailed Student’s / tests at the 0.05 level of significance was 
used for matching data.
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2.5 Standard buffer solutions
All buffers were prepared with deionised water from a Nanopure Ultrapure 
Water System and autoclaved at 121°C at 151b in-  ^ for 15 minutes when necessary. 
All buffer solutions were stored at room temperature unless stated otherwise.
2.6 Metal peroxide preparation
Magnesium peroxide (MgO]) and sodium percarbonate (2Na2C03 • 3H2O2) 
were dissolved in the 1 M Potassium Phosphate Buffer (PPB) pH 6.0. Both metal 
peroxides were freshly prepared prior to start of the experiment and used immediately 
once homogenized. On the other hand calcium peroxide (Ca02) is highly insoluble 
and was used in its powder form.
2.7 The effect of metal peroxides on the survival of bacteria in liquid assays
2.7.1 The effect of MgOi, Ca02 and 2Na2C0 3 .3H202 in MRD
Bacterial cultures (C jejuni, C.coli, S. Typhimurium and L. monocytogenes) 
were prepared as mentioned in section 2.3 and adjusted to an optical density (CD) of 
ODôoo 0.6. Three different concentrations of Mg02 and Ca02 were used to investigate 
the survival of the bacteria which were 0.26 mM, 2.6 mM and 5.2 mM respectively. 
However, for S. Typhimurium and L. monocytogenes, only the highest concentration 
of MgÛ2 (5.2 mM) was used and 2.6 mM and 5.2 mM were used for Ca02. For 
2Na2C0s.3H202, the concentrations of 2.6 mM and 5.2 mM of each compound were 
used for each survival assay. Because Ca02 was used in its powder form, 0.018g, 
0.018g and 0.036g Ca02 powder was weighed and added directly to the flasks with 
100 ml MRD to give a concentration of 0.26 mM, 2.6 mM and 5.2 mM respectively.
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Nosocomial pathogens namely Staphylococcus aureus and Methicillin-resistant 
Staphylococcus aureus (MRSA) were also tested with MgOa and CaO:.
Bacterial cultures (500 pi or 1 ml) were introduced into 250 ml Erlenmeyer 
flasks containing MRD with only bacterial culture added, or PBB as a control, and the 
aforementioned concentrations of peroxide compounds to a total volume of 50 ml (or 
100 ml) respectively. All flasks were then incubated aerobically at 25 °C with shaking 
at 150 rpm. Viable cell counts were estimated immediately after the addition of each 
peroxide compounds and at suitable time intervals thereafter. Plate counts were 
performed using the Miles & Misra technique using BMHA for C. jejuni and NA for 
the other species as mentioned in section 2.4. All experiments were performed in 
triplicate.
2.7.2 The effect of MgOi, CaOz and 2Na2C0 3 .3H202 on the survival of bacteria 
in UHT skimmed milk
A similar experiment to that described in section 2.7.1 was carried out with C. 
jejuni cultures using Ultra Heat Treatment (UHT) skimmed milk obtained from a 
local supermarket in order to provide a more complex and realistic environment than 
MRD. The bacterial cultures and survival assays inoculum was prepared similarly to 
section 2.7.1 using the concentration of 2.6 mM and 5.2 mM of each compound 
respectively. This experiment was performed in triplicate.
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2.7.3 The effect of MgO] and 2Na2C0 3 .3H202 on the survival of C. jejuni in soil
Soil used in this study was collected from the grounds of the University of 
Surrey, UK. The average identical composition of the topsoil layer was collected and 
other foreign organic materials such as the grass, grass root and small granule of 
gravels were removed until the soil sample was visually homogeneous. Five grams of 
the soil was weighed and placed into a universal bottle and this was sterilised by 
autoclaving. Six bottles were prepared for each of the sampling times and each was 
inoculated with 500 pi of C. jejuni ODeoo 0.6 as prepared in section 2.3. To each of 
the bottles Mg02 powder was added so that these contained 0 g, 0.05g, O.lg, 0.25g, 
0.5 g or 1.0 g of this compound respectively. In this way, a series of bottles containing 
30 replicates of 1.0 g (5 bottles), 0.5 g (5 bottles), 0.25g (5 bottles), O.lg (5 bottles), 
0.05 g (5 bottles) and no Mg02 (5 bottles) was set up to make a total of 5 suitable 
sampling times within 5 days. For 2Na2C0s.3H202, 50 pi of 0.26M 2Na2C03 3H2O2 
solution was added to the soil to make a final concentration of 2.6 mM. For 5.2 mM, 
100 pi of the 0.26 M mM 2Na2C03 3H2O2 solution was used. Fifty pi of C. jejuni 
cultures as mentioned in section 2.3 was added to the 5 g soil. On the sampling times, 
5 ml of MRD was added to each of the 6 bottles and was mixed thoroughly. One ml of 
each of the samples was then aliquoted into an empty 1.5 ml sterile tube. Serial 
dilutions were carried out and plate counts were performed as previously mentioned 
in section 2.4. This experiment was performed in triplicate.
2.7.4 Persistence of Mg02 and H2O2 in soil
An experiment was performed to determine the persistence of the bactericidal 
activity of Mg02, in comparison to H2O2, in soil to mimic conditions within the farm 
environment. The persistence experiment was carried out to assess whether the Mg02
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and H2O2 that were left in soil for 4 days were still be able to kill C. jejuni. This was 
done to give a better insight into how long these compounds can be left in the soil and 
still maintain their antibacterial activity. Five gram aliquots of soil were weighed and 
placed in universal bottles and autoclaved as mentioned in section 2.7.3. In this 
manner, three bottles with pre-added soil were set up. Nothing was added to the first 
bottle, 1.0 g of Mg02 and 3.33 ml of H2O2 9.79 M were added to the second and third 
bottle respectively to give a 2 M concentration of both. Triplicates were set up to 
make a total of 9 bottles for each of the Sampling times, in this case 9 bottles were 
needed per day. Four sets of the triplicates were prepared for sampling times up to 4 
days. On day one, all of the compounds were added respectively in each bottle (all 36 
bottles). This means that nothing was added to 12 bottles, 12 bottles had 1.0 g of 
Mg02 added and 12 bottles had 3.33 ml of H2O2 added. Oh day one, 50 pi of C. jejuni 
culture of ODôoo 0.6 (approximately 10  ^ cfu/ml) was added to the first 9 bottles (3 
control bottles, 3 Mg02 bottles and 3 H2O2 bottles) on each morning and kept for 8 
hours at 20°C and covered with aluminium foil. Then, after 8 hours, 5 ml of MRD 
was added to the bottles and mixed thoroughly. One ml of the mixture was added to 
an empty 1.5 ml tube and plate counts were performed after carrying out serial 
dilutions using the Miles & Misra technique with BMHA and mCCDA. Plates were 
incubated for 48 hours at 37°C under microaerophilic conditions. On the following 
day and onwards, the same procedure was carried out; 50 pi of C  jejuni culture was 
added to the 9 bottles and kept for 8 hours at 20°C, covered with aluminium foil, and 
then the contents resuspended using 5 ml MRD and then plate counting was 
performed. Another set of similar experiments were carried out with 0.05 g Mg02 and 
58 pi of H2O2 9.79 M to give a 0.1 M concentration of both compounds in 5 days.
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2.7.5 Survival of C. jejuni with 5.2 mM MgOz treated with catalase enzyme
Generally, Mg02 generates H2O2 on exposure to water and damp air whieh 
then decays to liberate O2. Survival experiments in the presence or absence of catalase 
were carried out to determine whether H2O2 was responsible for the bactericidal 
effect. A C. jejuni culture (500 pi) at ODôoo 0.6 was introduced into flasks containing 
50 ml MRD, with and without 5.2 mM Mg02 and with and without 1,000 and 5,000 
units of catalase. Survival was then determined using the aforementioned technique in 
section 2.4. Experiments were performed.in triplicate.
2.7.6 Survival of iS. Typhimurium treated with 5.2 mM MgOi and 5.2 mM Ca02
A similar experiment to that described in Section 2.7.1 was carried out to 
assess the difference in the killing efficacy of these two peroxides. In this experiment, 
Mg02 was not dissolved in IM PPB but the Mg02 powder was added directly to the 
flask instead. To get the concentration of 5.2 mM, 0.05g Mg02 powder, and 0.036g 
Ca02 powder were added and nothing was added for the control to 250 ml 
Erlenmeyer flask, respectively. One ml of ODeoo 0.6 bacterial culture was added and 
MRD was added to a total volume of 100 ml. Plate counts were performed as 
mentioned in Section 2.4. The experiment was done in triplicate.
2.7.7 Survival of S. Typhimurium treated with dissolved 5.2 mM MgO: and 5.2 
mM Ca02 powder
An experiment similar to 2.7.6 was carried out but this time with 5.2 mM 
Mg02 dissolved in IM PPB.
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2.7.8 Survival of C. jejuni treated with MgOz and CaOz powder in UHT skimmed 
milk
One ml C. jejuni culture was added to the 250 ml Erlenmeyer flasks and UHT 
skimmed milk was added to a total volume of 100 ml. 0.0018g, 0.018g and 0.036g 
CaO: powder were added to the respective flasks which gave a final concentration of 
0.26 mM, 2.6 mM Ca02 and 5.2 rnM Ca02 respectively. On the other hand, 0.0025g, 
0.025g and 0.05g Mg02 powder were also added to other flasks respectively to give a 
total concentration of 0.26 mM, 2.6 mM, 5.2 mM Mg02. The rest of the experiment 
was done according to Section 2.7.1 and plate count as mentioned in Section 2.4.
2.7.9 Persistence of MgOi, H 2 O2  and 2Na2C0 3  3 H 2 O2  in soil
This experiment is similar to Section 2.7.4 with the addition of 
2Na2C0s-3H202 as one of the oxygen releasing compounds. Five gram aliquots of 
soil were weighed and placed in universal bottles and autoclaved as mentioned in 
Section 2.7.3. In this manner, four bottles with pre-added soil were set up. Nothing 
was added to the first bottle, 0.05 g of Mg02, 58 pi of H2O2 9.79 M and 0.08 g 
2Na2C03 3H2O2 were added to the second, third and fourth bottle respectively to give 
a concentration of 0.1 M. Triplicates were performed to make a total of 12 bottles on 
each of the sampling time on day one. To determine the persistence of both of the 
compounds, 5 sets of the triplicates were prepared for sampling times up to 5 days (a 
total of 60 bottles). Fifty pi of C. jejuni culture was added to the first 12 bottles on the 
first day and kept for 8 hours at 20°C and covered with aluminium foil. Then, after 8 
hours, 5 ml of MRD was added to the bottles and mixed thoroughly. One ml of the 
mixture was added to an empty 1.5 ml tube and plate counts were performed using 
serial dilution using the Miles & Misra technique on BMHA. Plates were incubated
61
for 48 hours at 37°C in microaerophilic conditions. On the following day and 
onwards, the same procedure were carried out; 50 pi of C. jejuni culture was added to 
the 12 bottles and kept for 8 hours at 20°C, covered with aluminium foil, resuspended 
with 5 ml MRD and plate counting were performed.
2.7.10 pH determination of C. jejuni cultures treated with CaOi
The pH of the inoculum was assessed to ensure that the pH of these peroxide 
treated cell cultures was within the growth range pH and whether the pH was 
responsible for C. jejuni killing. This experiment was initially set up similar to the 
survival assay described in Sections 2.7.1 and the concentrations used for both 
compounds were 2.6 and 5.2 mM respectively. The pH reading of the treated and 
untreated inoculum was measured in suitable intervals times within 24 hours.
2.7.11 Survival of C. jejuni at pH 10.0
The experiment outlined in Section 2.7.11 indicated that the pH of C. jejuni 
culture when treated with CaOi was pH 10.0. Since the survival of C. jejuni treated 
with this compound showed a drastic killing effect as compared to MgO], it was 
hypothesized that the highly alkaline environment was responsible for C. jejuni 
killing. An experiment to assess the survival of C. jejuni when treated at two different 
pH values (pH 7.0 and pH 10.0) was thus carried out. C  jejuni culture was as 
described in section 2.3. An aliquot of these cultures (500 pi) was inoculated in 49.5 
ml MHB pH 7.0 as a control and MHB pH 10.0. Incubation conditions and plate 
counting were performed as described in section 2.4. The experiment was performed 
in triplicate.
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2.8. Transmission Electron microscopy (EM)
C. jejuni culture was treated with 5 mM MgO: and Ca02 respectively, similar 
to the previously mentioned survival assay in section 2.7.1. The peroxide treated 
bacterial cultures (25 ml) as well as the untreated control were centrifuged at 2100g 
for 15 minutes to pellet the bacterial cells. Bacterial pellets were re-suspended in 500 
pi of O.IM PBS pH 7.4 to get a concentrated suspension of bacteria. A 50 pi droplet 
of this bacterial suspension was placed on a sheet of dental wax. Formvar TM carbon 
coated grids were then floated on top of the bacterial suspension for ten minutes. 
Grids were then blotted dry and placed onto a drop of 2% (y/v) phosphotungstic acid 
negative stain for 15 seconds. Grids were carefully blotted dry and viewed using a 
Philips CM 10 transmission electron microscope.
Cloning of the C. jejuni corA gene
2.9 Extraction of C. jejuni NCTC 11168,11168H and 81116 genomic DNA
Genomic DNA was extracted from C. jejuni using guanidium thiocyanate 
(Pitcher et al., 1989). A 48-hour cultured bacterial lawn was harvested with MHB, 
and transferred into a 1.5 ml microcentrifuge tube and centrifuged for 3 minutes at 
22,000 g. The pellet was resuspended in 0.1 ml TE buffer, lysed with 0.5 ml 
Guanidine thiocyanate-EDTA-Sarkosyl (GES) reagent vortexed, incubated at room 
temperature for 10 minutes and then cooled on ice for 5-10 seconds. Two hundred and 
fifty microlitres cold ammonium acetate (7.5 M) was added to the sample, mixed and 
left on ice for 10 minutes. Five hundred microlitres of a mixture of chloroform and 
isoamylalcohol at a ratio of 24:1 was added, mixed thoroughly and then the mixture 
centriftiged for 10 minutes. The denatured protein forms a layer between the
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chloroform underneath and DNA above. The supernatant containing the DNA was 
removed and transferred into fresh microeentrifuge tubes and mixed with 0.54 
volumes of cold isopropanol to precipitate the DNA. It was then mixed and 
centrifuged at 10,000 g for 1 minute and the supernatant removed. The sample was 
then washed three times with 0.1 ml 70% ethanol. Finally, the pellet was resuspended 
in 0.05 ml TE buffer. The extracted genomic DNA was analysed by gel 
electrophoresis using a 1% agarose gel supplemented with GelRed™ (Biotium, 
Canada). One microlitre DNA sample was loaded with 1 pi loading buffer and 8 pi 
milli-Q water running along side a 1 kb ladder (Promega, USA). Alternatively, 
DNeasy® Blood & Tissue Kit (QLAGEN) was used to extract the genomic DNA as 
specified in the kit protocol.
2.10 Quantification of DNA
A Nanodrop® 1000 was used to quantify the genomic DNA sample (Thermo 
Scientific, UK).
2.10.1 Nanodrop method of DNA estimation
Two pi of a DNA sample was measured using the Nanodrop 
spectrophotometer at the 260 nm wavelength. An OD reading of 1.0 at this 
wavelength was equivalent to 50 pg/ml of double stranded DNA. The DNA was 
measured 3 times and the average reading was taken as the DNA concentration.
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2.11 Separation of DNA fragment by agarose gel electrophoresis
Gel analysis of large DNA fragments (greater than Ikbp) was carried out in 
0.8% (v/v) or using 1% (v/v) agarose in 0.5x TBE buffer for smaller DNA fragments 
(less than 1 kbp). GelRED™ (Biotium, UK) was added to the gel for staining. A DNA 
molecular marker,! kbp DNA ladder (Promega, UK) was run alongside the DNA 
samples. DNA samples were analysed by adding 1 pi of 6x DNA loading buffer and 
electrophoresing this in 1.0% or 0.8% agarose gels with 2.5 pi GelRED™ to a final 
volume of 100 ml. The gel was submerged in 0.5x TBE buffer and electrophoresis 
carried out at 100 volts for approximately 45 minutes. The DNA was then visualised 
using an ultra violet transilluminator (GeneFlash, Syngene) and a copy of the image 
was printed and saved.
2.12 PCR amplification of corA gene fragments
The oligonucleotide primers used for PCR were synthesized by Sigma- 
Aldrich. The corA gene (Cj0726C) was amplified from genomic DNA of C. jejuni 
wild type NCTC 11168 using the forward primer 5’- 
GCCCAAGTATCCTTCCAGTTTG -  3’, designated as Primer CorA Mut 1 and the 
reverse primer 5’- CCCTAAGCGATAGAGCAAGTAGTGG -  3’, designated as 
Primer CorA Mut 11 yielding a product of 1331 base pair (bp). A list of the primers 
used and restriction endonucleases used is listed in Table 2.2. The primers synthesized 
by Sigma (UK) were diluted to provide a 100 pi permanent stock and further diluted 
to provide 10 pM working concentration. The PCR reaction mix for the amplification 
of the gene fragment contained 4 pi of each 10 pM primers, 1 pi C. jejuni genomic 
DNA (80-100 ng/pl) 1 pi Taq polymerase (Promega, USA), 2 pi deoxynucleotide
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triphosphates (dNTPs) (Promega, UK) and 20 pi 5x buffer (Promega, USA). The 
reaction mix was made up to 68 pi with the addition of sterile Milli-Q water. A 
negative control was set up for the PCR reaction with the substitution of Ipl sterile 
mili-Q water for the genomic DNA. The reaction was performed using a 2720 
Thermal Cycler (Applied Biosystems) and involved a dénaturation period of 5 
minutes at 95°C, 30 cycles of 45 seconds at 95°C to denature, 45 seconds at 55°C to 
anneal, and 2 minutes at 72°C for extension. After the 30 cycles there was a final 
extension period of 10 minutes at 72°C then the samples were stored at 4°C. PCR 
products were analysed by electrophoresis using 0.8 % agarose gels. The PCR product 
possesses single 3’ A-nucleotide overhangs which enables it to be directly ligated to 
vectors containing compatible single T-nucleotide overhangs. The PCR product was 
digested with the enzyme PstI according to the manufacturer’s instruction, to further 
prove that the PCR product was the size of the corA gene fragment (please see section
2.16 for details on the restriction digestion experiment).
2.13 TA Vector cloning into pGEMT-Easy vector
The vector for cloning PCR products used in this study was the pGEM®-T 
Easy Vector System obtained from Promega, Southampton, UK. T4 DNA ligase 1-3 
Weiss unit/jul was also obtained from Promega, Southampton, UK and was supplied 
with a lOx reaction buffer (300 mM Tris-HCl (pH 7.8 at 25°C), lOOmM MgCb, 
lOOmM DTT and 10 mM ATP. Reactions were carried out according to 
manufacturer’s instructions, generally using a 1:1, 1:3 or 3:1 molar ratio of 
vector:insert DNA when cloning a fragment into a plasmid vector. A series of one, 
three and five microlitres (around 50 ng) of the PCR products were added to the
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ligation mix respectively containing 2 pi pGEM"-T Easy, 5 pi 2x buffer, 1 pi T4 
DNA ligase and sterile Milli-Q water to make the final volume of 10 pi. The ligation 
mixture was then incubated overnight at 4°C.
DNA sequence
Forward primer: Primer Mut 1 5’- GCCCAAGTATCCTTCCAGTTTG -  
3'
Reverse primer: Primer Mut 11 5’-
CCCTAAGCGATAGAGCAAGTAGTGG
- 3 ’
B glll 5’... A -G A T C T ...3’ 
3’...T C T A G -A ...5 ’
BamHl 5’...G-’GATCC ...3’ 
3’...AAGCT-T ...5’
PstI 5’ ...CTGCA-G ...3’ 
3’ ...G -A C G T C ...5’
Table 2.2: Primers and restriction endonucleases sequences used in this study
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2.14 Transformation oïE. co/i DH5a
Competent cells for use in transformation were obtained from Invitrogen (Cat 
No. 18265-017). The ligation mixture from Section 2.13 was used to transform the E. 
coli DH5a cells. Initially, the competent E. coli DH5a cells were thawed on ice for 
approximately 30 minutes. Ten microlitres of the ligation sample were added to 50 pi 
chemically competent E. coli DH5a in sterile microeentrifuge tubes. The tubes were 
left on ice for 30 minutes and then heat shocked at 42°C for 30 seconds, and then left 
to rest on ice for 1 minute. LB broth (950 pi) was added to the shocked cells and the 
culture incubated at 37°C in a water bath for 1 hour. Finally, 100 pi of the 
transformation reactions were plated onto LB agar plates supplemented with the 
appropriate antibiotic.
To select for E. coli which had successfully taken up the plasmids, the cells 
were spread onto LB agar containing 100 pg/ml ampicillin, 1 ml X-Gal (16pg/ml) and 
1 ml of IPTG 1 mM and incubated at 37°C overnight. The pGEM®-T Easy contains a 
gene for ampicillin resistance, therefore only colonies whieh had taken up the 
plasmid, were able to grow. The plasmid also contains a lacZ gene which encodes |3- 
galactosidase, this enzyme metabolises the chromogenic substrate X-Gal resulting in a 
blue product. The cloning site for the PCR product lies within the lacZ gene, 
rendering it inactive if an insertion occurs, thus X-Gal cannot be metabolised, 
resulting in white colonies. The plates were incubated at 37°C overnight for colonies 
to establish.
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2.15 Plasmid m ini-preparations
Colonies containing plasmids were selected froni the LB agar from section
2.14 and inoculated into 5 ml LB broth supplemented with 100 pl/ml ampicillin in 
sterile universal containers and incubated overnight at 37°C on a shaker at 250 rpm. 
Following the incubation, the cultures were centrifuged at 3500 rpm (Beckman 
Coulter Allegra® X-15R Centrifuge) for 15 minutes and the supernatant discarded. 
The plasmid was extracted from the E. coli cells using the QIAprep® Miniprep kit 
(Qiagen) as specified in the kit protocol. Briefly, the bacterial cell pellets were 
resuspended thoroughly in 250 pi of resuspension buffer PI. This was then followed 
by the addition of buffer P2. The mixture was gently inverted and incubated for 5 
minutes at room temperature and then 350 pi of buffer N3 was then added, mixed 
gently and incubated for a further 5 minutes. Samples were centrifuged at maximum 
speed for 10 minutes in a microeentrifuge and the supernatant removed and applied to 
a QIAprep®-spin column supplied. The column was then centrifuged at full speed for 
1 minute and washed once with 500 pi buffer PB and once with 750 pi buffer PE. To 
ensure complete removal of residual of the PE buffer, the column was centrifuged 
again for an additional 2 minutes and then placed in a fresh collection tube. Plasmid 
DNA was eluted by adding 50 pi TE buffer (pH 8.0) to the centre of the column and 
this was centrifuged for 1 minute. Plasmid DNA was stored at -20°C until required. 
PCR as described in section 2.12 was carried out to determine whether plasmids had 
the expected corA DNA insert and the products visualized using agarose gel 
electrophoresis A plasmid in which the corA gene was inserted into the pGEM®-T 
Easy cloning vector was designated as pEMl.
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2.16 Restriction digestion
Genomic, plasmid and DNA fragments were cut using restriction 
endonucleases obtained from Promega, Southampton, UK (Table 2.2). Digestions 
were carried out according to the manufacturer’s instructions with the appropriate 
reaction buffer. Generally, genomic DNA was incubated overnight at 37°C, (for 1 
hour for plasmids and DNA fragments) in 20-100 pi reaction volumes.
2.16.1 Restriction digest of pJMKSO
E. coli cells containing plasmid pJMK30 were grown on LB agar 
supplemented with 50 pg/ml kanamycin overnight and after the overnight incubation, 
a colony was inoculated on LB broth containing 50pg/ml kanamycin and purified 
using the plasmid mini-prep in a similar manner to that described in section 2.15. The 
kanamycin cassette inside the pJMK30 plasmid was digested using the restriction 
endonuclease BamHl (Roche) to extract the kanamycin gene fragment. BamHl 
cleaves the DNA at the short recognition sequence GiGATCC producing ‘sticky’ 
ends on both ends of the fragment. The restriction digest reaction comprised 15 pi 
DNA at a concentration of approximately 80-100 ng/pl, 1 pi BamHl, 2 pi 1 Ox buffer 
(Promega), and milli-Q water to make the total volume of 20 pi. The reaction was 
incubated in à 37°C water bath for 1 hour.
2.17 Gel extraction of the kanamycin resistance cassette
The digest reaction of pJMK30 was carried out to extract the kanamycin 
cassette and was scaled up to carry out a gel extraction of the kanamycin fragment. 
Digested DNA (section 2.16.1) was run on a 1% (v/v) agarose gel and the DNA
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fragment of interest was excised and subjected to QIAEX II DNA extraction 
procedure (Qiagen). The band of DNA comprising kanamycin fragment was viewed 
on a UV box and eut out of the gel using a sterile scalpel and placed in microfuge 
tubes. Briefly, the excised DNA fragment was weighed in a 1.5 ml microeentrifuge 
tube and 3 volumes of buffer QXl to 1 volume of gel was added. The gel slice was 
dissolved by incubating the tube at 50°C for 10 minutes and vortexing every 2-3 
minutes. One gel volume of isopropanol was added to the sample, and after mixing, 
and the sample applied to a QIAquick column. The column was centrifuged for 1 min 
at full speed at room temperature and the flow-through was discarded. To remove 
traces of agarose gel, the column was washed with 500 pi buffer QXl and spun for 1 
minute. A further wash was carried out with 750 pi buffer PE, the column was again 
centrifuged at high speed for 1 minute and the flow through discarded. The column 
was centrifuged for an additional 2 minutes to remove all traces of PE buffer and then 
placed in a clean microeentrifuge tube. The DNA was eluted from the column by 
adding 50 pi TE buffer (pH 8.0) to the centre of the column and centrifuged for 1 
minute. Purified DNA was stored at -20°C. A sample of this DNA was loaded onto a 
1% agarose gel which was then run to ensure that the extraction had been successful.
2.18 Restriction digest of pEMl
Plasmid pEMl was digested using the restriction endonuclease Bglll 
(Promega) to insert the kanamycin gene fragment. Bgll cleaves the DNA at the short 
recognition sequence A^LOATCT at the 586-bp site from the forward primer 5’ 
introducing ‘sticky’ ends which are compatible with the BamHl ‘sticky’ ends of the 
kanamycin fragment. The reaction comprised 2 pi DNA (80-100 ng/pl), 1 pi Bglll, 1 
pi Buffer (Promega) and milli-Q water to make the volume 10 pi. The reaction was
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incubated in a 37°C water bath for 1 hour. A sample of this DNA was loaded onto a 
1% agarose gel which was then run to ensure that the digestion had been successful.
2.19 Cloning of kanamycin fragment into pEMl
The kanamycin fragment from section 2.17 was cloned into pEMl using T4 
DNA ligase and for successful cloning the ligation reaction required a ratio of 1:3 
vector to fragment. The vector was approximately 4.5 kb, and the kanamycin cassette 
was approximately 1.6 kb. These sizes were used to calculate the 1:3 ratio. The 
appropriate quantities of vector, fragment, T4 ligase, 2x buffer and milli-Q water were 
put into microeentrifuge tubes to make a 20 pi volume, the reactions were mixed, and 
left to incubate overnight at 4°C.
2.20 Transformation into competent Æ co//DH5a cells
Transformation was carried out as specified in section 2.14. Cells were then 
spread onto LB agar plates containing 50 pg/ml kanamycin and incubated 37°C 
overnight. Only plasmids that had taken up the kanamycin fragment would allow cells 
to grow in this medium. A single colony was picked from the plates and streaked onto 
fresh LB plates containing kanamycin and the culture incubated at 37°C overnight. A 
plasmid in which the 1600 bp kanamycin fragment was ligated into the Bglll site of 
pEMl was designated as pEM2.
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2.21 pEM2 plasmid mini-prep
Kanamycin resistant colonies were inoculated into 5 ml LB broth 
supplemented with 50 pg/ml kanamycin and incubated at 37°C overnight on a shaker. 
The cultures were centrifuged at 3500 rpm for 15 minutes and supernatant discarded. 
Plasmids were extracted using the QIAprep® Miniprep kit (Qiagen) as described in 
Section 2.15, following the manufacturer’s instructions. Once again, a 1% agarose gel 
was run using 1 pi plasmid loaded with 1 pi loading buffer to confirm the presence of 
pEM2.
2.22 Plasmid MIDI prep of pEM2
Prior to the start of the MIDI prep, 5 ml of LB broth supplemented with
kanamycin at 50 pg/ml was set up in the morning and cells containing pEM2 were
inoculated. After 8 hours, the sample was then transferred to a falcon tube containing
25 ml of LB and kanamycin (50 pg/ml) and incubated overnight at 37°C in a shaker
with shaking at 250 rpm. The overnight cells were harvested by centrifugation at
5000g for 15 minutes at 4°C and the supernatant was discarded. The MlDIprep kit
(Qiagen) was carried out according to the manufacturer’s instructions. Briefly, 2 ml of
Buffer P2 was added to the bacterial pellet and this was gently mixed by inverting the
tube until the lysate appeared viscous. The mixture was then incubated at room
temperature for 3 minutes. Two millilitres of Buffer S3 was added to the lysate, and
this carefully mixed by inverting 4-6 times. The lysate was then transferred to a
QlAfilter cartridge and incubated at room temperature for 10 minutes. A QIAGEN
Plasmid Plus spin column was added onto the QIAvae 24 Plus. The Tube Extenders
were inserted into each column and were applied until all the liquid had been drawn
through all columns by gravity. Seven hundred microlitre of Buffer ETR was added to
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wash the DNA and applied until the liquid had been drawn through all columns. To 
further wash the DNA, 0.7 ml of Buffer PE was added and applied until the liquid had 
been drawn through all columns. The column was centrifuged at 10,000 x g for 1 
minute in a microcentrifudge to completely remove the residual wash buffer. The 
QIAGEN Plasmid Plus spin column was placed into a clean 1.5 ml tube and 200 pi of 
Buffer EB was added to the centre of the spin column to elute the DNA, and 
centrifuged for 1 minute.
2.23 Preparation of C jejuni competent cells for electroporation
A 48 hour old plate culture of C. jejuni (HCTC 11168, 11168H and 81116) 
was harvested by using MHB and a plastic spreader, and then centrifuged for 5 
minutes at 4°C, 13,000 rpm. The supernatant was discarded and the pellet was washed 
with C. jejuni wash buffer (272 mM sucrose, 15%, v/v, glycerol) 5 times after which 
it was then centrifuged for 5 minutes at 13,000 rpm at 4°C. Finally the pelleted cells 
were re-suspended in wash buffer to give a density of approximately 10  ^cfu/ml.
2.24 Transformation of pEM2 into C. jejuni by electroporation
Plasmid DNA pEM2 was introduced into C. jejuni by electroporation. A 50 pi 
aliquot of electrocompetent cells was added to an empty pre-chilled 1.5 ml tube and 
mixed with 1, 3, or 4 pi of the plasmid pEM2 MIDI prep from section 2.22 and 
incubated on ice for 10 min. The cell and plasmid mix was then transferred into a 
cooled electroporation cuvette (2 mm gap cuvette. Cell Projects, UK). High voltage 
pulses were delivered to ice-cold cells by using a Gene Puiser apparatus (BioRad 
Gene Puiser™). The pulse was adjusted at 2.5 kV, 25pF, 200 ohm and to a time
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constant of less than 4 seconds. Following electroporation, the contents of the cuvette 
were flushed with pre-warmed MHB (37°C) and this was then spotted onto two pre­
dried MHA plates for 24 hours for recovery. After 24 hours, cells within the DNA 
spots were harvested by adding 300 pi MH broth and gently scrapped off using a 
sterile plastic spreader, A 100 pi aliquot of the suspension was plated (in duplicate) 
onto dry MHA plates supplemented with 50 pg/ml kanamycin and 20 mM MgCb 
which were then incubated for 2 to 5 days at 37°C under microaerophilic conditions. 
Potential transformants were selected and single bacterial colonies of these were 
subcultured onto MHA supplemented with 50 pg/ml kanamycin and 20 mM MgCl] 
and then incubated for 48 hours at 37°C under microaerophilic conditions. Genomic 
DNA was extracted (Section 2.9) from either broth or plate cultures of the 
transformants and analysed by PGR (Section 2.12). The same method was used to 
introduce plasmid DNA into all 3 C. jejuni species. 111 68, 11168H and 81116.
2.25 Natural transformation
In some cases where strains were recalcitrant to electroporation, natural 
transformation was used as an alternative to introduce plasmid DNA into 
Campylobacters. This was performed according to the method of Wang & Taylor 
(1990) with some modifications. Fresh C. jejuni cells were grown under microaerobic 
conditions on MHA at 37°C for 48 hours and 2 drops of 20 pi aliquots of plasmid 
DNA (pEM2) with a concentration of approximately 0.2 pg/5pl were spotted directly 
onto the bacterial growth. The plates were then placed back into the microaerobic jar 
and incubated for 4 hours. After 4 hours, the cells within the DNA spots were 
harvested by adding 1 ml of MH broth and scraping the growth with a sterile plastic 
spreader. A 100 pi volume of resuspended cells was then spread out on to each of two
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selective media MHA plates supplemented with 50 pg/ml kanamycin and 20 mM 
MgCl: which were then incubated microaerobically at 37°C for 48 hours before being 
examined for growth of transformants.
2.26 Growth requirements of C. jejuni corA mutant
The growth requirements of the Cjejuni cor A mutant, was initially investigated 
by assessing growth on solid agar (MHA) to which 20 mM of magnesium chloride 
(MgCl:) had or had not been added. The C. jejuni cor A mutant and wild type were 
streaked onto MH plates with and without 20mM MgCl^ and the plates ineubated for 
48 hours at 37°C under microaerophilic conditions and a visual observation of colony 
growth made.
2.27 Growth assay of C. jejuni wild type and the C. jejuni corA mutant in the 
presence or absence of magnesium
The growth curves of all of the C. jejuni wild types and corresponding corA 
strains of 11168, 11168H and 81116 were determined. Both C. jejuni wild type strains 
and C. jejuni corA mutants were grown on MHA plates for 48 hours prior to the start 
of the experiment on media with and without 20 mM MgC^ supplementation 
respectively. The cells were then harvested and grown in Mueller-Hinton broth with 
and without 20 mM MgCl2 and were incubated microaerobically in a 150 rpm shaker 
for 24 hours. After 24 hours, MH broth (100 ml) containing 5 mM MgCl], 10 mM 
MgCl2, 20 mM MgCb and no added MgCl2 was added to 4 filtered tissue culture 
flasks. One ml aliquots of the C. jejuni cultures at ODeoo 0.6 were inoculated into the 
flasks and all flasks were incubated microaerobically at 37°C for approximately 5
76
days. The absorbance was determined at each sampling time. All experiments were 
done in triplicate. For further phenotypic analysis (below), only the C. jejuni corA 
mutant derived from the genome strain 11168 was used unless stated otherwise.
2.28 Survival of C. jejuni wild type and corA mutant treated with MgOz
C. jejuni wild type and corA mutant was treated with 0.26, 2.6 and 5.2 mM 
MgO] in a manner, similar to that described in section 2.7.1. This experiment was 
carried put to determine the role of CorA in MgO] killing in C. jejuni. AX suitable 
intervals, viability was assessed by plate counting as described in section 2.4 and all 
experiments were performed in triplicate.
2.29 Survival of C. jejuni wild type and corA mutant in UHT and Pasteurized 
skimmed milk
UHT and Pasteurized skimmed milk used in this study was obtained from the 
local supermarket (Tesco, UK). Both C. jejuni wild type and the C. jejuni corA mutant 
were grown, harvested and inoculated as previously mentioned in Section 2.3 with 
Mg supplementation for the corA mutant. UHT and Pasteurized skimmed milk with 
and without 20 mM MgCl] supplementation was added to the flasks for the wild type 
and the corA mutant respectively, which add up to 4 flasks altogether, to a total 
volume of 100 ml. All flasks were incubated aerobically at 25°C with shaking at 150 
rpm. At suitable intervals, viability was assessed by plate counting as described in 
section 2.4. All experiments were performed in triplicate.
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2.30 Survival of C jejuni wild type and corA mutant in UHT skimmed milk with 
added nickel
This experiment was done to determine whether the addition of Ni^ "^  would 
increase lactoperoxidase induced killing in wild type but not the corA mutant. Both C. 
jejuni and corA mutants were grown, harvested and inoculated as previously 
mentioned in Section 2.3. For the control, 1 ml of C. wild type and corA mutant 
culture was added to the flasks and milk was added to make a total volume of 100 ml. 
In the experiments with Ni^\ 4 ml of 2.5 M nickel (II) chloride hexahydrate 
(NiCl2.6H20) was added to each flasks to make a total NiCl2.6H20 concentration of 
100 mM, I ml of C. jejuni wild type and the corA mutant were added to each flask, 
and milk was added to make a total volume of 100 ml. When necessary, I ml of 2 M 
MgCl2 was added, to make a final concentration of 20 mM MgCl2. All flasks were 
incubated aerobically at 25°C with shaking at 150 rpm.
2.31 Growth experiments using different cations other than Mg
Growth of the corA mutant was assessed with cations other than Mg, to 
confirm that it was Mg and not the chloride anion that allowed the growth of the corA 
mutant. The cations used were Calcium, Sodium, and Magnesium as a control. The 
growth experiment was carried out using 20 mM CaCb, 20 mM NaCb, 20 mM MgCb 
and only MH broth as a control. Eight flasks were prepared with 20 mM 
concentrations of each compound respectively (4 flasks) with C. jejuni wild type and 
the corA mutant. Total volume of liquid in each flask was 100 ml and I ml of cells 
with the ODeoo of 0.6 were added as in previous experiments. All flasks were 
incubated microaerobically at 37°C shaking at 150 rpm. This experiment was 
performed in triplicate.
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2.32 Cobalt and nickel transport function for CorA
This experiment was carried out to investigate the phenotype of the corA 
mutant with respect to cobalt and nickel transport. For the control flasks with only 
MHB, 500 pi of the and wild type cultures were added to each flask. MHB was 
added to make a total volume of 50 ml. For the flasks containing 1 mM of nickel and 
cobalt, 50 pi of IM of each compound was added to make a total concentration of 1 
mM, and MHB was then added to make a total volume of 50 ml. For the other 
concentrations used in this experiment (2.5 mM and 5.0 mM) the volume of the 
additions was adjusted accordingly. Five hundred pi of C. jejuni culture, wild type 
and corA mutant were added to the flasks. The flasks were incubated at 37°C 
microaerobically and sampled at interval times thereafter as mentioned in Section 2.4. 
All experiments were performed in triplicate.
2.33 Motility experiments with the C. jejuni strain
The motility experiment was based upon the swarming of bacterial cells on 
semisolid agar. The 11168H strain is hypermotile and was expected to give rise to 
larger zones of motility. A 48 hour C. jejuni eulture was grown on MHA and cells 
were scraped from the plate and resuspended in 0.1 M PBS pH 7.4 to obtain a 
bacterial eount of approximately 10  ^ cfu/ml. Twenty-five ml of 0.4% MHA (semi­
solid) in a Petri dish was stabbed with 1 pi and 5 pi of the strains. Where corA 
mutants were being assessed the semi-solid agar was supplemented with 20 mM Mg. 
This experiment was performed in duplicate for each strain tested. To overcome any 
inconsistencies which may have affeeted bacterial swarming, one batch of semisolid 
agar medium was used per experiment. The plates were incubated in microaerobic 
conditions at 37°C. After 18 hours, the diameter of zone of motility was measured in
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cm. This assay was done in triplicate and in 3 independent experiments. Two-tailed 
Student's t tests were used to compare motility differences between strains.
2.34 Tissue culture
2.34.1 Culture of mammalian cell lines
Caco-2 (Human Caucasian embryonic intestine, epithelial. ECACC 85051004) 
cells were obtained from the European Collection of Animal Cell Cultures (ECACC, 
CAMR, Porton Down, Salisbury). The frozen ampoules were thawed quickly and 
added to 10 ml of pre-warmed DMEMIO medium (Invitrogen, UK). Cells were 
pelleted by centrifogation at 80 g for 5 min. The supernatant was removed and the 
cells re-suspended in 25 ml of complete medium and added to a sterile 250 cm  ^
polypropylene tissue culture flasks, The cells were ineubated at 37°C in 5% (v/v) CO2 
until a confluent monolayer was present. Confluent monolayers were trypsinised with 
0.05% (w/v) trypsin / 0.02% (w/v) EDTA in PBS and split in the ratio of 1:3 to 1:6.
2.34.2 The gentamicin protection invasion assay
A twenty-four-well tissue culture plate was seeded with Caeo-2 cells at a 
concentration of 2 x 10  ^ cells per well and incubated at 37°C with 5% (v/v) CO2 for 
48 hours to establish confluent monolayer (approx. 5x10^ cells per well). On the day 
of the assay, the monolayers were washed twice, with 2 ml Hank’s Balanced Salt 
Solution (HBSS) (Invitrogen, UK) per well, to remove any residual antibioties. 
Finally 900 pi of incomplete medium (Invitrogen, UK) per well was added.
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A volume of 0.1 ml of the bacterial suspension (10^ cfu/ml) was added to the 
maintenance medium covering the cell monolayers in the wells to give a bacterial to 
cell ratio of 1:200 or multiplicity of infection (MOI) o f200. Infected monolayers were 
incubated at 37°C in 5% (v/v) CO2 for three hours to allow the bacteria to invade the 
cells. The monolayers were washed three times with 2 ml HBSS. To inactivate any 
external bacteria that had not invaded, 2 ml of incomplete medium containing 
gentamicin at 250 pg/ml was added to each well and these incubated for a further two 
hours. Following incubation the monolayers were washed three times with HBSS as 
before and lysed with I. ml of 1% (v/v) Triton X-100 in PBS. A magnetic stirrer bar 
( 10x5  mm) was placed in each well of the 24-well plate. The plate was placed on a 
magnetic stirrer and after the Triton-X-IOO solution had been added these were stirred 
at approximately 100 rpm for 10 minutes. The total number of viable bacteria per well 
was determined by serially diluting the Triton-X-IOO lysed monolayer solution with 
PBS (neat to 10'^) and plating out 100 pi onto pre-dried BMHA plates. The plates 
were incubated for 24 hours at 37°C under microaerobic conditions and the colonies 
counted as mentioned in Section 2.4. Each isolate was tested in triplicate wells in 3 
independent experiments.
2.35 In vivo experiments
2.35.1 In vivo Galleria mellonella virulence model assay
Galleria melonella model system was used as an infection model to examine 
the CorA and its role in pathogenesis of C. jejuni. G. mellonella larvae were 
purchased from Live Foods UK Ltd (Rooks Bridge, Somerset, UK) and kept on wood 
chips at 15°C. Petri dish with a size of 100 x 18 mm were used to house the Galleria
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during the infection experiments, and a 90 mm Whatman # 1 filter paper was placed 
at the base of the Petri dish for the Galleria to crawl over. Petri dishes were labelled 
as non-infected, infected and control.
Campylobacter strains were cultured and grown as previously described in 
section 2.4. After centrifugation at 3,000 g for 10 minutes, the cell pellet was 
resuspended in 1 ml O.IM PBS (pH 7.2) to give a concentration of 1x10^ CPU ml'  ^
and this suspension was transferred to i.5 ml sterile tubes. For the control experiment, 
10 non-infected Galleria larvae were placed on to a Petri dish. For the infections, ten 
healthy Galleria were selected and placed into a Petri dish for eaeh strain. Prior to 
inoculation, the Galleria larvae were picked and placed into a new Petri dish using 
sterile forceps. The larva was pinned on its baek using the left thumb and forefinger, 
over a 1 ml pipette tip. A Hamilton® syringe was then used to inject 10 pi of the 
bacterial inoculum into the top right proleg of the Galleria larvae. The larvae were 
then placed into an appropriately labelled Petri dish which contained 10 larvae per 
group. After each infection, the Hamilton® syringe was disinfected with absolute 
ethanol and rinsed with sterile milli-Q water. Once the larvae had been infected, they 
were incubated at 37°C for 24 hours before scoring. The qualitative scoring of each of 
the infected Galleria was done by counting the number of dead for every Petri dish, 
assessing the colour of the Galleria larvae, by observing the presence of diarrhoea and 
observing whether the larvae could easily turn over if placed on their baeks. After 
scoring, the Petri dish containing the Galleria was plaeed at -20°C for at least 30 
minutes to euthanize the larva before autoclaving.
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For the histopathology analysis, C. yeywzzz-infected and unfected larvae were 
fixed by immersion in 10% (v/v) neutral buffered formalin for 3-7 days, and sent to 
AHVLA for histopathology analysis.
2.35.2 Chicken colonisation
A quantitative oral-chick colonisation assay was performed as described by 
Wassenaar et al., 1993. Specific pathogen free white Leghorn chicks were obtained 
fi-om Lohmanns, Germany and divided into 3 groups where 20 chicks were randomly 
seleeted and housed in 3 negative pressure isolators. At one day old, the chieks were 
challenged with C. jejuni 11168 wild type and the corA mutant by oral gavage. Group 
1 was given 10"^  cfu C. jejuni 11168 wild type whereas Group 2 and 3 were given 10"^  
cfu C. jejuni 11168 corA mutant. Group 1 and 2 were given untreated drinking water 
while Group 3 was given 50 mM MgCL supplemented drinking water. All the chicks 
were observed twice daily during this study. At day 5 and 14 following the oral 
gavage challenge, 10 birds per group were euthanized and post-mortem procedure 
was carried out to remove the caeca of the birds. Plate counting was performed to 
determine the C. jejuni in the cecum. This technique was carried out as mentioned in 
section 2.4.
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CHAPTER THREE
An investigation into the 
antimicrobial effects of metal 
peroxides and other oxygen releasing
compounds
Chapter 3: An investigation into the antimicrobial effects of 
metal peroxides and other oxygen releasing compounds.
3.1 Introduction
According to their chemieal composition, antibacterial agents can be divided 
into two categories, inorganic and organic agents. However, the disadvantages of 
using organic antibacterial agents in the environment and foods make these less 
popular than the inorganic agents. Problems include low heat resistance, high 
deeomposability and short life expectancy. Inorganic antimicrobial agents such as 
metal oxides are increasingly being used because of their stability under high 
temperatures and also because they are safe for human beings and animals 
(Stoimenov et ah, 2002; Dastjerdi & Montazer, 2012; Zollfrank et al., 2012). For 
example, AgNOs has been has been shown to have antimicrobial properties against S. 
aureus, E. coll and Pseudomonas aeruginosa (Balogh et al., 2001). Fang et al., in 
2006 also reported the antimicrobial properties of basic magnesium hypochloride 
against several important pathogens and Sawai in 2003 reported the antibacterial 
activities of various metallic oxide powders namely ZnO, MgO and CaO against E. 
coli and S. aureus (Sawai, 2003; Fang et al., 2006). ZnO is a metal oxide that has 
been shown to have a wide range of antibacterial activities against both Gram positive 
and Gram negative bacteria, including major food-borne pathogens (Sawai, 2003; 
Jones et al., 2008). One of the proposed mechanisms of the antibacterial function of 
ZnO is disruption of cell membrane activity (Sawai, 2003) or alternatively it may be 
due to the production of intercellular reactive oxygen species that are harmful to 
bacterial cells. One of the problems with metal oxides and peroxy compounds,
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however might be that in contact with ordinary combustible materials, they could pose 
fire or explosion hazard. They might also react with organic compounds to generate 
organic peroxides and hydroperoxides. Examples of some inorganic peroxy 
compounds are sodium peroxide, hydrogen peroxide, sodium perborate and sodium 
persulfate.
3.1.1 Mg02
Magnesium peroxide (MgOi) is an oxygen releasing agent which slowly 
decomposes to generate oxygen when in contact with hydrous media or water. It is a 
fine, odourless and tasteless, white powder, and the most temperature stable inorganic 
peroxide. It is environmentally friendly and often used as a bleaching, disinfecting 
and deodorizing agent. It is also widely used in the agricultural, environmental, 
pharmaceutical and cosmetic industries (Walawska et al., 2007). In addition, this 
eompound has been used in water treatment plants to eliminate cyanogens and heavy 
metals in industrial waste water. It is also capable of reducing the levels of 
contaminants in groundwater. It has also been used to assist in the remediation of 
petroleum hydrocarbons found in groundwater and in the bioremediation of 
contaminated soils to enhance and improve the soil quality for plant growth and 
metabolism (Chang et al., 2008).
In the aquaculture industry, it is used to release aqueous oxygen, adjusting 
water pH and lowering the aqueous ammonium/nitrogen content. Borden et al., in 
1997 demonstrated that MgO] released oxygen for up to 300 days while the CaO] and 
H2O2 only released oxygen up to 100 and 10 days respectively (Borden et al., 1997).
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3.1.2 CaO]
Another peroxy compound that was used in this study was ealeium peroxide 
(CaO]). CaO], which is another oxygen releasing compound, will immediately 
decompose into hydrogen peroxide (H2O2) and calcium hydroxide (Ca(OH)]) when in 
contact with water (H]0), and thus will eventually liberate 0].
CaO] + 2H]0 —^  Ca(OH)] + H2O2 
2H2O2 —^  O] + 2H]0
Caleium hydroxide Ca(OH)] is a strong alkaline substance, with a pH of 
approximately 12.5. In an aqueous solution, Ca(OH)] dissociates into calcium and 
hydroxyl ions.
Ca(OH)] has been widely used in endodontics since its introduction in 1920 
(Siqueira & Lopes, 1999). Ca(OH)] has also been recommended for use in several 
clinical situations and is acknowledged as one of the most effective antimicrobial 
dressings during endodontic therapy (Heithersay 1975). CaO] has been used by Park 
et a l, in 2006, to enhance the remediation of soil (Park et aL, 2006). In their study, 
the authors used the CaO] to enhance the ability of Shepherds’ Purse roots to 
remediate soil contaminated with 2,4-dichlorophenol. In addition, CaO] has also been 
used as a slow oxygen releasing agent for bioremediation of polluted sediments from 
intensive shrimp farms containing high organic carbon, nitrogen and phosphorus 
(Hanh et aL, 2005). This substance has been shown to have various biological 
properties such as antimicrobial activity (Bystrom et aL, 1985), tissue-dissolving 
ability (Hasselgren et aL, 1988, Andersen et aL, 1992), inhibition of tooth resorption
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(Tronstad, 1988) and the induction of repair in hard tissue formation (Foreman & 
Barnes 1990).
3.1.3 2Na2C03.3H202
The third peroxy compound used in this study was sodium percarbonate 
(2Na2C03 .3H202). It derives from sodium carbonate and hydrogen peroxide. It is a 
colourless, erystalline, hygroscopic and water soluble liquid. It will dissolve in water 
and produce hydrogen peroxide (which will eventually decompose to water and 
oxygen) and sodium carbonate.
2Na2C03.3H202 2Na2C03 + 3H2O2
2H2O2 ^ 2H20 + O2
2Na2C03 .3H202 is used in laundry products and many other cleaning products 
for bleaching, cleaning, and its stain removal capabilities. It is also used in the laundry 
industry to whiten, destain and to remove dirt from clothes. It is also an effective 
laundry pre-soak and when used in hot or warm water effectively removes heavy 
stains on clothes or materials. In contact with water, 2Na2C03 .3H202 will remain 
active for 5 to 6 hours. It is a biodegradable compound and breaks down into water, 
oxygen and soda ash. Its use is not limited to clothing materials, and 2Na2C03 .3H202 
is also used to clean kitchen appliances such as refrigerators as well as small kitchen 
appliances such as plastic ware, dishes, and to de-stain stained coffee and tea pots. It 
is also used to eliminate mould, mildew and other organic stains and to clean most
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domestic surfaces such as in the toilet or bathroom and kitchen counter tops, 
fireplaces, bricks, and almost everything in the household.
2Na2C03 .3H202 has been reported to have a low toxicity with an L D 5 0  of 
more than 1000 mg/kg bodyweight via the oral and dermal route (Fernandez et aL, 
2010). In addition, there is no concern of possible issues with genotoxicity or 
carcinogenieity following exposure to sodium percarbonate in humans. The only 
coneern is the possibility of local irritation to exposed skin during hand washing. It is 
however estimated that the concentration of the 2Na2C03 .3H202 in commercial 
products is often too low to cause skin irritation. However, exposure of the eyes to 
this compound by accident may cause eye irritation.
Campylobacters lack some important stress response factors such as RpoS 
(global stationary phase stress response), SoxRS and OxyR (oxidative stress response 
(Park, 2002), and are very sensitive to environmental stresses such as nutrient 
depletion, dehydration, low pH, and oxygen. However, a number of genes/proteins 
that play critical roles in protecting cells fi-om different stresses, especially oxidative 
stress, have been identified (Palyada et aL, 2009). Campylobacter is microaerophilic 
in nature, and thus oxidative stress is likely to place severe limitations on its growth 
and survival. Given its sensitivity to oxygen, this study was carried out to assess the 
killing efficacy of several oxygen liberating compounds, namely magnesium peroxide 
(Mg02), sodium percarbonate (2Na2C03 .3H202) and calcium peroxide (Ca02) on the 
survival of Campylobacters.
3.2 Results
3.2.1 Survival of C. jejuni in the presence of 2Na2C0 3 .3H202 in MRD
As a widely used and readily available oxygen liberating agent, sodium 
percarbonate (2Na2C0s.3H202) was chosen as a source of reactive oxygen species 
that might be toxic to microaerophilic Campylobacter. To gain an understanding of 
the antibacterial activity of 2Na2C03 .3H202, survival assays were carried out in liquid 
systems. The graph presented in Fig.3.1 shows the survival curve of C. jejuni when 
treated with 2Na2C03 .3H202 under aerobic conditions with an incubation temperature 
of 25°C. The viability of the bacteria was determined using plate counts with Miles 
and Misra technique.
Fig.3.1 illustrates that C. jejuni died rapidly after it was exposed to 
2Na2C03 .3H202. At the start of the experiment, the same inoculum was used for 
every assay with the same number of cells. However, due to the immediate killing 
effect of this compound, the treated cells have shown a rapid reduction even at 0 
times, which did not reflect the starting inoculum at this time. Cells treated with 2.6 
mM and 5.2 mM 2Na2C03 .3H202 showed a 3-log and 4-log reduction in survival 
within 10 minutes respectively and no viability observed after just 15 minutes. On the 
other hand, in the absence of 2Na2C03 .3H202, cells showed no decrease in survival 
over a period of 60 minutes.
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Figure 3.1: A histogram showing the survival of C. jejuni NCTC 11168 in the 
presence of different concentrations of 2Na2C03 .3H202 using BMHA for recovery. C. 
jejuni was incubated aerobically at 25°C, 150 rpm with no additions of 
2Na2C03 .3H202 (■), or to which 10 ml of 1 M Potassium Phosphate Buffer (■) had 
been added or with the addition of 2.6 mM (■) and 5.2 mM (■) of 2Na2C03 .3H202. 
Survival was assessed by plate counting using BMHA incubated under 
microaerophilic condition at 37°C for 48 hours. Data shown are a mean of triplicates. 
Bars indicate one standard error of the mean.
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3.2.2 Survival of C. jejuni in the presence of 2Na2C0 3 .3H202 in UHT skimmed 
milk
To determine whether 2Na2C0s.3H202 would be effective at reducing the 
survival of C  jejuni in a complex food commodity, survival experiments were 
repeated at 25°C but using UHT skimmed milk. In this experiment, 2Na2C0s.3H202 
proved again to be highly effective at killing C. jejuni in skimmed milk. When the 
recovery of C. jejuni was measured (Fig.3.2), in the absence of 2Na2C03 .3H202 
survival was constant over an 8 hour period with no decrease in cell counts. However, 
for cells treated with 2.6 mM and 5.2 mM 2Na2C03 .3H202 viability had fallen to 
undetectable limits within 1 hour, giving rise to a 5-log and 4-log reduction in 
viability respectively.
3.2.3 Survival of other non-mlcroaerophilic food-borne pathogens in the 
presence of 2Na2C0 3 .3H202
Other more aerotolerant food-borne pathogens, namely Salmonella 
Typhimurium and Listeria monocytogenes were also assessed for sensitivity to 
2Na2C03 .3H202. S. Typhimurium showed a reduction in survival of 7-logs cfu/ml 
when treated with 2.6 mM and 5.2 mM sodium percarbonate over a period of 24 hours 
and 8 hours respectively when exposed to this agent (Fig.3.3a).
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Figure 3.2: A histogram showing the survival of C. jejuni NCTC 11168 in UHT 
Skimmed Milk in the presence of different concentrations of 2Na2C03 .3H202 when 
recovery was measured on BMHA. C. jejuni was incubated aerobically at 25°C, 150 
rpm with no additions of 2Na2C03 .3H202 (■), or to which 10 ml of 1 M Potassium 
Phosphate Buffer (■) had been added or with the addition of 2.6 mM (b) and 5.2 mM 
(b) of 2Na2C03 .3H202. Survival was assessed by plate counting using BMHA 
incubated under microaerophilic condition at 37°C for 48 hours. Data shown are a 
mean of triplicates. Bars indicate one standard error of the mean.
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Fig 3.3a: Survival of S. Typhimurium challenged with 2Na2COs.3H202. S. 
Typhimurium in MRD alone (♦), or to which 10 ml of 1 M PPB was added (■), or 
when S. Typhimurium was treated with 2.6 mM ( ) and 5.2 mM (x) 
2Na2COs.3H202. Data shown are a mean of three independent experiments. Bars 
indieate one standard error of the mean. Downward pointing arrows indicate that the 
eount was below the limit of detection.
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In addition, exposure of Z. monocytogenes to this agent gave rise to a 
reduction of 7-logs cfu/ml when treated with 2.6 mM and 5.2 mM 2Na2C0s.3H202 
over a period of 24 hours and 4 hours respectively (Fig. 3.3b). Both of these results 
indicate. that whilst sodium percarbonate is baeterieidal towards other food-borne 
pathogens, C. jejuni, and presumably other mieroaerophilic Campylobacters are 
hypersensitive to 2Na2C0s.3H202.
3.2.4 The survival of C. jejuni in MRD containing MgOi
Sodium perearbonate is powerful oxygen based bleach and might also cause 
damage and organoleptie ehanges to the produets exposed to it, and are relatively 
expensive. So whilst it was effeetive against Campylobacters, another oxygen 
releasing agent was investigated. To gain an understanding of the antibaeterial activity 
of MgÛ2, survival assays were earried out in liquid systems. The graph presented in 
Fig.3.4 shows the survival curve of C. jejuni when exposed to MgÛ2 and ineubated 
under aerobic conditions with an incubation temperature of 25°C. The viability of the 
bacteria was determined using the Miles and Misra teehnique. Fig.3.4 illustrates that 
C. jejuni died rapidly after it was exposed to MgÛ2 and this effeet was proportional to 
the eoncentration used. Cells treated with 0.26 mM Mg02 showed no viability after 32 
hours, whereas loss of viability in cells treated with 2.6 mM and 5.2 mM oeeurred 
after just 8 hours and 4 hours respectively. On the other hand, in the absence of Mg02, 
or when PPB was added to the eultures (the solvent for Mg02) as a control, cells 
survived for over 120 hours, thus indicating the baeterieidal effect was due to Mg02 .
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Fig 3.3b: Survival of L. monocytogenes challenged with 2Na2C03 .3H202. L. 
monocytogenes in MRD alone (♦), or to which 10 ml of IM PPB was added (■), or 
when the L. monocytogenes was treated with 2.6 mM ( ) and 5.2 mM (x) of 
2Na2C03 .3H202. Data shown are a mean of three independent experiments. Bars 
indicate one standard error of the mean. Downward pointing arrows indicate that the 
count was below the limit of detection.
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Figure 3.4: Survival of C. jejuni NCTC 11168 in the presence of different 
concentrations of MgO] using BMHA for recovery. C. jejuni was incubated 
aerobically in MRD at 25°C, 150 rpm with no additions of MgO] (■), or to which 10 
ml of 1 M Potassium Phosphate Buffer ( ♦ ) had been added or with the addition of 
0.26 mM ( ), 2.6 mM (□) and 5.2 mM (0) of MgO]. Survival was assessed by plate 
counting incubated under microaerophilic conditions at 37°C for 48 hours. Data 
shown are a mean of three independent experiments. Bars indicate one standard error 
of the mean. Downward pointing arrows indicate that the count was below the limit of 
detection.
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3.2.5 The effect of MgO] on other non-mieroaerophilic food-borne pathogens
Aerobic organisms such as Listeria monocytogenes and Salmonella 
Tyhpimurium must also deal with reactive oxygen species to avoid oxidative damage. 
However, microaerophilic organisms are generally more sensitive to oxidative stress, 
thus an experiment was carried out to determine whether or not MgO] was also active 
against aerobic food-borne pathogens. In general, the survival of S. Typhimurium and 
L. monocytogenes in MRD in the absence of MgO] was almost constant over a period 
of 120 hours (Fig.3.5). When the survival of L. monocytogenes and S. Typhimurium 
was assessed in the presence of 5.2 mM MgO], S. Typhimurium showed a reduction 
in viable cells of 8-logs cfu/ml over a period of 32 hours. On the other hand, L. 
monocytogenes was more resistant, showing a gradual decrease in counts of 3-logs in 
the same time period and viability fell to undetectable limits only after 96 hours. 
These two species of aerobic food-borne pathogen showed sensitivity to MgO], but to 
a much lesser extent compared to C. jejuni which died in just 4 hours of exposure to 
the same concentration of MgO].
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Figure 3.5: Survival of aerotolerant food-borne pathogens and C. jejuni in the 
presence of MgO]. Cells of S. Typhimurium ( ), L. monocytogenes (*) and C. jejuni 
(♦) were incubated in the absence of Mg02 and when 5.2 mM MgO] was added to S. 
Typhimurium (x), L. monocytogenes (•) and C. jejuni (■) inoculum cultures 
respectively. Survival was assessed by plate counting using NA incubated aerobically 
for aerobic pathogens and using BMHA incubated mieroaerophically for C. jejuni, at 
37°C overnight. Data shown are based on triplicate experiments. Downward pointing 
arrows indicate that the count was below the limit of detection. Bars indicate one 
standard error of the mean.
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3.2.6 Survival of C. jejuni in Ultra Heat Treatment (UHT) skimmed milk 
containing MgOz
Milk is one of the most common vehicles for the transmission of C. jejuni to 
human beings. To determine whether MgO] would be effective at reducing the 
survival of C. jejuni in a complex food commodity, survival experiments were 
performed at 25°C in UHT skimmed milk. This type of milk was chosen because it 
would be free of a significant bacterial load, allowing C. jejuni to be easily isolated 
and without the use of selective media. In this experiment, MgO: proved to be highly 
effective at killing C. jejuni in skimmed milk. When the recovery of C. jejuni was 
measured (Fig.3.6), in the absence of MgO], survival declined gradually over a period 
of 80 hours and had fallen to the undetectable limit in 96 hours. When 2.6 mM and
5,2 mM MgÛ2 was added, survival declined to undetectable levels in just 8 and 4 
hours respectively.
3.2.7 Survival of C. jejuni in soil containing MgOz
It has been proved that C. jejuni can survive in groundwater and soil for 
months where several factors including soil moisture and temperature influence its 
survival (Nicholson et a l, 2005). Land application of metal peroxides to farm soils 
and poultry bedding may be a potential antibacterial treatment to reduce the 
opportunity for transfer of C. jejuni from soils to frocks, within frocks, and ultimately 
to humans. With this in mind, the survival of C. jejuni in soil was assessed in the 
presence or absence of undissolved MgÛ2 powder. When C. jejuni in soil was treated 
with Mg02, a dramatic decrease in the viability of this bacterium was observed when 
recovered on BMHA.
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Figure 3.6: Survival of C. jejuniNCTC 11168 in UHT Skimmed Milk in the presence 
of different concentrations of MgO] when recovery was measured on BMHA. C. 
jejuni was incubated aerobically at 25°C, 150 rpm with no additions of MgO] (♦), or 
to which 10 ml of 1 M Potassium Phosphate Buffer (■) had been added or with the 
addition of 2.6 mM ( ) and 5.2 mM (□) of MgO]. Survival was assessed by plate 
counting using BMHA incubated under microaerophilic condition at 37°C for 48 
hours. Data shown are a mean of triplicates. Bars indicate one standard error of the 
mean. Downward pointing arrows indicate that the count was below the limit of 
detection.
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In the absence of Mg02, survival declined less than 3-logs over a period of 50 hours 
(Fig. 3.7a). When 0.05 g and 0.1 g of Mg02 powder were added, the survival showed 
a reduction of 5-logs and 3-logs in 24 hours and no viable cells were detected after 32 
hours and 48 hours respectively. An 8-log reduction was seen when C. jejuni was 
treated with 0.25 g and 0.5 g of Mg02 powder respectively over a period of 8 hours. 
In addition, when C. jejuni was challenged with I.O g Mg02, an 8-log reduction in cell 
count was seen over a period of 4 hours.
When survival was assessed on mCCDA, the same pattern of survival was 
observed where the viability of C. jejuni was generally proportional to the 
concentration of Mg02 treatment (Fig. 3.7b). However, the survival time of C. jejuni 
treated with 0.05 g and 0.1 g Mg02 was seen to be shorter than that measured using 
BMHA, and viability fell to undetectable levels in 32 hours as compared to 48 hours 
in BMHA. This is most likely because of the blood supplementation in the BMHA, 
and the absence of selective antibiotics which can inhibit sub-lethally injured cells.
3.2.8 Persistence of MgOi and H2O2 in soil
To determine the persistence of Mg02 and H2O2 in soil and the retention of 
their anti-Campylobacter activity, an experiment was carried out in a soil sample for 4 
days which was likely to mimic the farm environment. The survival of C. jejuni may 
be used as an indicator for the persistence of both compounds. Both compounds were 
added to the soil for a period of four days and then fresh C. jejuni cultures were
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Figure 3.7a: Survival of C. jejimi NCTC 11168 in soil in the presence of different 
concentrations of MgO] powder using BMHA for recovery. Survival of C. jejuni 
NCTC 111 68 in the absence (♦) or presence of l.Og (■), 0.5g ( ), 0.25g (x), 0.1 g (x) 
and 0.05g (•) MgO] powder in soil using recovery on BMHA. C. jejuni culture was 
added to 5g of soil and challenged with the aforementioned MgO], incubated 
aerobically at 25°C. Survival was assessed by plate counting using BMHA incubated 
under microaerophilic condition at 37°C for 48 hours. Data shown are a mean of three 
independent experiments. Bars indicate one standard error of the mean. Downward 
pointing arrows indicate that the count was below the limit of detection.
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Figure 3.7b: Survival of C. jejuni NCTC 11168 in soil in the presenee of different 
eoncentrations of Mg02 powder using mCCDA for recovery. Survival of C. jejuni 
NCTC 11168 in the absence (♦) or presenee of l.Og (■), 0.5g (A), 0.25g (x), 0.1 g (x) 
and 0.05g (•) MgO: powder in soil using recovery on mCCDA . C. jejuni culture was 
added to 5g of soil and challenged with the aforementioned MgO], incubated 
aerobically at 25°C. Survival was assessed by plate counting using mCCDA incubated 
under microaerophilic conditions at 37°C for 48 hours. Data shown are a mean of 
three independent experiments. Bars indicate one standard error of the mean. 
Downward pointing arrows indicate that the count was below the limit of detection.
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added to the treated soil eaeh day. In this experiment, the soil was treated with 1.0 g 
MgOi powder and 3.33 ml H2O2 (which is equivalent to 1.0 g of H2O2).
When viability was assessed on BMHA it was apparent that these compounds 
can persist, and remain active for up to 4 days as no viable cells were detected in the 
treated soils throughout the period of the experiment (Fig 3.8a). The same pattern of 
survival was observed when C. jejuni was recovered using mCCDA (Fig. 3.8b).
Another experiment was carried out using a lower concentration of each 
compound (0.5 g) (Fig. 3.8c). On day one, the survival of C. jejuni in the presence of 
MgÛ2 showed a 3-log reduction compared to the counts of C. jejuni without treatment 
after 8 hours, and a 5-log reduction in the presence of H2O2. However, statistical 
analysis using the two-tailed t test showed no significant difference between the 
inoculum treated with H2O2 and the control inoculum after 24 hours. There was also 
no statistical difference between the H2O2 treated cell counts after 24 hours as well as 
the MgÛ2 treated cell counts. There was only a 1- to 2-log reduction for both MgÛ2 
and H2O2, that further indicates that at these lower concentrations, MgÛ2 and H2O2 
and their bactericidal activity might persist no more than 48 hours.
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Figure 3.8a: Survival of C. jejuni NCTC 11168 in the absence ( |)  of MgO] and H2O2 
after 8 hours, or in the presenee of 1.0 g (■) Mg02 powder and 3.33 ml (1  ) H2O2 in 
soil using recovery on BMHA, equivalent to a final concentration of 2 M, 
respectively. The initial counts of C. jejuni (% were also assessed. Please note that the 
values of the treated cells ( i )  and ( i )  were below the limit of detection. C. jejuni 
culture was added to 5g of soil and challenged with the aforementioned Mg02 and 
H2O2 concentration, incubated aerobically at 20”C for 8 hours on each sampling day 
up to 4 days. Survival was assessed by plate counting after 8 hours using BMHA 
incubated under microaerophilic condition at 37°C for 48 hours. Data shown are a 
mean of three independent experiments.
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Figure 3.8b: Survival of C. jejuni NCTC 11168 in the absence (I ) of MgO] and H2O2 
after 8 hours, or in the presence of 1.0 g ( | )  Mg02 powder and 3.33 ml (g) H2O2 in 
soil using recovery on mCCDA, equivalent to a final eoneentration of 2 M, 
respectively. The initial counts of C. jejuni (■) were also assessed. Please note that the 
values of the treated cells ( i)  and ( | )  were below the limit of detection. C. jejuni 
culture was added to 5g of soil and challenged with the aforementioned Mg02 and 
H2O2 concentration, incubated aerobically at 20°C for 8 hours on eaeh sampling day 
up to 4 days. Survival was assessed by plate counting after 8 hours using mCCDA 
incubated under microaerophilic condition at 37°C for 48 hours. Data shown are a 
mean of three independent experiments.
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Figure 3.8c: Survival of C. jejuni NCTC 11168 in the absence (1 ) of MgOi and H2O2 
after 8 hours, or in the presence of 0.5g (Q) Mg02 powder and 58 pi ( () H2O2 in soil 
using recovery on BMHA, equivalent to a final concentration of 0.1 M, respectively. 
The initial counts of C. jejuni (g ) were also assessed. C. jejuni culture was added to 
5g of soil and challenged with the aforementioned Mg02 and H2O2 concentrations, 
incubated aerobically at 20°C for 8 hours on each sampling day up to 5 days. Survival 
was assessed by plate counting after 8 hours using BMHA incubated under 
microaerophilic condition at 37°C for 48 hours. Data shown are a mean of three 
independent experiments. Statistical evaluation was done using two-tailed Student’s t 
test.
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3.2.9 Comparison of the bactericidal effect of MgO] on other Campylobacter 
strains
C. jejuni and C. coli are the two main species that cause campylobacteriosis in 
humans. So far, the antimicrobial activity of Mg02 had only been assessed against one 
strain of Campylobacter and therefore, an experiment was carried out to assess the 
bactericidal activity of 5.2 mM MgÛ2 on different strains of Campylobacter. These 
strains included C. jejuni NCTC 11168, NCTC 11352, CJl and CJ2, whereas the C. 
coli strains were C. coli NCTC 12110, NCTC 11437 and NCTC 11350. 
Concentrations of approximately 1x10^ clu/ml cells of these strains were exposed to
5.2 mM Mg02 and in all cases viability was reduced in a similar manner to that seen 
with NCTC 11168 which declined rapidly to undetectable limit within 2 hours of 
exposure (Fig.3.9)fln this particular experiment, the rate of death of C. jejuni ^ C ïC  
11168 was faster when compared to previous experiments in which the same loss of 
viability took 4 hours. This might be due to small errors in the sampling time, or could 
also be due to small differences in the amount of oxygen released by the MgÛ2 when 
in contact with the buffer.
3.2.10 Survival of C. jejuni in the presence of 5.2 mM MgOi with and without 
catalase
As MgÛ2 liberates H2O2 to produce O2, experiments were carried out to 
determine whether H2O2 was involved in cell killing, either as an intermediate or 
directly. When catalase was added alone, it had little impact on C. jejuni survival 
(Fig.3.10). On the other hand, when MgÛ2 was added to cultures, in the absence of
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Figure 3.9; Time needed for an initial eell of count 1 x 10 cfu/ml of each 
Campylobacter strain tested to reach undetectable levels when treated with 5.2 mM 
MgÛ2. All Campylobacter were incubated aerobically in MRD at 25°C, 150 rpm with 
the addition of 5.2 mM Mg02 (■) or no additions (■) of this compound. Survival was 
assessed by plate counting using BMHA incubated under microaerophilic conditions 
at 37°C for 48 hours.
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Figure 3.10: Survival of C. jejuni NCTC 11168 in the presence of MgO] with and 
without the addition of different concentrations of catalase. C. jejuni was incubated 
aerobically in MRD at 25®C, 150 rpm with no additions (♦); or to which 5.2 mM 
MgO] alone (■), or MgO] containing either 1000 (□) and 5000 (•) units of catalase 
had been added. Cultures containing 1000 ( ) and 5000 (x) units of catalase without 
Mg02 were also assessed. Survival was assessed by plate counting using BMHA 
incubated under microaerophilic conditions at 37°C for 48 hours. Data shown are 
representative of a single experiment. Downward pointing arrows indicate that the 
count was below the limit of detection.
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catalase, viability declined to undetectable levels in 4 hours (7-log reduction), yet 
when either 1000 or 5000 units of catalase were present, viability declined by less 
than 1-log in 25 hours. This suggests that the formation of H2O2 from Mg02 is a key 
part of the killing process but whether this effect is directly due to H2O2 or due to 
oxygen release is not yet known.
3.2.11 Survival of C. jejuni in MRD containing CaOz powder, an alternative 
metal peroxide
To gain an understanding of the antibacterial activity of Ca02, survival assays 
were carried out in liquid systems. Unlike Mg02 which was dissolved in PBB, 
survival assays with Ca02 had to be carried out using Ca02 powder as this compound 
is only sparingly soluble in water based systems. When treated with Ca02 under 
aerobic conditions with an incubation temperature o f 25°C, C. jejuni died rapidly and 
as seen before with Mg02 this effect was proportional to the eoneentration used with 
viable counts falling to undetectable levels in 10 minutes and 30 minutes in the 
presence of 5.2 mM and 2.6 mM of Ca02 respectively (Fig. 3.11). On the other hand, 
in the absence of Ca02 , there was no reduction in the total number of cells, thus 
indicating the killing effect was due to Ca02 .
3.2.12 Survival of C. jejuni in UHT skimmed milk containing CaOi
To determine whether Ca02 would be effective at reducing the survival of C. 
jejuni in a complex food commodity, survival experiments were assessed at 25°C in 
UHT skimmed milk, in a similar manner to the experiments described in section
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Figure 3.11: Survival of C. jejuni NCTC 11168 in the presence of different 
eoncentrations of CaO] using BMHA for recovery. C. jejuni was incubated 
aerobically in MRD at 2 5 ° C ,  150 rpm with no additions of Mg02 (♦), or with the 
addition of 2.6 mM (■), and 5.2 mM ( ) of CaOi. Survival was assessed by plate 
counting incubated under microaerophilic conditions at 3 7 ° C  for 48 hours. Data 
shown are a mean of three independent experiments. Bars indicate one standard error 
of the mean. Downward pointing arrows indicate that the count was below the limit of 
detection.
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3.2.6. In this experiment, CaO] proved to be effective at killing C. jejuni but far less 
than when it was present in just MRD. When the recovery of C. jejuni was measured 
(Fig.3.12), in the absence of this metal peroxide and in the presence of 0.26 mM 
CaOi, survival was parallel over a period of 24 hours. When 2.6 mM and 5.2 mM 
Ca02 was added, survival declined by 3- and 2-logs in 6 hours respectively. In MRD, 
in the presence of 5.2 mM Ca02 a six-log reduction in viability was seen in just 10 
minutes (Fig. 3.11) indicatating that milk provides some protection against the killing 
activity of this compound. The same effect was not seen for MgÛ2 (Figs. 3.5 and 3.6) 
suggesting that this compound might provide the most effective bactericidal activity 
in complex organic environments such as food. However, when this experiment was 
repeated and the bactericidal activity of Mg02 and Ca02 compared simultaneously a 
different profile of survival was observed (3.2.13).
3.2.13 Survival of C. jejuni in UHT skimmed milk containing CaO] and MgOi
This experiment was performed to compare MgÛ2 and Ca02 treatments 
simultaneously in the same experiment. When C. jejuni was treated with 0.26 mM 
Ca02 and Mg02 respectively, there was no significant difference between the 
survivals here compared to that seen with the untreated cells (Fig. 3.13). On the other 
hand, when C. jejuni was treated with 2.6 mM and 5.2 mM Mg02, as well as 2.6 
Ca02, the survival showed a gradual reduction and eventually fell to undetectable 
levels over a period of 24 hours. In the presence of 5.2 mM Ca02, C. jejuni showed a 
7-log reduction in viability over a period of 8 hours indicating that in this experiment 
Ca02 was more effective at inactivating C. jejuni than Mg02.
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Figure 3.12: Survival of C. jejuni NCTC 11168 in UHT Skimmed Milk in the 
presence of different eoncentrations of CaO] when recovery was measured on 
BMHA. C. jejuni was incubated aerobically at 25°C, 150 rpm with no additions of 
CaO] (♦), or with the addition of 0.26 (■), 2.6 (A) and 5.2 (x) mM of CaO]. Survival 
was assessed by plate counting using BMHA incubated under microaerophilic 
condition at 37"C for 48 hours. Data shown are a mean of triplicates. Bars indicate 
one standard error of the mean. Downward pointing arrows indicate that the count 
was below the limit of detection.
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Figure 3,13: Survival of C. jejuni NCTC 11168 in the absence or presence of MgO] 
and CaO] at various concentrations in UHT skimmed milk using BMHA for recovery. 
C. jejuni was treated in the absence (♦) or presence of 0.26 Mg02 (■), 0.26 Ca02 
( ), 2.6 Mg02 (x), 2.6 Ca02 (x) and 5.2 mM Mg02 (•) or (+) 5.2 mM Ca02. C. jejuni 
was incubated aerobically in UHT skimmed milk at 25°C, at 150 rpm. Survival was 
assessed by plate counting using BMHA incubated under microaerophilic condition at 
37"C for 48 hours. Data shown are a mean of three independent experiments. Bars 
indicate one standard error of the mean. Downward pointing arrows indicate that the 
count was below the limit of detection.
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3.2.14 Survival of S. Typhimurium in MRD containing CaOz powder
As Ca02 had been shown to be effective against Campylobacters its action was 
also tested against another food-borne pathogen. In the absence of this compound, 
there was little change in the survival of the S. Typhimurium over a period of 4 hours 
(Fig. 3.14). However, when the survival of this food-borne pathogen was assessed in 
the presence of 5.2 mM Ca02, a 7-log reduction in viability occurred in an hour and 
with 2.6 mM, the same reduction was seen in 4 hours. Whilst this oxygen releasing 
compound was bactericidal towards S. Typhimurium, C. jejuni, which only survived 
for 10 minutes and 30 minutes at respective concentrations would appear to be 
hypersensitive to this compound and its action.
3.2.15 Survival of S. Typhimurium in MRD containing either CaOz or MgOz
To compare the killing efficiency of Ca02 and MgÛ2 against S. Typhimurium 
simultaneously, an experiment was carried out in a liquid culture and this pathogen 
was treated with these two compounds. Exposure of this bacterium to 5.2 mM MgÛ2 
caused viability to decline to undetectable levels in 32 hours whereas 5.2 mM Ca02 
caused the same decline in viability of S. Typhimurium within just 1 hour (Fig. 3.15).
3.2.16 Survival of Staphylococcus aureus in MRD containing CaOz and MgOz
Due to their effectiveness in killing C. jejuni and other food-borne pathogens, 
it was decided to test the activity of the metal peroxides against the important 
nosocomial pathogen. Staphylococcus aureus. In these experiments, three strains of S.
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Figure 3.14: Survival of S. Typhimurium in the presence of CaO] in MRD. Cells of S. 
Typhimurium was incubated in the absence (♦) of CaO] and when 2.6 mM (■) and
5.2 mM CaO] ( ) was added to S. Typhimurium inoculum cultures respectively. 
Survival was assessed by plate counting using NA incubated aerobically at 37°C 
overnight. Data shown are based on triplicate experiments. Downward pointing 
arrows indicate that the count was below the limit of detection. Bars indicate one 
standard error of the mean.
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Figure 3.15: Survival of S. Typhimurium in the presence of CaO] and Mg02 using 
BMHA for recovery. S. Typhimurium was incubated aerobically in MRD at 25°C, 
150 rpm with no additions of any compounds (♦), or with the addition of 5.2 mM 
MgO] (■), and 5.2 mM ( ) of CaO]. Survival was assessed by plate counting
incubated under aerobic conditions at 37°C for 24 hours. Data shown are a mean of 
three independent experiments. Bars indicate one standard error of the mean. 
Downward pointing arrows indicate that the count was below the limit of detection.
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aureus were used, namely MRSA 42517 (Fig. 3.16a), S. aureus USCC 1500 (Fig. 
3.16b) and S. aureus NCTC 6571 (Fig 3.16c). In these experiments, only 5.2 mM 
CaO] was observed to be markedly effective in inactivating these organisms and 
generally gave rise to a 7-log reduction, to undetectable levels, but only after 24 hours 
exposure. On the other hand, when MRSA was treated with 2.6 mM and 5.2 mM of 
MgOi, only 2-log reduction was observed in cell counts over a period of 48 hours, 
whereas 2.6 mM CaOi caused less than a 1-log reduction within the same period.
When S.aureus USCC 1500 was treated with these compounds (Fig. 3.16b), a 
6-log reduction in viability was observed in the presence of 5.2 mM CaO: after 8 
hours whereas the lower concentration (2.6 mM) only generated a 2-log reduction 
over a period of 72 hours. When this strain was exposed to 2.6 mM MgOi, no loss in 
viability was measured up to 72 hours, whereas exposure to 5.2 mM Mg02 gave rise 
to a 3-log reduction in cell count after 72 hours. The same pattern of survival was seen 
when these compounds were used with 6". aureus NCTC 6571 (Fig. 3.16c) except that 
in the presence of 5.2 mM Ca02 it took 8 hours for a 7-log decline in viability to 
occur.
119
00
0 8 12 16 20 24 36 524 28 32 40 4844
Time (Hours)
Figure 3.16a: Survival of MRSA 42517 treated with MgO] and CaO] using NA for 
recovery. MRSA was incubated aerobically in MRD at 25°C, 150 rpm with no 
additions (♦) of MgOi or CaO], or to which 10 ml of 1 M Potassium Phosphate Buffer 
(■) had been added or with the addition of 2.6 ( Jjj^  and (x) 5.2 mM of MgO] and 2.6 
(x) and 5.2 (•) CaO] to the inoculum respectively. Survival was assessed by plate 
counting incubated under aerobic conditions at 37°C for 48 hours. Data shown are a 
mean of three in dependent experiments. Bars indicate one standard error of the mean. 
Downward pointing arrows indicate that the count was below the limit of detection.
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Figure 3.16b: Survival of S. aureus USCC 1500 treated with MgO] and CaO] using 
NA for recovery. MRSA was incubated aerobically in MRD at 25°C, 150 rpm with no 
additions of MgO] or CaO:, or to which 10 ml of 1 M Potassium Phosphate Buffer 
(■) had been added or with the addition of 2.6 (J^ and (X) 5.2 mM of MgO] and 2.6 
(X) and 5.2 (•) CaO] to the inoculum respectively. Survival was assessed by plate 
counting incubated under aerobic conditions at 37°C for 48 hours. Data shown are a 
mean of three in dependent experiments. Bars indicate one standard error of the mean. 
Downward pointing arrows indicate that the count was below the limit of detection.
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Figure 3.16c: Survival of S. aureus NCTC 6571 treated with MgO] and CaO] using 
NA for recovery, MRSA was incubated aerobically in MRD at 25°C, 150 rpm with no 
additions ( ❖ ) of MgO] or CaO], or to which 10 ml of 1 M Potassium Phosphate 
Buffer ( 0 had been added or with the addition of 2.6 ( ^  and (X) 5.2 mM of MgO] 
and 2.6 (X) and 5.2 (•) CaO] to the inoculum respectively. Survival was assessed by 
plate counting incubated under aerobic conditions at 37°C for 48 hours. Data shown 
are a mean of three in dependent experiments. Bars indicate one standard error of the 
mean. Downward pointing arrows indicate that the count was below the limit of 
detection.
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3.2.17 Characterization of the change in pH following CaOz treatment
Ca02 is converted into Ca(0H)2 during its deeay whieh ean be a strong alkali. 
To determine whether medium alkalinity, due to the formation of Ca(0H)2, was 
responsible for the killing of C. jejuni, the pH of the medium treated with this 
eompound was assessed at various time points. Previously, when the same experiment 
was earried out with Mg02 the treated eultures remained a pH 6.0 irrespective of the 
eoneentration used (Mohd Esah, 2009) demonstrating that the antimierobial 
meehanism was not likely due to be related to pH. However, when C. jejuni was 
treated with Ca02 (Fig. 3.17), the pH of the medium rose to a range between pH 9 to 
pH 10 when treated with 2.6 mM Ca02, and to pH 9 to pH 11 when treated with 5.2 
mM Ca02. The faet that the medium beeame highly alkaline, suggests that the 
meehanism of Ca02 killing is likely to be due to pH eombined with oxidative stress 
generated from the formation of H2O2 and O2.
3.2.18 Survival of C. jejuni at alkaline pH
Due to the alkalinity of the medium treated with Ca02, the survival of C. 
jejuni at pH 10 was studied to determine if the baeterieidal meehanism of Ca02 is due, 
at least in part, to the alkaline pH due to the formation of Ca(0H)2. This experiment, 
demonstrated that Campylobacters were rapidly killed at this pH value as the viable 
eount fell to undetectable levels in 8 hours (Fig. 3.18). The alkalinity generated by 
Ca02 then must play a major role in the killing of C. jejuni, and the other pathogens 
tested, by this eompound. This is not the ease with Mg02 though as the pH did not 
beeome alkaline and eatalase inhibited its aetion.
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Figure 3.17: The pH of C. jejuni inoculum when incubated in MRD, without the 
addition of CaO] ( and with the addition of 2.6 mM ( |  and 5.2 mM (J) Ca02. The 
pH was measured on each sampling time over a period of 16 hours. Data shown are a 
mean of three independent experiments. Error bars represent +/-1 standard error of the 
mean.
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Figure 3.18: The effect of pH on the survival of C. jejuni NCTC 11168 at two 
different pH values. C. jejuni was inoculated into MHB at pH 7 (♦) and pH 10 (■) 
and incubated under aerobic conditions at 25°C with shaking at 150 rpm. Survival 
was assessed by plate counting using BMHA, incubated aerobically at 37°C 
overnight. Data shown are based on triplicate experiments. Downward pointing 
arrows indicate that the count was below the limit of detection. Bars indicate one 
standard error of the mean.
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3.2.19 Morphological changes in C. jejuni when treated with MgOi and CaOi as 
observed using an electron microscope
Transmission electron microscopy (TEM) provides direct visualisation of the 
morphological changes in microorganisms that may occur as a result of antimicrobial 
treatment. The effect of Mg02 and CaOi on C. jejuni cell morphology was examined 
by using transmission electron microscopy. After a 4 hour treatment with 5 mM of 
MgO: and CaO] in MH broth, spiral-shaped C. jejuni cells underwent a dramatic 
change from spiral to coccoid morphological forms. It is also apparent that the cell 
envelope of Campylobacter is significantly damaged upon peroxide treatment and 
eventually this causes the cell contents to leak out (Fig 3.19). The image of untreated 
cells clearly shows the typical spiral shape of C. jejuni with intact polar flagella (Fig. 
3.19a-b).
Transmission electron microscopy also demonstrated that treatment by these 
two peroxy compounds gave rise to different changes in the cell integrity and 
conformation in C. jejuni. Exposure to Ca02 resulted in the formation of an irregular 
conformation and the loss of the structural integrity of the cell wall as well as loss of 
its polar flagella (Fig 3.19c-d). On the other hand, when this organism was treated 
with MgÛ2 (Fig. 3.19e-i), this gave rise to a predominance of coccoid forms with 
irregular cell surfaces and cell wall blebs.
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Figure 3.19: Transmission electron micrograph images showing morphological 
changes in C. jejuni NCTC 11168 when treated with 5 mM CaO] and MgO] 
respectively, (a) Image of untreated C. jejuni cell and buffer treated cells (b), both 
represent control cells. Image (c-d) showing C. jejuni cells treated with CaO] whilst 
image (e-i) shows C. jejuni cells treated with MgO]. Numerals to the right of scale 
bars represent pm.
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3.3 Discussion
Campylobacter jejuni is a major cause of gastroenteritis in humans, causing 
acute bacterial enteritis worldwide. The symptoms caused by C  jejuni are generally 
mild, often self-limiting, and last between 3-7 days (Humphrey et al., 2007). 
However, its serious sequelae such as Guillam-Barre Syndrome (GBS) are a potential 
source of more severe disease (McCarthy & Giesecke, 2001; Islam et al., 2012). 
Oxygen generating compounds such as magnesium peroxide (MgO]), calcium 
peroxide (CaO:) and sodium percarbonate (2Na2C03 .3H202) may lead to oxidative 
stress dependent killing and might be applied to reduce transmission of C. jejuni given 
its microaerophilic nature and inherent sensitivity to oxidative stress. Mg02 and Ca02 
are both highly insoluble but will release oxygen in contact with water.
To identify the agents with potential antibacterial effects, particularly with 
regard to Campylobacters, the three aforementioned oxygen generating compounds 
were selected for studies in liquid broth culture with aeration. In order to examine the 
antibacterial activity of the metal peroxides against various microorganisms, survival 
was assessed initially in Maximum Recovery Diluent (MRD) in order to avoid any 
interference from media components.
All of the oxygen generating compounds used in this study had remarkable 
antibacterial activity against C. jejuni (and to some extent other food-borne 
pathogens) even at very low concentrations. The metal peroxides were selected for 
further study because of their slow release of oxygen, their non-bleaching action, low 
cost, and low toxicity. This study demonstrated for the first time that C. jejuni
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exhibited a rapid loss in viability when the bacteria were exposed to the metal 
peroxides in MRD, Ultra-Heat Treated (UHT) skimmed milk and soil. The 
concentration of these metal peroxides was found to be an important factor affecting 
the survival of C. jejuni with higher concentrations killing this bacterium more 
rapidly.
Preliminary experiments were carried out to determine the antibacterial effect 
of the oxygen releasing compound, sodium percarbonate (2Na2C03 .3H202). It was 
observed that exposure to 5.2 mM of this compound generated a 6-log decline in C. 
jejuni cell count within 15 minutes in MRD and within an hour in UHT skimmed 
milk. Because the first time point used to determine plate count in UHT skimmed 
milk was 1 hour, it would be worthwhile to assess this survival in a shorter period of 
time, for example, within a few minutes. Nevertheless, this compound still possessed 
a potent antibacterial property against C, jejuni perhaps due to the reactive oxygen 
species generated. When sodium percarbonate was used against S. Typhimurium and 
L. monocytogenes, concentrations of 2.6 mM and 5.2 mM caused a 7-log reduction in 
cell within 24 hours and 4 to 8 hours respectively. This could also indicate the 
effectiveness of using this compound as an alternative effective antimicrobial agent 
against important food-borne pathogens.
Sodium percarbonate is a powerful oxygen based bleach and might also cause 
damage to, and changes to the organoleptic properties of the food products exposed to 
it. This compound is also relatively expensive. So whilst it was effective against 
Campylobacters, another oxygen releasing agent was investigated. Mg02 at 
concentrations of 0.26 mM, 2.6 mM and 5.2 mM in MRD reduced the viability of C.
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jejuni to undetectable levels within 32 hours, 8 hours and 4 hours respectively, whilst 
in the absence of MgO:, C. jejuni survived up to 140 hours. The effectiveness of this 
compound against other major food-borne pathogens was also assessed. When 
Salmonella enterica serovar Typhimurium and Listeria monocytogenes were 
challenged with 5.2 mM MgÛ2, they too showed a reduction in viable cell counts 
compared to the controls, but the time required to give rise to a 7-log reduction was 
much longer than for C. jejuni, indicating that C. jejuni is hypersensitive to this 
oxygen liberating compound. In detail, exposure to 5.2 mM Mg02 generated a 7-log 
reduction in cell counts of L. monocytogenes cells within 96 hours and 32 hours for S. 
Typhimurium, as opposed to C. jejuni which declined to undetectable levels within 4 
hours following exposure to the same concentration of Mg02 .
Survival in MRD offers some useful information in vitro but it may not always 
reflect what occurs in other microcosms. Survival in UHT skimmed milk and soil 
were therefore used to investigate the effect of metal peroxides in other more complex 
environments. The killing efficacy of the oxygen generating compounds was similar 
in complex food commodities such as UHT skimmed milk, demonstrating that these 
agents could be effective at killing C. jejuni in real foods. For example, in UHT 
skimmed milk, Campylobacter cells were not detectable after 4 and 8 hours when 
exposed to 5.2 mM and 2.6 mM Mg02 respectively but these were able to survive for 
up to 96 hours when MgÛ2 was not added.
On-farm transfer of Campylobacter has been recognized as a potential means 
of transfer of this pathogen to food. Livestock and particularly flocks of poultry that 
are infected with Campylobacter can excrete this bacterium into their faeces, and this
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has been implicated as a source of infection in a number of human food-borne 
illnesses. In addition, soil contaminated with faeces infected with Campylobacter will 
subsequently contaminate the groundwater through poorly drained soils and also other 
animals (Ross & Donnison, 2003). Because of its powerful antimicrobial activity in 
MRD and milk, the application of Mg02 in soil and farm environment could be 
potentially used as the antibacterial treatment to reduce the occurrence of 
Campylobacter. When 0.05 g and 0.1 g of MgÛ2 powder were added to 5 g soil 
without being pre-dissolved, initial cell counts of 1 x 10  ^ cfu ml"^  decreased to 
undetectable limits in 48 hours, whereas in soil samples treated with 0.5 g and 0.25 g 
of MgÛ2 an 8-log reduction in cell count was measured in 8 hours. In addition, when 
C. jejuni was challenged with 1.0 g Mg02, no viability was observed after just 4 hours 
of exposure. Because of its powerful antimicrobial activity in soil, Mg02 could be 
potentially used as antibacterial treatment to reduce the occurrence of Campylobacter 
in the farm environment.
Given that Mg02 might be unstable in soil, an experiment was carried out to 
assess its persistence in soil. A eoneentration of 2 M of Mg02 and H2O2 respectively 
were added to soil which was then incubated for various periods of time before being 
challenged with C. jejuni. Every morning, a fresh C. jejuni culture was added to the 
soil samples (which had been initially pretreated with Mg02 and H2O2) and incubated 
for 8 hours before the survival was determined. When viability was assessed, these 
compounds apparently remain active for up to 4 days as no viable cells were detected 
throughout the period of the experiment. The same pattern of survival was observed 
when C. jejuni was recovered using mCCDA.
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However, when the concentration of MgOi and H2O2 were reduced to 0,1 M 
respectively, a different survival pattern was observed. On day one, the exposure of 
Campylobacter to the day old soil samples containing H2O2 and Mg02 gave rise to a 
5-log and 2-log reduction in viability respectively. On the other hand, on days 2, 3, 
and 4, when C. jejuni was added to the soil samples, there was no significant 
reduction on the survival of C. jejuni for both Mg02 and H2O2, which likely indicates 
that at these concentrations, Mg02 and H2O2 might persist for no more than 48 hours 
in soil samples and effective killing regimes might require repeated treatments with 
this agent.
To determine whether the bactericidal effect of Mg02 was general amongst 
Campylobacters, a selection of Campylobacter strains was tested. These included C. 
jejuni NCTC 11351, and CJl and CJ2 which were both obtained from the AHVLA 
and C. coli species including NCTC 12110, 11437 and 11350. The survival of both C. 
jejuni and C. coli species was similar to that of C. jejuni NCTC 11168 which indicates 
that Mg02 has an effective and generic activity against all microaerophilic 
Campylobacters.
In bacteria, the detoxification systems for reactive oxygen species include 
eatalase, catalase/peroxidases, alkyl hydroperoxide reductase (AhpR), peroxiredoxins, 
superoxide dismutases (SOD) and the organic hydroperoxide resistance protein (Ohr) 
(Mongkolsuk et al., 1998, Storz & Imlay, 1999, Carmnel-Harel & Storz, 2000, Zheng 
& Storz, 2000). H2O2 is generally decomposed by the enzyme eatalase. H2O2 is 
continuously produced during metabolism in vivo and can be produced in large 
amounts which sometimes may exceed the endogenous antioxidant defences of a
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bacterial cell and therefore will promote injury (Rose et al., 2003). Further to this, if 
substantial amounts of H2O2 are accumulated, it can also be converted into highly 
damaging hydroxyl radicals (OH). This means that H2O2 must be destroyed by the 
cell. To determine whether the bactericidal activity of Mg02 was related to its 
liberation of H2O2 survival in the presence of this compound was assessed in the 
presence or absence of eatalase. In the presence of Mg02, the survival of C. jejuni was 
strongly enhanced by the presence of 1000 and 5000 units of eatalase and the killing 
effect of Mg02 decreased remarkably, demonstrating that the H2O2 generated by 
Mg02 is key to the killing effect either through direct action on its own or through its 
release of oxygen.
Similar experiments to those performed with Mg02 were carried out with 
Ca02, another peroxide compound that also generates hydrogen peroxide (H2O2) and 
oxygen (O2). When Ca02 was added to MRD containing C. jejuni cells, a faster 
decline in viability was observed, compared with Mg02 and no colony forming units 
could be detected after just 10 minutes exposure. Viable cell counts of C. jejuni fell to 
undetectable levels in 10 minutes and 30 minutes in the presence of 5.2 mM, 2.6 mM 
mM Ca02 respectively. This indicates that Ca02 may also be potentially used to kill 
C. jejuni.
An aerotolerant food-borne pathogen, S. Typhimurium also showed a decrease 
in viability when treated with Ca02 where a 7-log reduction was observed within an 
hour and 4 hours when cells were treated with 5.2 mM and 2.6 mM Ca02 
respectively. This indicates that Ca02 might also be used as an effective antimicrobial 
agent against other food-borne pathogens.
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Methicillin-resistant Staphylococcus aureus (MRSA) is known to cause major 
healthcare problems and nosocomial infections worldwide. It is estimated that more 
than 150,000 healthcare patients are affected in the European Union annually with the 
burden of this estimated to be EUR 380 million (Kock et al., 2010). It is therefore 
important to have a control system to effectively control the spread of this infection. 
In light of its rapid lethal effect against other pathogens tested here the bactericidal 
activity of Ca02, was assessed against a variety of different S. aureus strains, 
including MRSA. In the presence of this agent, even though the cell counts did not 
decline as rapidly as compared to C. jejuni, there was still a decrease in a number of 
cells in the presence of this compound but this was only marked at the highest 
concentration used. A concentration of 5.2 mM Ca02 generated a 7-log decline in the 
number of bacterial cells in 24 hours for MRSA and 8 hours for S. aureus USCC 1500 
and S. aureus NCTC 6571, which might also indicate that Ca02 has some promise as 
a future control measure for nosocomial infection.
It was determined previously (Mohd Esah, 2009) that the killing mechanism of 
Mg02 was not likely due to the magnesium component of Mg02 because when the 
cells were treated with MgCl2, another compound of magnesium metal, it did not give 
rise to the killing effect against C. jejuni. This further indicates that it is the anion 
component that is fully responsible for the killing of C. jejuni and that it is most likely 
related to the oxidative stress from the production of oxygen species. In addition, a 
previous study (Mohd Esah, 2009) also showed that the killing mechanism of Mg02 
was not due to changes in pH. For most strains of Campylobacter, the optimum pH 
for growth is reported to be pH 6.5 to 7.5 and ranges from 4.9 to 9.5 (AIFST, 2003). 
When the pH of the inocula with and without Mg02 was measured, Mg02
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unexpectedly generated a decrease to pH 6.1 (pH 6.3 without MgO:) but this pH is 
still within the optimum range of C. jejuni growth and would not cause cell death. 
This finding indicates that pH does not affect the survival of C. jejuni when its cells 
are treated with MgOi. However, when C. jejuni was treated with CaO:, the pH of the 
medium became highly alkaline and rose to a range between pH 9-11. The fact that 
exposure to these alkalinities led to significant cell death in the absence of Ca02, 
suggests that the mechanism of Ca02 killing is likely to be due to the increase in pH, 
combined with oxidative stress generated from the formation of H2O2 and O2.
The optimum pH for C. jejuni growth and survival is between 6.5 and 7.5, 
with a maximum of about 9.0 (Chaveerach et al., 2003). The viability of C. jejuni 
significantly decreases when the pH of the growth medium is above 9.0 or below 4.0 
(Caveerach et al., 2003). Higher cell counts of C. jejuni were observed at pH values of
5.0 and 6.0 versus 6.5-7.0 at temperatures of 22°C and 30°C (Kelana & Griffiths 
2003). Since the pH of the medium treated with Mg02 and Ca02 was different, it was 
hypothesized that Mg02 killing was caused dominantly by oxidative stress and on the 
other hand, Campylobacter inactivated with Ca02 treatment was inactivated by a 
combination of alkaline pH and oxidative stress. This difference was examined under 
the transmission electron microscope to determine the killing effect of these two 
compounds.
When observed under transmission electron microscope, there was a dramatic 
change in C. jejuni cell morphology in cells exposed to 5 mM of Mg02 and Ca02. 
Both compounds gave rise to pronounced membrane blebs and an increase in 
membrane permeability which induced membrane leakage in the C  jejuni cell. The
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treated cells also showed a predominance of coccoid forms while the untreated cells 
remained spiral. Many studies have reported the occurrence of coccoid form of 
Campylobacter when its cells are exposed to different stresses (He & Chen, 2010; Xie 
et al., 2011). This morphological alteration has also been observed in related 
organisms such as Helicobacter and is thought to be specific to spiral bacteria as no 
changes are observed in E. coli or other rod shaped bacteria when exposed to stress 
(Bode et al., 1993; Anderson et al., 2009). There has been controversy concerning 
whether the coccoid form is a non-viable degenerative state that is essentially dead, or 
a dormant state that allows the organism to restore culturability when exposed to 
favourable conditions (Moore, 2001; 2002). Thomas et al. in 1999 have reported 
during the process of coccoid cell formation, membrane blebs were formed and new 
protein synthesis was inhibited (Thomas et al., 1999).
When C. jejuni cells were treated with CaO], not only did they form irregular 
cell morphology, but also the presence of extracellular matrix surrounding its cell wall 
was apparent. It is thought that these peroxides might be able to increase membrane 
permeability leading to the accumulation of the foreign particles from these 
compounds in the bacterial membrane and cytoplasm regions of the cells. Although 
the antibacterial mechanism of these compounds is still unknown, it is likely that it is 
caused by membrane damage by direct or electrostatic interaction between these 
compounds and cell surfaces, cellular internalization of these compounds, and the 
production of active oxygen species such as H2O2 in cells due to metal oxides. It 
might involve direct interaction between Ca02 and cell surfaces which affects the 
permeability of membranes and eventually causing cell death. Hydroxyl radicals and 
superoxides are negatively charged and cannot penetrate into the cell membrane and
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they will remain on the cell surface unlike H2O2 that can penetrate into bacterial cells. 
In addition, cells treated with Ca02 also showed loss of polar flagella. Exposure to 
Mg02 also induced morphological changes of C. jejuni to coccoid form, loss of the 
structural integrity of the cell wall as well as the intracellular matrix. Cell 
deformation, breakage of cell walls and membranes were also observed in damaged 
C. jejuni cells. Surprisingly, as opposed to the effects seen with Ca02, the flagella of 
C. jejuni cells treated with Mg02 remained intact. Because of the distinctive 
morphological changes of C  jejuni cells when treated with Mg02 and Ca02, it can be 
speculated that the antibacterial mechanism of these two compounds differs. This also 
confirms the previous experiment that the mechanism of killing in Ca02 is primarily 
due to the highly alkaline pH in the medium paired with the oxidative stress, whilst 
the bactericidal effect of Mg02 is caused predominantly by oxidative stress generated 
by the oxygen liberating compound.
In summary, during all trials, the survival of C. jejuni was dramatically 
affected by the presence of oxygen releasing compounds, and reduced to undetectable 
levels in 4 hours, 2 hours, and 10 minutes when exposed to 5.2 mM Mg02, 
2Na2C03 .3H2Q2 and Ca02 respectively in MRD. The same compounds also exhibited 
remarkable antibacterial activities against C. jejuni when it was present in UHT 
skimmed milk and soil microcosms. Not only that, but these compounds have also 
been shown to have bactericidal activity against other Campylobacter strains and 
species and other food-borne pathogens, for example L. monocytogenes and S. 
Typhimurium as well as the nosocomial acquired pathogen, S. aureus. Persistence 
experiments showed that MgÛ2 could persist in the soil for more than 4 days and 
provide continuous killing. Even after four days exposure to soil in conditions
141
mimicking the natural environment, 1.0 g of Mg02 in 5 g soil could still generate a 
kill of up to 7-logs perhaps due its slow oxygen releasing trait. Of the oxygen 
releasing agents assessed in this study, in terms of relative cost, and efficiency of 
killing without undesirable increases in pH or bleaching properties, Mg02 offers the 
most promise as a treatment that could reliably and efficiently reduce levels of 
Campylobacters in various environments.
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CHAPTER FOUR
Characterization of a magnesium 
transport system in Campylobacter
jejuni
Chapter 4: Characterization of a magnesium transport 
system in C. jejuni.
4.1 Introduction to magnesium transport
Magnesium (Mg^^) is the most abundant divalent cation in prokaryotic and 
eukaryotic cells. It is involved in many cellular functions including modulating signal 
transduction, energy metabolism and cell proliferation. Mg^ "^  is important in bacterial 
growth and is a cofactor in ATP-requiring enzymatic reactions (Reinhart, 1988). It is 
also directly involved in membrane stability (Nikaido & Vaara, 1985).
4.1.1 Magnesium transport in prokaryotes
There are three classes of magnesium transporter that have been characterized 
in bacteria and archaea, namely MgtE, CorA and MgtA/B (Kehres & Maguire, 2002). 
A strain of Salmonella enterica serovar Typhimurium (& Typhimurium), that lacks 
CorA, MgtA and MgtB and thus all Mg^ "^  transporters requires supplementation with 
100 mM Mg^ "^  to grow (Hmiel et al., 1986, 1989; Snavely et al., 1989, 1991).
4.1.1.1 MgtE
MgtE is a CorA-like transporter that has been cloned from Bacillus firmus 
0F4 (Smith et al., 1995) and Providencia stuarti (Townsend et al., 1995) and this 
Mg^ "^  transporter is likely to be involved in bacterial pathogenesis. MgtE is known to
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not resemble any other known class of proteins, except for a short 100 amino acid 
sequence in the middle of the protein that resembles archaeal inosine monophosphate 
dehydrogenase (Kehres & Maguire, 2002). An MgtE homologue was characterized in 
Aeromonas hydrophila, an opportunistic pathogen, and was reported to be involved in 
biofilm formation and adherence (Merino et ah, 2001). MgtE transporters have also 
been described to have more than 5 transmembrane domains with a large hydrophilic 
domain at the N-terminus (Smith e/a/., 1995, Townsend a/., 1995).
4.1.1.2 MgtA & MgtB
The presence of these magnesium transporters was first suspected in E. coli by 
Nelson and Kennedy as long ago as 1972 (Nelson & Kennedy, 1972). They predicted 
two subclasses of Mg^^ uptake system, which were the Mg^ "^  repressible and the non- 
repressible type. Non-repressible Mg^ "^  uptake is now known to be mediated by the 
protein CorA, and on the other hand, the repressible Mg^ "^  transport system comprises 
MgtA and MgtB in S. Typhimurium (Hmiel et al., 1989). MgtA and MgtB are 
regulated by the PhoPQ system and are transcribed during infection by S. 
Typhimurium (Smith et al., 1998, Snavely et al., 1989, Groisman, 2001). Figure 4.1 
illustrates the schematic topology of the MgtB protein.
These proteins are both P-type ATPases and do not show any similarity to 
CorA. There are some minor differences between MgtA and MgtB. MgtB is very 
sensitive to temperature and can lose the Mg^ "^  transport activity at a temperature of 
20°C (Snavely et al., 1989). The activity of these proteins is also inhibited by 
different ranges of cations (Snavely et al., 1989). The MgtB protein is also reported to 
assist in the long term survival of the pathogen within cells (Moncrief & Maguire,
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1999). In addition, when the intracellular eoneentration of falls below 50 gM, 
the mgtB gene is upregulated (Snavely et al., 1991).
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Figure 4.1: The transmembrane topology of the MgtB protein (Taken from: Smith et 
al., 1993). TM domains are shown in light blue and the positions of the N- and the C- 
termini are also indicated. The MgtB protein has ten TM-spanning helices with the 
termini in the cytoplasm.
145
4.1.1.3 CorA
Silver and colleagues first identified the genetic locus for the CorA transporter 
in Escherichia coli back in 1969 (Silver, 1969). CorA is now known to be an inner 
membrane protein that is present ubiquitously in prokaryotes and known to transport 
divalent metal ions. CorA is present in almost all bacteria and the archaea with the 
exception of only a few species, generally those with the smallest genomes, and in 
these the Mg^^ transporter system is replaced by MgtE (Kehres et al., 1998). Because 
of its ubiquitous distribution, CorA is believed to be the primary Mg^ "^  transporter 
present in these two kingdoms. However, multiple CorA-like sequences are present in 
some species (Kehres et ah, 1998; Smith & Maguire 1995).
In bacteria such as H. pylori, S. Typhimurium and E. coli, this protein has 
been extensively studied and in these bacteria, CorA is the major Mg^ "*" transporter and 
is also known to mediate the influx of Mg^\ Co^^ and N f  ^  (Hmiel et al., 1986; 
Snavely et al., 1989). CorA was first cloned from S. Typhimurium in 1985 by Hmiel 
et al. (Hmiel et al., 1986). In S. Typhimurium, CorA is required for full virulence in a 
mouse model although other Mg^ "^  transport systems are also present (Papp-Wallace 
et al., 2008).
The promoter of CorA in S. Typhimurium does not respond to changes in 
extracellular magnesium concentration (Smith et al., 1998; Tao et al., 1998). No 
recognizable ATP binding site is found in CorA sequence and transport via CorA is 
sensitive to membrane potential. The mechanism of Mg^ "^  transport is thought to be 
through CorA functioning as a Mg^ "^  channel and is driven by the inward 
electrochemical Mg^ "^  potential or as a Mg^^/H+ antiporter driven by the overall
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electrochemical gradient (Smith & Maguie, 1998). Figure 4.2 illustrates the 
transmembrane (TM) domain topology of the S. Typhimurium CorA protein, with 
three membrane spanning regions in the C-terminal part of the protein (Smith et aL, 
1993). In addition, CorA in H. pylori is required for viability under limiting Mg^ "^  
conditions (Pfeiffer et aL, 2002).
There are two major groups within the CorA family. One of them is called the 
MPEL group, and all members of this group contain a highly conserved sequence 
between TM domain 1 (TM2) and TM3. The CorA characterized in & Typhimurium 
is a member of this group (Smith et aL, 1998). The second group is termed the CorA- 
II sequences and it has been suggested that the CorA-II proteins are efflux systems 
and do not transport Mg^ "^  into the cell (Smith & Maguire, 1998).
In the previous chapter, magnesium peroxide had been shown to be a potent 
bactericidal agent for Campylobacters. The aim of this chapter was to investigate 
magnesium transport by generating a CorA-deficient mutant and to determine whether 
transport was necessary for magnesium peroxide mediated killing. In addition, 
magnesium transport is necessary for pathogenesis and survival in other pathogens so 
the study might also give a better insight into the role of this as yet uncharacterized 
function in C. jejuni virulence.
An analysis of the C  jejuni NCTC 11168 genome sequence showed it to 
encode a homolog of CorA (Cj0726c) but this transporter homologue has not been 
studied so far. CorA has been demonstrated to be conserved among different strains of 
various Gram negative bacteria. Comparison of the NCTC 11168 sequence with that
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of 81-176 and NCTC 81116 confirmed the high degree of conservation of CorA 
within C. jejuni (Table 4.1). Only 2 and 3 of the amino acids in CorA of NCTC 81116 
and 81-176 respectively of the total of 327 amino acids of the whole of CorA 
molecule were different in these strains when compared to the NCTC 11168 (Fig.4.3). 
C. NCTC 11168 CorA shares 99%, 99%, 48%, 31%, 30% and 30% identity 
with the amino acid sequences of C. jejuni 81-176, C. jejuni 81116, 77. pylori, E. coli, 
S. Typhimurium and B. subtilis respectively (Table 4.1).
6 A A ^ C
230 AA
Figure 4.2: Topology of corA protein illustrated by Smih et aL, 1993, blue showing 
the membrane-spanning region.
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Conservation with C. je jun i NCTC 11168 CorA protein sequence
CorA orthologues Overall % identity (Similarity) Blast E value
C. jejun i S l-1 7 6 99% (100%) 0
C  jejun i 81116 99% (99%) 0
H. pylori 26695 48% (69%) le-105
£  coli K-12 31% (53%) 3e-47
S. Typhimurium LT2 30% (53%) 3e-46
B. subtilis 168 30% (51%) 3e-10
Table 4.1: Comparison of the C. jejuni NCTC 11168 CorA protein sequence with 
other bacterial orthologues
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4.2 Results
4.2.1 Chromosomal DNA extraction of C jejuni NCTC 11168
The chromosomal DNA of C. jejuni NCTC 11168 was extracted by using the 
DNeasy Blood and Tissue Qiagen kit and analysed by using gel electrophoresis as 
shown in Figure 4.4.
4.2.2 PCR amplification of corA gene fragments
The corA gene of C. jejuni NCTC 11168 was amplified using the 
oligonucleotide primers stated in section 2.8.2. The amplification of the corA gene 
was successful yielding products of 1331 bp which were the estimated band sizes 
expected, as shown in Figure 4.5.
4.2.3 Enzyme digestion of the PCR product {corA) with B glll and PstI
Restriction enzyme digestion with Bglll was carried out to determine the size 
of the band that will be obtained from the digestion and to confirm the presence of a 
Bglll site internal to the corA gene which would be used to insert an antibiotic 
resistance marker. As predicted from the corA genome sequence, Bglll will cut CorA 
approximately in the middle of the gene and the products obtained were as expected, 
which were 526 and 806 bp respectively, indicating the right size of the corA 
fragment (Fig. 4.6).
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Figure 4.4: Gel electrophoresis were run at 6V/cm for 1.5 hours with 1% agarose gel 
stained with GelRed™ of C. jejuni NCTC 11168 genomic DNA isolated using the 
DNeasy Blood & Tissue Qiagen kit. Lane 1: 1.0 kb DNA molecular weight marker. 
Lane 2 & 3: Genomic DNA products.
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Figure 4.5: Gel electrophoresis were run at 6V/cm for 1.5 hours with 1% agarose gel stained 
with GelRed™ showing the amplification of C. jejuni NCTC 11168 PCR product using 
primers Mut 1 and Mut 11. Lane 1 and 2 both showing 1331 bp products which represent the 
size of the corA gene amplified from the wild type strain. Lane M shows a LO kb DNA 
ladder marker.
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Figure 4.6: Gel electrophoresis were run at 6V/cm for 1.5 hours with 0.8% agarose gel 
stained with GelRed™ showing the corA PCR fragment digested with Bglll 
restriction enzyme, producing two fragments of 526 and 805 bp respectively (Lane 1 
& 2). Lane M showed a 1.0 kb DNA ladder marker.
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4.2.4 TA cloning of the PCR product
The purified corA gene fragments were cloned into the TA cloning vector 
pGEM®-T Easy which was linearised and had a single 3’ deoxythymidine (T) residue 
which allows efficient ligation with PCR inserts, as the PCR products have a single 
deoxyadenosine (A) added to the 3’ end by Taq polymerase. The plasmid was then 
transformed into chemically competent E. coli DH5a for selection. Cells containing 
the vector were selected using LB agar plates supplemented with 100 pg/ml 
ampicillin, X-gal and IPTG. White colonies were picked and a rapid plasmid 
preparation and PCR were carried out to screen all the colonies for the possession of 
the corA gene (data not shown).
The pGEM®-T Easy plasmid has a recognition site for PstL Double enzyme 
digestion with Bglll and PstI was carried out to confirm the insertion of the corA 
fragment into the vector pGEM®-T Easy as shown in Figure 4.7. The DNA fragments 
obtained from this digestion appeared to be 834 bp and 3513 bp, which indicate that 
the corA fragment has been incorporated into the plasmid. A plasmid containing the 
inserted corA gene fragment was designated pEMl. Figure 4.8 illustrates the DNA 
sequence of the plasmid pEM l.
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Figure 4.7: Gel electrophoresis were run at 6V/cm for 1.5 hours with 1% agarose gel 
stained with GelRed™ showing the pEMl plasmids cut with Bglll and PstI producing 
834 and 3513 bp fragments (Lane 1-5). Lane M showed a 1.0 kb DNA ladder marker.
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g g g c g a a t t g g g c c c g a c g t c g c a t g c t c c c g g c c g c c a t g g c g g c c g c g g g a a t t c g a t | c c c a a g t a t c c t t c c a g t t t g c c c a
AGTATCAGGCATAGCTAAAGAATTTACCCTACCTTCTGCTTGCGCAGCTTTAATCAAATTCTCATCAATAGCTTGTGAATTTGAAA
ACAATAAAGCAACAAGACCTAAACTTAAGAAAAATTTCTTACTCATTTTTTTCCTTTCAAAAAATATTTTGGAAATTTAATGAGTT
TTAGAAACATTTTAGAAACAAGTTAATTTTTAAGCAAACAAGGTTATAATTTTAAAGTCATAAACAAGGAGCGATCATGCTTTATA
TTTATATCAAAACTCAAAATGCTTTAGTTCAAAGAATCAATTTTAATCTCGATAGTCAAGAACTACCGCAAAATATTTTATGGATT
GATTTACTTCATCCAAGTGCAGCAGAAATTGCTTTTATATCAAGTGAATTTAATCTTGAGTTTCCTACAAAAGAAGAAAGGGAAGA
AATAGAGCTTAGCGCAAAATATTGGGAAGATAATGCAACAATAACCATCAATGCTCATTTTTTAGTAAGAGATCTTAAAAGTGATG
AAGAAGATAGAAATTTAATCAAGCTTCGCACAGAAATTGTTACTTTTGCTACCGCTAAAAATATCTTATTTACTATAAGATATAAC
GAATTTAGCACTTTTGAAGAAATTCAAGCAAGGATTTTAGCTAGTCCGAAGAATTTTGAAGATGGTTTTGATATTATTGATAAAAT
GTTTGAAGTACGCGTTGAAAAAGATGCGGATTTACTAGAATGGATAGATAAAGAAGCAAGACGCTTAAGAACAAGTGTTTTAGAAA
AAAAAGATGAATATAGTTATGATGAAATGCTAAAGGATATTTCAAGTTTGCAAGAGCTTAATATGCGCGTAAGAGATTCTTTATTT
GATAAGCGTCGCGCTATGACTTCTTTGTTAAAAAGCGATAAAATCGATAAAGACATAAAACAAAATCTCACTATAGTTTTAAAAGA
CTTAAATTCTTTGGTTGAATTTAGCGTTTCGCAACTTAATATCTTAGATAATATCCAAACCATTTTAGCCAGTCAAATCAACATAG
AACAAAACAAAGTCATTAAAATTTTCACCGTTGCAACTGTTGCCATGATGCCACCTACTTTAATAGGAACTGTTTATGGTATGAAT
TTTAAATTCATGCCCGAACTTGAACTTCACTATGCTTATCCCATAGTGCTTGGCGTGATGGTAATTTCTATCATTTTACCTTTGGT
TGTTTTCAAGAAAAAAGGATGGTTATAAAAATTTATTAAGGAGAAACAATGGATACAATAAACATAGGAATTTTAACCCTAAGCGA
TAGAGCAAGTAGTG#AATCACTAGTGAATTCGCGGCCGcE Î '# d 4 Ë GTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAG
CTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTAT
TGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGG
TAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAG
GCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCC
GACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACC
TGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGT
AGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATC
TCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTAT
CAAA7VAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGAC
AGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTA
GATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTAT
CAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGC
CGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTC
GTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCT
CCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACT
GTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTG
CTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGC
GAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACT
TTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACT
CATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAA
ATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAA
ATACCGCATCAGGAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCAC
TATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCA
AGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGC
GAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCA
CCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGC
GGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCA
CGACGTTGTAAAACGACGGCCAGTGAATTGTAATACGACTCACTATA
Figure 4.8: DNA sequence of the corA gene fragment (indicated in red) of C. jejuni 
incorporated into the pGEM-T® Easy vector (plasmid pEMl) (indicated in black). 
Underlined is the primer 3’ and 5’ respectively, with the start of the primers 
highlighted in red. Bglll and PstI restriction sites are highlighted in yellow and green 
respectively.
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4.2.5 Enzyme digestion of plasmid pE M l with Bglll
Plasmid pEMl contains a unique restriction site for BgUI internal to the corA 
gene. Enzyme digestion was performed to generate a Bglll sticky end to allow 
insertion of a kanamycin resistance cassette from pJMK30 into corA. Digestion of 
pEMl with 5g///generates a linear fragment and this linear fragment was ligated with 
the 1.6 kb kanamycin cassette from pJMK30 (Figure 4.9).
4.2.6 Enzyme digestion of pJMK30 with BamHI: DNA purification and 
extraction of kanamycin cassette from gel electrophoresis
Digestion of pJMK30 with the restriction endonuclease BamHI liberates a 1.6 
kb kanamycin-resistance fragment and an approximately 3.0 kb fragment from the 
plasmid backbone. The DNA fragment containing the kanamycin resistance cassette 
from pJMK30 was excised from the agarose gel (Figure 4.10).
4.2.7 Insertion of kanamycin resistance cassette into pEMl
A ligation reaction was carried out to incorporate the kanamycin cassette into 
plasmid pEMl. The ligation mixture was then introduced into E. coli DH5a cell by 
chemical transformation and plasmids which had taken up the kanamycin resistance 
gene were selected on LB agar supplemented with 50 pg/ml kanamycin. One 
kanamycin resistant transformant was selected and inoculated in 5 ml LB broth 
supplemented with 50 pg/ml kanamycin. Plasmid DNA was isolated from this using 
the Qiagen mini-prep kit. PCR using this as a target was carried out to confirm the
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Figure 4.9: Gel electrophoresis were run at 6V/cm for 1.5 hours with a 1% agarose gel 
stained with GelRed™ of pEMl digested with 5g///(Lane 2) showing a linearised 4.3 
kb band and the kanamycin resistance cassette from pJMK30 digested with BamHI 
(Lane 1), showing a 1.6 kb band. Lane M showed a 1.0 kb DNA ladder marker.
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Figure 4.10: Gel electrophoresis were run at 6V/cm for 1.5 hours using 
1% agarose gel stained with ethidium bromide showing a kanamycin 
cassette of pJMK30. Lane 1 showed a 1600 bp kanamycin fragment 
digested with BamHI from pJMK30. This fragment was extracted from 
the gel and inserted in to the plasmid pEMl. Lane M showed a 1.0 kb 
DNA ladder marker.
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plasmid’s construction and the presence of the kanamycin resistance gene. The 
plasmid with a putative kanamycin resistance cassette insertion in corA was 
designated pEM2. Gel electrophoresis of the PCR fragments derived from pEMl 
containing the corA fragment and pEM2 containing truncated corA and kanamycin 
cassette are shown in Figure 4.11. The PCR product illustrated the size of the corA 
with the inserted kanamycin cassette (2931 bp), which indicates that the 1331 bp corA 
fragment from pEMl now contained the 1600 bp kanamycin fragment from pJMK30. 
This confirms the disruption of the corA gene, thus confirming the genotype of the 
mutated plasmid which is also illustrated in Figure 4.12.
4.2.8 Transformation and PCR of CJEMl
pEM2 containing corA and a kanamycin resistance gene cassette was 
introduced into C. jejuni NCTC competent cells via electroporation and natural 
transformation techniques. Only cells, which had taken up the plasmid, were able to 
grow on MHA (+20 mM MgCl]) supplemented with 50 pg/ml kanamycin as pEM2 
contains a gene which encodes for kanamycin resistance, thus enabling selection of 
the C. jejuni corA mutant. Single colonies were re-streaked onto fresh selective 
medium containing the kanamycin supplement and 20 mM MgCl] as the mutant was 
expected to be deficient in magnesium transport. Putative mutants were selected and 
the chromosomal DNA was extracted from them using the Qiagen kit so that they 
could be rapidly screened by PCR to confirm the occurrence of allelic exchange by 
double homologous recombination. Figure 4.13 shows PCR products of the C. jejuni 
corA mutant and that of the wild type. The wild type PCR product showed a 1331 bp 
product, a size which was similar to that when corA gene fragment was amplified
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Figure 4.11: Gel electrophoresis were run at 8V/cm for 1.5 hours using 1% agarose 
gel stained with GelRed™ showing PCR products from plasmid pEMl and pEM2 
using primer Mut 1 and Mut 11. Lane 1 shows the 1331 bp PCR product from 
pEMI confirming the insertion of the corA gene fragment into the plasmid. Lane 2 
shows a 2930 bp product from pEM2 which indicates that pEM2 contained a 
kanamycin fragment (1600 bp) inserted into the corA fragment of pEMl. Lane M 
showed a 1.0 kb DNA ladder marker.
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Figure 4.12: A diagrammatic presentation of the integrational plasmid pEM2 
containing the truncated corA fragment and the kanamycin resistant marker.
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Figure 4.13: Gel electrophoresis were run at 8V/em for 1.5 hours using 1% 
agarose gel stained with GelRed® showing PCR products obtained from a 
wild type strain and a suspected C. jejuni corA mutant. PCR was carried 
out using primer Mut 1 and Mut 11. Lane 1 shows the corA mutant of C. 
jejuni with a size of 2931 bp. Lane 2 shows the corA gene fragment from 
the wild type strain showing a 1331 bp product. The 1600 bp difference in 
size between the PCR products from the corA mutant and the wild type 
confirmed the genotype of mutated C. jejuni corA strain. Lane M showed a 
1.0 kb DNA ladder marker.
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initially, whereas the C. jejuni corA mutant showed a 2931 bp product, which showed 
that the corA gene fragment had been inserted with the 1600 bp kanamycin fragment, 
thus confirming the genotype of the mutated strain (CJEMl).
4.2.9 Growth of the C  jejuni corA mutant on MgCb plates
To investigate whether the corA mutation had had an effect on the magnesium 
transport of C. jejuni, the C. jejuni corA mutant was grown on plates with and without 
20 mM MgCb. The mutant did not grow on MH plates without 20 mM MgCli 
supplementation, but grew on the MH plates supplemented with MgCb, indicating 
that corA plays an important and major role in magnesium transport in C. jejuni 
(Fig.4.14).
Figure 4.14: The C. jejuni corA mutant showing no growth when inoculated onto an 
MH plate without 20mM MgCC (A) and growth of C. jejuni corA mutant when grown 
on a MH plate supplemented with 20 mM MgCf (B).
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4.2.10 Growth of the C. jejuni corA mutant
The requirement caused by the corA mutation was further investigated 
by growth experiments using various concentrations of MgCl2. The optical density 
(OD) reading of the C. jejuni corA mutant when growing in media supplemented with 
10 mM and 5 mM MgCl: was about 50% less than the absorbance reading of the wild 
type with and without the addition of MgCb (Fig. 4.15), and thus after 56 hours of 
growth, MgCl] concentrations of less than 20 mM in MH broth do not restore full 
growth in the mutant. In addition, supplementation of MH broth with 20 mM MgCb 
enabled the corA mutant to grow in a manner identical to that of the wild type. In 
contrast, unlike the wild type, the corA mutant did not grow in unsupplemented broth, 
thus further confirming the role of CorA in magnesium transport.
4.2.11 Survival of the C. jejuni wild type and the corA mutant in the presence of 
Mg02
To assess whether transport was necessary for the bactericidal activity of 
MgOi, the wild type strain and the corA mutant strain were exposed to MgOi and 
survival was investigated. This compound was added to MHB cultures of each strain 
to a final concentration of 0.26, 2.6 and 5.2 mM and the cultures were incubated 
aerobically at 25°C. At regular intervals, the number of viable bacteria present was 
assessed by plate counts in BMHA or BMHA supplemented with 20 mM MgCl2.
In the absence of Mg02, there was a gradual decline in viability of the cultures 
with viability for the CorA-deficient cells being 1-log less than the
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parental strain during the experiment, and eventually at the end of the experiment this 
differenee had risen to 2-logs at 52 hours. This might indicate that the corA mutant is 
less able than the wild type to survive exposure to air than the wild type strain 
(Fig.4.16).
The survival of wild type and the mutant when challenged with 0.26 mM 
MgOg was similar, in that they declined to undetectable limits within 24 hours of the 
challenge, but again, the survival of the corA mutant was less than the wild type at 8 
h. When exposed to 2.6 mM and 5.2 mM MgOg, all the strains showed no viability 
after 4 hours. However, with these two concentrations of MgOg, there was no 
significant difference between the survival of the wild type and the corA mutant. The 
result here however does differ ftom a previous and similar experiment with the wild 
type (Chapter 3) which showed that C. jejuni cells challenged with 2.6 mM could 
survive for up to 8 hours. This might be because of discrepancies with the solubility 
of MgOg or to other unknown environmental factors affecting sensitivity to this 
compound. Regardless of this difference, it appears that CorA and thus magnesium 
transport plays no role in the MgOg mediated killing.
4.2.12 Survival of the C. jejuni wild type and the corA mutant in UHT and 
pasteurised skimmed milk
The enzyme lactoperoxidase (which is present in pasteurised skimmed milk 
but not UHT milk) (Al-Sallaqi, 2012) is a natural antimicrobial defence system that 
can oxidize different substrates, though primarily thiocyanate, using hydrogen 
peroxide, to generate bactericidal agents (Zapico et aL, 1998). Exposure to 
lactoperoxidase induces expression of several genes in E. coli, amongst them corA
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Figure 4.16: Survival of C. jejuni 11168 wild type and corA mutant in the absence or 
presence of various concentrations of MgO]. C. jejuni wild type was challenged with 
0.26 (■), 2.6 ( ) and 5.2 (X) mM MgO] and no addition (♦) of this compound as a 
control. The corA mutant was also challenged in a same manner, with 0 (x), 0.26 (•), 
2.6 (+) and 5.2 (-) mM MgOi, respectively. The inoculum was incubated aerobically 
at 25°C and shaking at 150 rpm and samples were taken at suitable interval times. 
Survival was assessed by plate counting using BMHA for the wild type strain and 
BMHA supplemented with 20 mM MgCl] for the corA mutant. Data shown are the 
means of three independent experiments. Bars indicate one standard error of the 
mean. Downward pointing arrows indicate that the count was below the limit of 
detection.
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and both E. coli and S. Typhimurium corA mutants are hypersensitive to 
lactoperoxidase but not to direct hydrogen peroxide challenge or to superoxide stress 
generated by addition of plumbagin (Sermon et aL, 2004, Sermon et al, 2005).
This experiment was performed to assess whether the C. jejuni corA mutant 
was similarly sensitive to lactoperoxidase. When cell survival was assessed under 
aerobic conditions in pasteurized skimmed milk, the number of recoverable wild type 
cells decreased steadily by 7-logs during the experiment and eventually no viable cells 
were recoverable after 24 hours. On the other hand, the corA mutant demonstrated a 
marked decrease in survival irrespective of the presence or absence of 20 mM MgCb 
and declined by 7-logs to undetectable levels after 9 hours of incubation at 25 °C 
(Fig.4.17a).
When survival of both strains was assessed in UHT skimmed milk (with no 
lactoperoxidase activity), there was a far less marked decrease in viability (Fig.4.17b). 
These results suggest that the Campylobacter corA mutant is hypersensitive to 
lactoperoxidase.
4.2.13 Survival and growth of C. jejuni and the corA mutant in media 
supplemented with alkaline earth cations other than MgCh
The survival and growth of C. jejuni and the corA mutant was tested in the 
presence of other chloride compounds other than MgCh to determine whether it was
171
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Figure 4.17a: Survival of C. jejuni and the corA mutant in pasteurised skimmed milk. 
C. jejuni wild type strain was inoculated in pasteurised skimmed milk only (♦) and 
when 20 mM MgCb (■) was added to the culture. C. jejuni corA mutant was also 
inoculated in the same manner, with (x) and without (A) the addition of 20 mM 
MgCb. The inoculum was incubated aerobically with shaking at 150 rpm and samples 
were taken at suitable interval times. Survival was assessed by plate counting using 
mCCDA for the WT strain and mCCDA supplemented with 20 mM MgCb for the 
corA mutant. Data shown are a mean of triplicates. Bars indicate one standard error of 
the mean. Downward pointing arrows indicate that the count was below the limit of 
detection.
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Figure 4,17b: Survival of C. jejuni and the corA mutant in UHT skimmed milk. C. 
jejuni wild type strain was inoculated in UHT skimmed milk only (♦ ) and with 20 
mM MgCb (■) added to the culture. The C. jejuni corA mutant was also inoculated in 
the same manner, with (x) and without (A)  the addition of 20 mM MgCb. The 
inoculum was incubated aerobically with shaking at 150 rpm and samples were taken 
at suitable interval times. Survival was assessed by plate counting using mCCDA for 
the WT strain and mCCDA supplemented with 20 mM MgCh for the corA mutant. 
Data shown are a mean of three independent experiments. Bars indicate one standard 
error of the mean. Downward pointing arrows indicate that the count was below the 
limit of detection.
73
The magnesium ions or the chloride anion that were influencing the growth and 
survival of the corA mutant. As can be seen from Figure 4.18, there was no growth of 
the C. jejuni corA mutant when supplemented with other chloride compounds, namely 
calcium chloride (CaC^) and sodium chloride (NaCb). The near zero absorbance 
readings (ODeoo) measured in the absence of MgCli indicates that it must be the 
provision of magnesium ions alone that give rise to the growth of the corA mutant. 
However, when the mutant was treated with 20 mM MgCb, the growth was similar to 
that of the wild type. Two-tailed t test reported no statistical difference of the growth 
between the corA mutant supplemented with 20 mM MgCl2 and the parental strain 
without any supplementation.
4.2.14 Growth of C. jejuni and the corA mutant in media supplemented with 
cobalt (II) chloride (C0CI2)
The primary fimction of CorA is to transport magnesium, but it can also transport
nickel and cobalt (Mincrief & Maguire, 1999) and experiments were next carried out
to determine whether homeostasis of these metals was influenced by CorA. The
growth of the corA mutant was assessed in the presence of C0CI2 (Fig.4.19). In the
presence of 1 mM C0CI2 the optical density of the wild type culture declined initially
but after 10 hours it began to increase again and eventually matched that of cells
grown in the absence of this compound. At concentrations of 2.5 mM and above the
growth of the wild type was severely restricted suggesting that at these concentrations
that cobalt might be toxic. In the absence of any added C0CI2 the optical density of
the CorA mutant declined for the first ten hours and thereafter rose until after 70 hours
it was the same as that at the beginning of the experiment. The
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higher concentrations of C0CI2 did not induce this effect but did not promote growth 
either. In addition, statistical evaluation showed a significant difference (P < 0.05) 
between the parental strain and the corA mutant added with either 5 mM, 2.5 mM or 1 
mM C0CI2 suggesting that indicating that CorA is not involved in maintaining cobalt 
homeostasis.
4.2.15 Growth of C. jejuni and the corA mutant in media supplemented with 
nickel (II) chloride hexahydrate (NiClz.hHzO)
The growth of corA mutant was also assessed in the presence of NiCl2.6H20 
(Fig.4.20). Overall, a similar pattern of growth to that seen with cobalt 
supplementation was observed indicating that CorA is not involved in maintaining 
nickel homeostasis.
4.2.16 Survival of C. jejuni wild type and the corA mutant in pasteurised 
skimmed milk supplemented with nickel
It has been reported in S. Typhimurium, that the addition of Ni^ "^  increased
lactoperoxidase induced killing in the wild type, but not a corA mutant (Papp-Wallace
et al., 2008). Therefore, an experiment was carried out to access whether Ni^ "^  could
also increase lactoperoxidase induced killing in C. jejuni. Figure 4.21 illustrates the
survival of C. jejuni wild type and the corA strain when supplemented with Ni^^ in
pasteurised skimmed milk. It was observed that the survival of the C. jejuni wild type
without any supplementation was higher than cells treated with Ni^ "*" as well as when
the inoculum was supplemented with both Ni^ "^  and Mg^^ over a period of 24 hours.
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Figure 4.20: The growth of the C. jejuni corA mutant and wild type in MHB with and 
without the addition of NiCl2.6H2. The C. jejuni corA mutant was incubated 
microaerophically at 37°C with shaking at 150 rpm with no additions of NiCl2.6H2 
(x), or to which 1 mM (•), 2.5 mM (+) and 5 mM (-) of NiCl2.6H20 were added to the 
broth respectively. In addition, wild type C. jejuni growth was also assessed as a 
control with no addition of NiCl2.6H2 (♦), or to which 1 mM (■), 2.5 mM ( ) and 5 
mM (x) of NiCl2.6H2 were added to the broth respectively. Growth was assessed at 
regular intervals using optical density (ODeoo)- Data shown are a mean of triplicates. 
Bars indicate one standard error of the mean.
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Figure 4.21: Survival of C. jejuni wild type and the corA mutant in pasteurised 
skimmed milk with and without added niekel. C. jejuni wild type strain was 
inoculated into pasteurised skimmed milk only (♦), or to which 100 mM NiCl2.6H20 
was added to the culture (■) or when 20 mM MgCb ( ) and 100 mM N1C12.6H20 
were added to the culture. The C. jejuni corA mutant was also inoculated in the same 
manner, with the addition of 100 mM NiCl2.6H20 (x) or to which 20 mM MgCb and 
100 mM NiCl2.6H20 were added to the culture (•), or without anything added to the 
milk (X). The inoculum was incubated aerobically and shaking at 150 rpm and 
samples was taken at suitable interval times. Survival was assessed by plate counting 
using mCCDA for the WT strain and mCCDA supplemented with 20 mM MgCb for 
the corA mutant. Data shown are a mean of triplicate experiments. Bars indicate one 
standard error of the mean. Downward pointing arrows indicate that the count was 
below the limit of detection.
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Initially, the difference in cell counts between the wild type with and without 
supplementation was less than 1-log, but this difference increased to 2-logs in 9 
hours and eventually to an approximately 5-log difference in 24 hours, indicating that 
might enhance the lactoperoxidase mediated killing of wild type C. jejuni.
The corA mutant showed a similar pattern of survival to that seen in the wild 
type in that without any addition it showed higher survival than when the cells 
were treated with Ni^ "^  and Ni^^ with Mg^ "^ . Whilst the presence of nickel seems to 
increase cell death in pasteurized milk as reported by Papp-Wallace et ah, (2008) 
consistent with its ability to induce lactoperoxidase killing, contrary to this report, the 
C. jejuni CorA-mutant was not resistant to this effect.
4.2.17 Assessing the motility of C. jejuni 11168 variants
The next stage of this study was to assess the impact of the corA mutation on 
Campylobacter virulence. As motility has also been shown to be important for 
virulence it was necessary to assess the motility of the laboratory strain of C. jejuni 
NCTC 11168 used in this study as some variants of this strain have been shown to be 
poorly motile (Karlyshev et al., 2002). To the contrary the 11168H strain is known to 
be hyper virulent and to display increased motility (Karlyshev et al., 2002; Jones et 
al., 2004). Motility was assessed by measuring growth and movement in MHA 
containing 0.4% agar. The strains to be tested were grown for 18 hours and 
standardized to the absorbance of ODeoo 0.6 and stabbed onto the agar. Motility was 
scored visually based on the ability of colonies of a strain to extend through the agar 
from the point of inoculation.
1 8 0
The laboratory strain of C. jejuni NCTC 11168 used throughout this study was 
less motile than the 11168H strain, its halo of motility being smaller compared to 
11168H (Fig.4.22). C. jejuni 11168H produced 1.45 cm halos after 1 day of 
incubation, while the 11168 strain gave rise to halos of 0.9 cm when the agar was 
stabbed with 1 pi of the culture at an ODeoo of 0.025 (Fig.4.23). The extent of the 
motility zones was proportional to the concentration of bacteria used, the higher the 
concentration, the bigger the halos, but all of the results showed that 11168H strain is 
hypermotile compared to the 11168 strain. Analysis using two-tailed t test indicated 
that there was a statistically significant difference in the zone of motility between the 
NCTC 11168 and NCTC 11168 H strains {P < 0.05).
(A) ODgoo 0.025 (B) ODôoo 0.25
Figure 4.22: Motility assays of C. jejuni NCTC 11168H and NCTC 11168. 11168H 
(upper section) and 11168 (lower section). Strains were stabbed into 0.4% semisolid 
MHA and allowed to grow at room temperature for 24 hours. (A) represents the MHA 
plates stabbed with a culture at an ODôoo of 0.025 and (B) was inoculated with a 
bacterial culture of an ODôooof 0.25. The data are representative of three independent 
experiments.
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Figure 4.23: A histogram showing the diameter of the halo of motility of C. jejuni 
NCTC 11168 (■) and 11168H (■) in 0.4% semisolid MHA. The absorbances of the 
cultures used were ODgoo 0.025 and 0.25 and the volumes used were 1 pi and 5 pi for 
each absorbance, respectively. Bacteria were allowed to grow at 37°C 
microaerobically for 24 hours. The data are representative of three independent 
experiments. Error bars indicate standard deviation of the mean. The motility between 
the two strains was significantly different based on a two-tailed t test (T*<0.05).
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4.2.18 Assessment of the motility of corA mutants of various C. jejuni strains
Another altered phenotype reported for corA mutants is reduced motility as 
has been demonstrated in S. Typhimurium (Papp-Wallace et al., 2008). In C. jejuni, 
motility has been attributed to virulence, and pathogenesis, so the motility of the corA 
strain compared to that of the parental strain was assessed.
When the wild type strain was stabbed into the 0.4% semisolid MHA, the zone 
of motility was greater than for the corA mutant strain. In MHA without any 
supplementation the wild type gave rise to a 6.2 cm of halo compared to no zone at all 
for the corA on this medium. This is expected since corA mutant needs magnesium 
supplementation for its growth. When the medium was supplemented with 20 mM 
MgCl], the parental strain still gave rise to a larger halo compared to the corA mutant 
which was 7 cm compared to 4.75 cm for the corA strain (Table: 4.2). This might 
indicate that CorA does contribute to the motility of C. jejuni in some way. Similar to 
the previous experiment, the size of the zone of motility depended on the volumes and 
concentration used (Fig 4.24), but in all cases the mutant was less motile than the wild 
type and was statistically different when tested using a two-tailed t test (P < 0.05).
4.2.19 Transformation of pEM2 into other C. jejuni strains in order to generate 
corA mutants from different parental strains.
Previously, plasmid pEM2 was introduced into C. jejuni NCTC 11168 via 
electroporation and a corA mutant generated via its allelic exchange. However, a 
number of variants of this strain exist with different motility and virulence. For
183
Strain Diameter of halo (cm) 
0.4% MHA
Diameter of halo (cm) 
0.4% MHA + 20 mM 
MgCl2
Wild type 6.2 7
corA 0 4.75
Table 4.2: Preliminary experiment to assess the motility of C. jejuni wild type and the 
corA mutant. Data represents the diameter of halo produced in semisolid 0.4% MHA 
medium with and without 20 mM supplementation with MgCb and inoculated with 1 
pi of an ODgoo 0.025 culture.
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Figure 4.24: A histogram showing the diameter of the zone of motility of C. jejuni 
NCTC 11168 wild type strain (■) and the corA strain (■) in 0.4% semisolid MHA 
without 20 mM MgCb supplementation. The absorbance used was ODgoo 0.25 and the 
volumes used were 1 pi, 2 pi and 5 pi, respectively and allowed to grow at 37°C 
mieroaerobically for 24 hours. The data are representative of three independent 
experiments. Error bars indicate standard deviation of the mean. The motility between 
the two strains was signifieantly different based on a two-tailed t test {P < 0.05).
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example, 11168H is a hyper motile variant (also potentially more virulent) of the 
11168 strain (Karlyshev et al., 2002). One of the aims of this study was to assess the 
impact of the corA mutation on virulence as measured in a number of model systems. 
As a consequence of this, attempts were made to introduce pEM2 into a range of 
parental strains in order to make corA mutants in these and then to select the most 
suitable parental strain/mutant strain combination for virulence studies. Attempts were 
made to introduce pEM2 into three other Campylobacter strains either by 
electroporation or natural transformation (two versions of 11168H and 81116).
Initially, several repeated transformations using both techniques failed to 
incorporate the pEM2 into the 11168H strain obtained from the AHVLA (Weybridge, 
UK) but when the same strain obtained from London School of Hygiene & Tropical 
Medicine, London, UK (LSHTM), transformation was deemed successful using both 
methods. This eould be due to variants due to the presence of homopolymeric tracts in 
C. jejuni (Wassenaar et al., 2002). A motility test was also performed to compare the 
motility between 11168H obtained from the AHVLA and that from LSHTM. The 
results showed that the zone of motility of the AHVLA strain was larger than the 
LSHTM strain (data not shown) but the fact that pEM2 could not be introdueed into 
this strain despite many attempts excluded it from further study here.
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4.2.20 Tissue culture invasion assay
Intracellular survival in various cell types is often used to assess 
Campylobacter virulence (Melo et al., 1989; Hickey et al., 2005). Consequently, 
Caco-2 cells were infected with C. jejuni 81-176, 11168, 11168H and 81116 and all 
the corresponding corA mutant strains for each parental strain as well as E. coli DH5a 
as a control and intracellular survival assessed using the gentamycin protection assay. 
The results are illustrated in Figure 4.25 and unexpectedly showed that the corA 
strains survived at higher levels intracellularly compared to wild type strains. For 
example, the 11168 corA strain gave rise to an intracellular survival count of 4.5-logs 
whereas for the wild type this was 4-logs. In addition, for the 81116 wild type, the 
count was 3.3-logs as opposed to the corA strain which gave rise to 3.6-logs. In 
contrast, however, the count of recovered cells for the 11168H strain was higher in the 
wild type than that seen in the mutant. However, in light of the high standard 
deviation between these two sets of data, there was no statistieal difference of the 
intracellular survival between the mutants and the parental strains based on a two- 
tailed t test (P > 0.05). For the hyper-virulent control strain, which is 81-17 (Hofreuter 
et al., 2006), the count was also surprisingly lower than the rest of C. jejuni strains. 
This was not expected as the cell count for this strain should be higher than the rest of 
the strains. The E. coli strain used here as a non-invasive control gave rise as 
expected, to a low count of 2.2-log.
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Figure 4.25: Epithelial cell invasion by wild type (■) and corA (■) strains of C. jejuni. 
A histogram showing the average number of internalized baeteria per cell, which was 
the cell eount of reeovered bacteria, plated on BMHA with 20 mM MgCli 
supplementation. C. jejuni were allowed to invade Caco-2 epithelial eells for 3 hr 
before being washed and allowed to replieate for 2 hours in the presence of 
gentamicin. E. coli DH5-a and C. jejuni 81-176 strains were used as controls. 
Invasion assays are an average of at least live independent experiments. The cell 
invasion of three types of strains between the wild type and the parental strains was 
not significantly different based on a two-tailed / test {P > 0.05).
188
4.2.21 In vivo invasion assay
4.2.21.1 Galleria mellonella model
The Galleria mellonella system has been used previously as an effective 
virulence model (Jander et al., 2000; Cotter et al., 2000; Champion et al., 2010) and 
consequently this was used as an infeetion model to examine CorA and its role in the 
pathogenesis of C. jejuni. G. mellonella larvae were purchased from Live Foods (UK) 
and kept on wood chips at 15°C. The larvae were infected with 10 pi of 10 °^ cfu ml'  ^
C. jejuni using the micro-injection technique using a Hamilton® syringe to introduce 
the bacteria via the right foreleg. After incubation for 24 hours at 37°C, the 
macroscopic appearance of the larvae was recorded.
Infection with approximately 10^  colony-forming units (CFUs) of C. jejuni 
strain 11168 resulted in a 60% average survival rate at 24 hours after challenge 
(Fig.4.26). Similar doses of C. jejuni strain 11168H and 81116 resulted in average 
survival rates at 24 h of 78.3% and 68%, respectively. All of the uninfected control 
larvae or larvae challenged with PBS were alive at 24 hours. The mutants showed 
differing abilities to kill G. mellonella larvae. However, the larvae infected with any 
of the corA mutants showed higher survival than the wild type and gave rise to 
average survival rates of 95%, 98%, 85.71% with 11168 corA, 11168H corA and 
81116 corA respectively. The survival of the Galleria mellonella when infected with 
the wild type strain and the mutant strain was significantly different based on a two- 
tailed t test {P < 0.05). The higher survival rates seen when G. mellonella was infected 
with the corA mutants might indicate that the corA mutant is attenuated in its 
virulence capabilities. The
189
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Figure 4.26: The ability Campylobacter jejuni wild type and corA strains (10^ colony- 
forming units) to kill Galleria mellonella at 37°C. Results are expressed as percentage 
survival of G. mellonella larvae. Groups of 10 larvae were used, and the results shown 
are the means of at least 5 independent experiments recorded at 24 hours after 
ehallenge. Error bars indicate standard deviations. Statistical significance was tested 
using two-tailed t test {P < 0.05).
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simplest explanation for this affect would be that in the absence of CorA, the
organism cannot obtain sufficient intracellular Mg^^ for optimal growth and virulence.
All the infected larvae were also seen to have irregular bleeding and diarrhoea 
as compared to the healthy uninfected control larvae which only shed normal green 
faecal pellets. Table 4.3 summarizes the macroscopic appearance of the larvae, 
observations of the faecal pellets and diarrhoea, and the mean survival of infected and 
non-infected larvae and Figure 4.27 illustrates the macroseopic appearance of the 
larvae.
C. jejuni 
strains/control
Macro
colour
(0-3)
Number of 
Galleria
Diarrhoea or 
pellet
Mean
Galleria
survival
(%)
Control/uninfected 0 69/70 Normal 100
larvae faecal pellet
1 1/70
2 0/70
3 0/70
Control/PBS 0 69/70 Green/yellow 98.57
infected larvae pellets
1 0/70
2 0/70
3 1/70
11168 wild type 0 12/60 Diarrhoea, 60
some faecal
1 19/60 pellets.
2 29/60
3 0/60
11168 corA mutant 0 34/60 Diarrhoea 95
1 6/60
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23
20/60
0/60
11168H 0 20/50 Brown 86
diarrhoea all
1 7/50 over the
plates
2 20/50
3 3/50
11168H cofW 0 35/50 Brown 98
mutant diarrhoea all
1 3/50 over the
plates
2 12/50
3 0/50
81116 wild type 0 17/70 No faecal 68.57
pellet, brown
1 18/70 diarrhoea all
over the
2 33/70 plates
3 2/70
81116 corA mutant 0 25/70 Diarrhoea 85.71
but not as
1 18/70 much as wild
type. Maybe
2 26/70 dead.
3 1/70
Table 4.3:Maeroseopic evaluation of G. mellonella larvae following C. jejuni 
infection in terms of colour and presence of blood and diarrhoea. C. jejuni infected 
and uninfected larvae were incubated at 37°C. A score of 3 refers to fatality. Cream, 
score 0; beige score 1; dark beige to dark brown score 2; black score 3. Based on 5-7 
replicates of group (10 larvae per group).
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Figure 4.27: Appearance of groups of 10 Galleria mellonella larvae 24 h after 
injection with 10^  cfu of broth-grown C. jejuni wild type (A&C) and the corA mutant 
(B&D) as well the PBS infected control (F) and the non-infected control (E). Larvae 
were incubated at 37°C for 24 hours after challenge.
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4.2.21.2 Histopathology analysis of C. jejuni infected Galleria mellonella
For histopathology analysis, C. jejuni-mSecXtà and uninfected larvae were 
fixed by immersion in 10% (v/v) neutral buffered formalin for 3-7 days, and sent to 
AHVLA for analysis. Fig.4.28 illustrates Hematoxylin and Eosin (H&E) - stained 
sections of uninfected and infected larvae of both wild type and corA mutant of C. 
jejuni NCTC 11168, 11168H and 81116 strains. Bacterial colonies were observed in 
the haemocoel and sections of the gut lumina in infected larvae, but were absent in 
sections from PBS controls. The PBS infection control remained healthy with no 
bacteria observed.
Wild type and corA infected larvae showed evidence of damage to the midgut 
and loss of integrity to the gut wall in the infected larvae which was not presence in 
the control sections. Pigmented nodules were also present in the infected larvae, and 
bacteria might have an association with these nodules. These nodules were also not 
visible in the uninfected control larvae. Larvae showed lesions similar to those 
previously observed in other experiments with the same host model (Senior et al., 
2011).
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Figure 4.28: Hematoxylin and Eosin stained gut sections of G. mellonella 
(Magnification, X40). (A) Control larvae (0.1 M PBS inoculation). (B) Larva infected 
with C. jejuni 11168 (B-C) Larvae infected with C. jejuni 11168 corA mutant (D-E). 
Structures are annotated as follows: a, adipose bodies; b, bacterial colonies; c, cuticle; 
h, haemolymph; p, pigmented structures.
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4.2.21.3 Chicken colonisation assay
CorA might play a key role in adaptation to low-Mg^^ conditions, such as 
those found in the gut and consequently experiments were undertaken to determine 
the effects of inactivating the corA gene on chick colonisation. The chicks were 
colonised with the corA mutant and the parental strain and with and without 
magnesium supplementation of 50 mM (magnesium chloride) to assess whether any 
detrimental effect due to the corA mutation could be overcome.
The abilities of C. jejuni corA mutant and the parental strain to colonize 
chicken were compared. Both parental and corA strain appeared to colonize the 
chickens and all chickens appeared to be positive for C. jejuni. However, the bacterial 
count for the parental strain during the first 5 days of infection was 1 -log less than for 
the corA strain, with CPU g'  ^ of 10^  and 10^  for each strain, respectively (Fig.4.29a). 
After 14 days of incubation, the level of colonisation by corA strain in chickens given 
water supplemented with 50 mM MgCl] was 1-log lower than that without 
supplementation (Fig.4.29b). One outlier was identified, however, re-running the 
model without this observation did not change any of the coefficients.
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Figure 4.29: Variation in colonisation levels of C. jejuni NCTC 11168 and the corA 
mutant in the 1-day old model of colonisation. Mean values for the different flocks are 
marked with (-) and values for individual chickens within a flock are marked with 
( A) .  The different flocks are represented on the x-axis, and are infected with wild type 
( A )  and corA mutant ( A )  respectively. (A) Illustrates the colonisation of C. jejuni 
after 5 days post infection and (B) illustrates the colonisation after 14 days post 
infection.
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4.3 Discussion
A molecular biological approach was used to generate a mutant deficient in 
CorA, the main magnesium transporter of C. jejuni. CorA is a 37-kDa integral 
membrane protein that forms the primary constitutive Mg^ "^  uptake system in many 
bacteria and some Archaea (Moncrief & Maguire, 1999). Initially, PCR was 
performed to extract a corA gene fragment from C. jejuni NCTC 11168. The purified 
PCR product was then ligated into the T-cloning vector, pGEM®T-Easy (Promega) to 
generate pEMl. This plasmid was chemically transformed into E. coli and 
transformants selected on LB agar plates containing ampicillin. Plasmid DNA, 
isolated fi*om antibiotic resistant transformants, was found to contain a 1.3 kb insert, 
which corresponds to the size of the original corA PCR product. To construct corA- 
deficient mutants, the structural C. jejuni corA gene present in pEMl was disrupted by 
the insertion of a 1.6 kb BamHI kanamycin-resistance cassette into the unique Bglll 
site at position 252 within the corA gene.
To achieve the inactivation of corA, the plasmid pEM2, which carried a 
mutated corA gene with an inserted kanamycin fi*agment, was introduced into C. 
jejuni NCTC 11168, 11168H and 81116 by electroporation and natural
transformation. During the selection process, MH agar was supplemented with 20 mM 
Mg^  ^to avoid possible killing of corA mutants by Mg^ "^  depletion.
After PCR analysis revealed the correct insertion of the kanamycin cassette in
the corA gene, the phenotype of this mutant was further investigated. To examine the
phenotype of the kanamycin-resistant colonies, magnesium transport activity was
assessed using the qualitative plate assay with and without Mg supplementation. The
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c. jejuni corA mutant was grown on MH agar with and without 20 mM Mg^ "^  
supplementation to assess whether the mutant could grow without magnesium 
supplementation. The C. jejuni corA mutant only grew in the supplemented agar 
media, providing evidence that CorA is the major magnesium transporter in C. jejuni. 
This also indicates that transformants exhibited a corT-negative phenotype consistent 
with allelic exchange resulting from a double crossover recombinational event. 
During the selection process, some of the transformants appeared to be the corA- 
positive transformants (data not shown) which is likely caused if integration of pEM2 
had occurred via a single crossover which would regenerate an intact copy of the corA 
structural gene (Dickinson et al., 1995).
The inability of this strain to grow in media without Mg^ "^  supplementation 
demonstrates that CorA is essential for Mg^ "^  acquisition and most likely should be 
required for survival in low Mg^ "^  environments, such as the gut. Some 24-75% of the 
300 mg Mg^ "*" consumed daily in the human gut is absorbed by the human intestine 
which suggests that a relatively low concentration of Mg^^ exists in the intestine 
(Kayne & Lee, 1993). Under this condition, it seems very unlikely that the C. jejuni 
corA mutant would persist in the human or poultry gut for an extended period of time. 
The inability of the corA mutant to grow within the gut in the absence of magnesium 
supplementation may provide the basis of potential future attenuated vaccine strains.
The growth of the corA mutant was further assessed using concentrations 
lower than 20 mM MgC^. The growth assay revealed that even with the provision of 
5 mM and 10 mM MgCl], the growth of the corA mutant was still restricted and only 
the addition of 20 mM of Mg^^ could restore the growth to wild type levels. The
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complete growth deficiency in media without Mg^ "^  supplementation and the 
requirement for 20 mM magnesium supplementation displayed by corA mutants 
indicates that C. jejuni CorA is essential for Mg^^ acquisition and is required for 
growth in low Mg^  ^environments.
Mg^ '*' deficiency can induce oxidative damage in cells or tissues. One study by 
Yang et al., in 2006, used chick embryo hepatocyte cells exposed to various 
concentrations of Mg^ "^  and dimethylthiourea (an H2O2 scavenger), to assess whether 
the oxidative damage induced by low levels of Mg^^ is caused by the disrupted H2O2 
homeostasis. This study revealed that Mg deficiency induces H2O2 production and 
decreased catalase activity which eventually led to oxidative stress damage to the 
chick embryo hepatocytes (Yang et al., 2006).
Mg^ "^  also possesses protective characteristics in the context of cellular 
oxidative damage (Garcia et al., 1998, Cemak et al., 2000, Mak et al., 2000, Manuel 
& Keenoy et al., 2000, Maulik et al., 2001). Several studies have also characterized 
the association between increased oxidative stress responses and Mg deficiency, 
followed by an inflammatory response and subsequent tissue injury in mammalian 
cells (Freedman et al., 1991, Weglicki et al., 1996, Malpuech-Brugere et al., 2000). 
Oxidative damage in the heart, increased plasma levels of lipoproteins are enhanced 
by Mg deficiency and this can also impose oxidative damage on erythrocytes, 
endothelial and neuronal cells (Freedman et al., 1991, Dickens et al., 1992).
The sensitivity of the wild type strain and the corA mutant strain to MgÛ2 was 
investigated to assess whether CorA and thus magnesium transport was necessary for
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the bactericidal effect of this compound. Generally, the corA mutant did not exhibit a 
higher sensitivity towards Mg02 killing and thus CorA activity and magnesium 
transport do not play a role in Mg02 killing.
The enzyme lactoperoxidase (which is present in pasteurised skimmed milk 
but not UHT milk) (Al-Sallaqi, 2012), is a natural antimicrobial defence system that 
can oxidize different substrates, though primarily thiocyanate, using hydrogen 
peroxide, to generate bactericidal agents (Hirano et aL, 1998; Zapico et al., 1998). 
Both E. coli and S. Typhimurium corW mutants are hypersensitive to lactoperoxidase 
but not to direct hydrogen peroxide challenge or to superoxide generated by addition 
of plumbagin (Sermon et al., 2004, Sermon et al, 2005), so an experiment was 
performed to assess whether the C. jejuni corA mutant was similarly sensitive to 
lactoperoxidase. In pasteurized milk (with lactoperoxidase activity), but not in UHT 
milk (with no lactoperoxidase activity) the corA mutant was killed more quickly than 
the wild type suggesting that CorA provided some resistance to lactoperoxidase 
killing similar to what was seen in E. coli and Salmonella (Sermon et al., 2004, 
Sermon et al, 2005).
It has been reported in S. Typhimurium, that the addition of Ni^ "^  increases 
lactoperoxidase induced killing in the wild type, but not in a corA mutant (Papp- 
Wallace et al., 2008). Therefore, an experiment to assess whether Ni^^ could also 
increase lactoperoxidase induced killing in C. jejuni was carried out. Here, it was 
observed that both the wild type and the corA strain showed increased sensitivity to 
lactoperoxidase-induced killing as opposed to the situation in S. Typhimurium where
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nickel enhances killing of the wild type but not the corA mutant (Papp-Wallace et aL, 
2008).
Flagella have long been implicated as Campylobacter adhesins. Flagellum- 
independent motility and the flagellum itself also appear to be essential for C. jejuni 
invasion of epithelial cells, but the mechanism(s) remains unknown. Strain NCTC 
11168 is known to be less invasive than 11168H and 81-176, possibly due to the 
expression of reduced numbers of invasion-specific components or expression of 
surface factors that interfere with these. In this study, it was shown that motility was 
significantly reduced in a corA strain. In other studies by Papp-Wallace et al., in S. 
Typhimurium, the expression of flagellar genes such as fUB, fUN and fUM  are 
repressed in the corA mutant which leads to a lower halo of motility compared to the 
wild type strain (Papp-Wallace et al., 2008).
A standard method to determine the importance of a potential colonisation or 
virulence factor is to knockout a gene encoding a particular protein and then to test the 
mutant in a range of phenotypic assays including animal models. A way to investigate 
the contribution of CorA towards Campylobacter virulence would be to compare the 
survival of the wild type and the CorA deficient strain of C. jejuni in a series of in 
vivo and in vitro experiments. In S. Typhimurium, it has been reported that corA 
mutant strain is attenuated in mice after infection by oral gavage and intraperitoneal 
injection (Papp-Wallace et al., 2008).
Cultured mammalian cells have been developed and used extensively to 
investigate host cell-bacterial interaction in vitro. Human colonic carcinoma (Caco-2)
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cells were originally derived from transformed human colonic carcinoma cells and 
during 7 to 10 days in culture, these cells will form polarized monolayers with 
intercellular tight junctions with defined apical and basolateral surfaces (Pinto et aL, 
1983). The apical surface also has a dense brush border of microvilli containing 
typical intestinal brush border enzymes and antigens. Differentiated Caco-2 cells 
provide a substrate monolayer similar to which Campylobacter shows a natural 
tropism in vitro (Everest et aL, 1992; Baker & Graham, 2010). The Caco-2 cell line 
also allows assessment of the ability of C. jejuni to penetrate and pass through a 
differentiated intestinal cell barrier, a process that typically occurs in the infected 
intestine (Everest et aL, 1992; Szymanski et aL, 1995).
Cells were infected with wild type C. jejuni and the corA mutant and bacterial 
survival determined using the gentamicin protection assay. In this study it was 
observed that corA cells do not have a decreased ability to invade Caco-2 epithelial 
cells. Strain 81-176 has been used as the highly virulent control. However, the 
recovery of this strain showed an unexpectedly lower intracellular survival than the 
other C. jejuni wild type strains. This might be due to the variation in 81-176 
following subculture and so that in this case it did not show the hyper-virulent/hyper 
invasive characteristic. In a study which examined the role of CorA in the virulence 
of S. Typhimurium, a corA mutant strain showed a decreased ability to invade Caco-2 
cells by 40% compared to that of the wild type which indicates that, in contrast to 
what has been observed with Campylobacter here, CorA is required in S. 
Typhimurium invasion within Caco-2 cells (Papp-Wallace et aL, 2008).
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The advantages of using G. mellonella larvae as an infection model include the 
fact that it is commercially available as a live food for reptiles and amphibians, cheap, 
and the small size makes the larvae easy to handle and keep, and they can survive up 
to 3 weeks before pupating and do not require feeding. The model can also be used to 
screen large panels of C. jejuni isolates or mutants for pathogenesis screening studies. 
Champion et aL, in 2010, have previously demonstrated the use of G. mellonella 
larvae to screen for important virulence genes in Campylobacter (Champion et aL,
2010). Additionally, Senior et aL, in 2011, reported that this model could be used to 
provide important information on intracellular survival in C. jejuni (Senior et aL,
2011). In this study, almost all of the uninfected control larvae or larvae challenged 
with PBS were alive at 24 h, but the survival rate of larvae infected with C. jejuni was 
reduced compared to the control larvae. In addition, corA mutant was less efficient at 
killing the larvae and was attenuated compared with the wild type indicating that 
CorA may be an important virulence factor in this larvae model of infection.
Histopathology analysis of the C. jejuni infected larvae demonstrated that 
bacteria were found in the haemocoel region and in the gut. Tissue damage was also 
observed in the gut of the larvae. This might happen because the haemocytes that are 
present in the gut tissue that have ingested the bacteria in the haemocoel produce an 
immunological defense response such as the release of free radicals, as well as 
peroxides, which cause tissue damage in this area. Aggregations of these haemocytes 
will also produce pigmented nodules which also indicate an immune response to the 
infection (Lackie, 1980). Melanogenesis is the colour change that can be seen in the 
larvae and this product results from the circulation of bacteria in the body cavity of 
the larvae (Nappi & Christensen, 2005).
206
Campylobacter is common in the lower avian cecum where amino acids are 
abundant, and microbial biosynthesis occurs. C  jejuni is able to utilize anaerobic 
fermentation by-products from the gut such as small organic acids as carbon and 
energy sources (Kelly 2001, Leach et aL, 1997, Velayudhan et aL, 2004, Westfall et 
aL, 1986).
Understanding colonisation of the avian host is key to understanding the 
survival and replication of Campylobacter within the food chain. Campylobacter is 
known to be particularly well adapted for growth within the gut of chicken, this being 
its primary environmental reservoir. Thus, a chick (poultry) model is of direct 
relevance and the most appropriate for colonisation studies. By providing important 
information on the process of colonisation and the bacterial factors involved it may 
lead to the development of intervention strategies, such as vaccination or improved 
biosecurity designs.
Generally, C. jejuni colonizes the chicken gut as a commensal and colonized 
chickens carry a large number of bacterial cells, around 10  ^ to 10^  CFU/g of cecal 
content and as few as 35 CFU is sufficient for successful colonization within 2 hours 
after ingestion (Cawthraw et aL, 1996). However, due to the protection from maternal 
antibodies, most flocks only become colonized at the age of two to four weeks (Evans 
& Sayers, 2000).
The chicken colonisation assay was performed to determine the effect of 
mutating the corA gene on the colonisation potential of C. jejuni. The C. jejuni corA 
mutant was tested in a one-day chick model (Cawthraw et aL, 1996) at the AHVLA
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with the assistance of Dr. Shaun Cawthraw. In this test system, the C. jejuni CorA- 
mutant gave rise to a similar colonisation potential as did the parental strain after 5 
days post infection with a slight reduction in the survival of chicks in group 3 after 14 
days. This would appear to indicate that either CorA is not involved in colonisation of 
the chicken gastrointestinal tract, or if it is, that an alternative or compensatory 
mechanism exists in the mutant. Therefore, the results obtained with the one-day old 
chick model do not rule out a possible role for CorA in human campylobacteriosis.
There are microbiological and physiological differences between a day old 
chicken and a 14 day old chicken. Major physiological changes including changes in 
the gut flora and the nutritional status occur during the first two weeks after hatching. 
On the other hand, the gut flora of a 1 day old chick is still developing and does not 
reflect the complexity of the flora present in older birds. In addition, there is also 
evidence that the colonization of bacteria is less efficient in older birds due to the 
presence of adaptive immune system. After 2 weeks, the birds possess an established 
gut flora (Wassenaar et aL, 1993; Cawthraw et aL, 1996; Ringgoir & Korolik, 2002).
Although animal models as well as cultured cells have been used and 
developed to investigate the virulence factors of Campylobacter, they still do not 
mimic the human disease because the avian gut is a very different environment to the 
gastrointestinal tract of man and this factor should always be taken into consideration. 
In addition, Campylobacters do not cause disease in chickens and only live as 
commensal organisms.
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CHAPTER FIVE
General conclnsions and futnre
directions
CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
One aspect of this study aimed to investigate the potential and novel use of 
oxygen generating compounds (metal peroxides) as antimicrobial treatments that 
could reduce transmission of C. jejuni in the food chain or farm environment. The 
metal peroxides used in this study namely sodium percarbonate, and magnesium and 
calcium peroxide all demonstrated antimicrobial properties when tested in the 
laboratory in a range of microcosms such as the MRD, UHT skimmed milk and soil. 
Other food-borne pathogens, Salmonella Typhimurium and Listeria monocytogenes, 
as well as nosocomial pathogens such as Staphylococcus aureus and MRS A also 
exhibited sensitivity to the oxygen releasing compounds but generally killing was 
slower and required higher concentrations of the agents compared to Campylobacter. 
The hypersensitivity of Campylobacters to these agents was predicted and most likely 
is a reflection of their microaerophilic nature, and sensitivity to oxygen. Because of 
their powerful antimicrobial activities as measured in a variety of microcosms, the 
application of the oxygen liberating compounds in soil and the farm environment 
could be potentially used as the antibacterial treatment to reduce the occurrence of 
Campylobacter. Of the agents assessed in this study, sodium percarbonate is a 
powerfiil oxygen based bleach and might also cause damage and organoleptic changes 
to the products exposed to it, and is relatively expensive. Whilst it was effective 
against Campylobacters, these issues might limit its use as a commercial treatment. 
Similarly, calcium peroxide was the most effective bactericidal compound tested but 
it was shown to act via a combination of oxygen release and the generation of a highly 
alkaline pH, which again might limit its widespread use. For these reasons magnesium
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peroxide which had none of these drawbacks and which still possessed a potent anti- 
Campylobacter action might make the best commercial treatment.
However, demonstrating efficacy in laboratory trials is only the starting point 
in the process of using the oxygen releasing compounds as a potential antimicrobial 
treatment. There are a number of general practical considerations and additional 
important issues that need to be addressed before these compounds can be used. 
Efficacy will need to be assessed in field trials and risk assessment of the safety of 
treated products will be required.
The cell wall structure is generally the main target for the prevention and 
control of bacteria. This is due to the composition of the surface proteins in the cell 
wall of most pathogenic bacteria that will be important for adhesion, colonization, and 
several components that protect the bacterial against host defences and environmental 
conditions such as the polysaccharides and techoic acid (Navarre & Schneewind, 
1999). C. jejuni cells treated with the metal peroxides showed an irregular 
morphology of the cell wall, loss of their polar flagella and were converted to their 
coccoid form when observed under electron microscope. One of the hypotheses could 
be that the metal peroxides have exerted their antibacterial activities by oxidizing the 
components of the cell envelope of C. jejuni. However, further investigation is needed 
to elucidate the mode of action and to explore the interaction between the compounds 
and the bacterial cell membrane.
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In this study, plate counting was carried out to assess viability following 
exposure to oxygen releasing compounds. Other assays of bacterial viability exist and 
these could be used in future studies and might provide more information on whether 
treated cells had undergone the conversion into the viable but nonculturable state 
(VBNC). For example, a novel method which uses ethidium monoazide (EMA) in 
combination with real-time PCR to detect the VBNC cells could be used as an 
alternative assay of viability in peroxide treated cells of C. jejuni. This method was 
initially developed by Rudi et al. in 2005 to detect and differentiate between viable 
and dead cells of C. jejuni (Rudi et al., 2005). In this method, EMA only penetrates 
into injured or dead cells which have compromised cell membranes. Once inside cells, 
EMA binds to DNA molecules and photo-induced cross-linking of EMA to DNA is 
performed, which inhibits PCR amplification of the DNA from those cells. The 
amount of reduction in DNA amplification is then used for quantification of the 
proportion of viable and dead cells (Rudi et ah, 2005). Another alternative assay for 
viability that could be used in future studies is viability staining. One such technique 
is the LIVE/DEAD BaclÀ^X Bacterial Viability Assay (Molecular Probes, Eugene, 
OR). This staining protocol utilizes different fluorescent dyes to differentially stain 
both living and dead cells, so that they can be visualized under the fluorescent 
microscope. In this technique, SYTO 9, a green fluorescent nucleic acid stain stains 
all bacteria, and propidium iodide, a red fluorescent nucleic acid stain labels only 
bacteria with damaged membranes (Alonso et al., 2002).
The second aim of the work described in this thesis was to determine whether
the putative magnesium transporter CorA was necessary for magnesium peroxide
mediated killing and also to investigate whether CorA contributed to Campylobacter
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virulence using a molecular genetic approach. Following an analysis of the genome of 
C. jejuni strain NCTC 11168, CJ0726 was identified as a probable magnesium 
transport (Parkhill et aL, 2000). However, characterization of a mutant deficient in 
CJ0726 was required to establish whether this protein has the ability to transport 
magnesium into the cell. A corA mutation was generated in C. jejuni NCTC 11168 
initially, and then in 11168H and 81116. The generation of a corA mutant allowed a 
detailed assessment of how CorA affected magnesium homeostasis and virulence of 
this oxygen sensitive species.
Mg^^ homeostasis is poorly understood in many cell types, including bacterial, 
archaeal or eukaryotic. In bacteria, Mg^^ has been linked to virulence. In this study, a
C. jejuni CorA-deficient mutant was unable to grow in laboratory media without 
additional magnesium supplementation confirming the role of this protein in 
magnesium transport. Interestingly, the corA mutant was also less motile than the 
parental strain. In Salmonella Typhimurium, flagellar genes are repressed in corA 
mutant strain (eg: fljB,fHN  and jUM) resulting in decreased ability to swim compared 
to the wild type strain (Papp-Wallace et aL, 2008). In this regard, it would be worth 
further investigating whether the corA mutant cells expressed normal flagella perhaps 
initially by using the electron microscopy observations. In addition to this, the 
expression levels of flagella related proteins from the mutant and parental strains 
could be quantitatively compared by methods such as quantitative Western blotting 
analysis.
The contribution of CorA to Campylobacter virulence was also assessed using
a number of virulence assays. In the gentamycin protection assay for invasion and
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intracellular survival, using the Caco-2 cell line, both the wild type C. jejuni and the 
corA mutant were found to be invasive and to be able to survive intracellulary at the 
same level. This would appear to provide evidence for the fact that the CorA protein 
is not involved in the invasion of host intestinal cells or survival inside these cells. 
However, it does not rule out the involvement of CorA in some other aspect of 
virulence. Indeed, CorA was shown to be important for virulence when it was 
assessed in vivo using the Galleria mellonella insect larva model (Champion et aL, 
2010). In this study, the cor^-infected larvae showed a higher survival rate (10-40% 
higher) compared to the wild type, indicating that CorA might play a role in virulence 
towards Galleria killing.
When colonisation was measured in the one-day-old chick model, contrary to 
expectations, the corA mutant gave rise to a higher level of colonisation, compared to 
the wild type strain. C. jejuni may have evolved numerous strategies, including the 
presence of CorA activity, to maintain intracellular magnesium levels to defend 
themselves against the magnesium deficiency and it is possible that in the absence of 
CorA activity other transport activities compensate for this deficiency. Interestingly, 
the genome of strain NCTC 11168 contains genes encoding numerous 
uncharacterized putative transporters.
Future work could involve the complementation of the corA through insertion 
of the wild type gene on a plasmid and the introduction of this into the mutant strain 
and reversion to the wild type genotype. This would rule out the possibility that the 
magnesium deficiency seen in the corA mutant was due to polar effects on gene
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expression, although this seems very unlikely given the similarity with studies on 
CorA in other bacteria (Pfeifer et aL, 2002, Pap-Wallace et aL, 2008). In addition, 
using either reporter genes (Aim et aL, 1993; Miller et aL, 2000; Hendrixson & 
DiRita, 2003) or microaarays (Severgnini et aL, 2011; Trevors, 2011; Xue et aL,
2012), the expression of corA in response to magnesium concentration could be 
assessed with a future aim of identifying a possible regulatory protein. Any such 
regulatory protein could affect transcription by directly binding to the corA promoter 
or it could be involved in a more complex signalling network that results in 
transcription of corA. To assess whether the protein could directly regulate corA 
transcription by binding to the corA promoter, either ChlP or DNase footprinting 
assays could be conducted (Delany et aL, 2002; Gonzales et aL, 2007).
Finally, this study for the first time identifies CorA as the main magnesium 
transporter in C. jejuni and demonstrated that it plays a vital role in magnesium 
homeostasis. The most obvious role of the transporter may be to provide C  jejuni 
with magnesium for its cellular metabolism, enabling the organism to survive and 
grow in the host intestinal tract. This study also represents the first step in establishing 
the role of this protein in Campylobacter virulence.
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APPENDICES
All reagents and chemicals used were obtained from Sigma Aldrich (Poole, Dorset) 
unless otherwise stated.
A. Culture media
All culture media were obtained from Oxoid (Basingstoke) and prepared using 
distilled water. Sterilization was carried out by autoclaving at 121°C for 15 minutes at 
15 pounds per square inch (p.s.i). Blood and antibiotics were added to warm (50°C) 
media. The media plates were stored at 4°C.
Mueller-Hinton Agar
Mueller Hinton Agar 3 8g
Distilled Water 1 L
Nutrient Agar
Nutrient Agar 28g
Distilled Water 1 L
Mueller-Hinton Broth
Mueller Hinton Broth 21 g
Distilled Water 1 L
Nutrient Broth
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Nutrient Broth 25g
Distilled Water 1 L
Blood Mueller-Hinton Agar (BMHA) Plates with 5% (v/v) Blood 
Mueller-Hinton Agar Based 3 8g
Defibrinated sheep blood 50 ml
Distilled Water 950 ml
Maximum Recovery Diluent (MRD)
Bacteriological Peptone O.lg
Natrium chloride 0.85g
Distilled Water 100 ml
Luria-Bertani (LB) agar
Tryptone 2g
Yeast extract Ig
Sodium chloride 2g
Agar 3 g
Distilled water 200ml
LB Broth
Tryptone 2g
Yeast extract Ig
Sodium chloride 2g
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Distilled water 200ml
mCCDA
mCCDA agar base 22.75 g
Distilled water 500 ml
After sterilization, mCCDA supplement (Cat 6053) that has previously reconstituted 
in 2 ml distilled water was added to the warm (45-50°C) media.
DMEMIO
Dulbecco’s modified Eagle’s medium 440 ml
10% normal calf serum 50 ml
1% penicillin/streptomycin (Invitrogen) 5 ml
1% L-glutamine (Invitrogen) 5 ml
The media was filter-sterilized through a 0.22-pm filter.
Incomplete Media
Dulbecco’s modified Eagle’s medium 445 ml
10% normal calf serum 50 ml
1% L-glutamine (Invitrogen) 5 ml
The media was filter-sterilized through a 0.22-pm filter.
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B. Buffer
Potassium Phosphate Buffer IM (PPB) pH 6.0
1 M Dipotassium hydrogen phosphate (K2HPO4) 13.2 ml
1 M Potassium dihydrogen phosphate ( K H 2 P O 4 )  86.8 ml
The buffer was sterilised by using 0.22 pm Millex GP filter and pH measured
using the Orion model 410A pH meter.
Potassium phosphate buffer (PBS)
One tablet was dissolved in 200 ml of distilled water (0.01 M phosphate 
buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 7.4, at 
25°C) and filter sterilised with 0.22 pm filter.
lOX TBE Buffer
To make 1 liter of lOX TBE buffer, 108 g Tris Base, 55 g boric acid, 20 ml 
0.5M EDTA were added with distilled water and volume adjusted to 1 liter.
Tris-EDTA (TE) buffer
To make 50 ml volume, 0.5 ml Tris-HCL 10 mmol (pH 8) and 0.1 ml EDTA 
mmol (pH 8) was added to 49.4 ml distilled water.
C. jejuni wash buffer
9 g sucrose and 15 ml glycerol and distilled water added to make 100 ml.
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c . o th e r reagents and chemicals
0.010 M magnesium peroxide (MgOz); FW: 96.61 
MgO] 0.04g
1 M PPB Bring up to volume 40 ml
1 M sodium percarbonate (2Na2C03 .3H202); MW: 157.01 g/mol
2Na2C03.3H202 3.14 g
1 M PPB Bring up to volume 20 ml
1 M calcium chloride (CaCh); F.W: 147.02
CaCh 14.70 g
H2O Bring to volume 100 ml
5 M sodium cloride (NaCl); F.W: 58.44)
NaCl 146.1 g
H2O Bring to volume 500 ml
1 M nickel (II) chloride hexahydrate (NiCl2.6H20); MW 237.69108 g/mol
NiCl2.6H20 4.75 g
H2O Bring to volume 20 ml
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1 M iron (III) chloride hexahydrate (FeCI3.6H20); MW: 270.29568 g/mol
FeC13.6H20 5.40 g
H20 Bring to volume 20 ml
Hydrogen peroxide (H2O2); >30% w/v; FW: 34.01; 0.026 M 
H2O2 0.30 ml
Distilled water 99.70 ml
Catalase; 1340 unit/mg
Stock concentration of 50,000 units 
Catalase 37.3 mg
PBS 1 ml
Ammonium acetate 7.5 M
To make 10 ml volume, 5.78Ig ammonium acetate was added and made up to 
10 ml with sterile miliQ water and filter sterilised
Magnesium chloride 2M
To make 100 ml, 19 g magnesium chloride was added and made up to 100 ml 
with distilled water.
GES reagent
To make 100 ml volume, 60 g guanidium thiocyanate was weighed in fume 
hood and added to 20 ml EDTA and 20 ml sterile distilled water, mixed until
255
dissolved at 65°C. 5 ml 10% v/v Sarkosyl (N-laurolysarcosine) was added and 
made up to 100 ml with distilled water.
Chloroform and isoamylalcohol 24:1
To make 100 ml volume, 96 ml chloroform and 4 ml isoamylalcohol made up 
to 100 ml with distilled water.
1% agarose
To make 200 ml volume, 1 g agarose was weighed and added with 200 ml 
0.5XTBE.
5-bromo-4chloro-3-indolyl-B-D-galactosidase (X-Gal)
1 ml of dimethyl formamide was added with 0.04g X-Gal in fume hood.
1% Triton-X
Triton-X-100 1 ml
Distilled water 99 ml
D. Antibiotics
Ampicillin
To make 50mg/ml, O.lg ampicillin was added to 2 ml miliQ water and filter 
sterilised.
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Kanamycin
To make 50mg/ml, O.lg kanamycin was added to 2 ml miliQ water and filter 
sterilised.
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